Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature
Office of the Revisor of Statutes

HF 4757

3rd Engrossment - 93rd Legislature (2023 - 2024) Posted on 04/22/2024 08:02am

KEY: stricken = removed, old language.
underscored = added, new language.
Version List Authors and Status
Pdf Rtf

Current Version - 3rd Engrossment

Line numbers 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 1.23 1.24 1.25 1.26 1.27 1.28 1.29 1.30 1.31 1.32 1.33 1.34 1.35 1.36 1.37 1.38 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19
2.20 2.21 2.22 2.23 2.24 2.25 2.26 2.27 2.28 2.29 2.30 2.31 2.32 2.33 2.34 2.35 2.36 2.37 2.38 2.39 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 3.11 3.12 3.13 3.14 3.15 3.16 3.17 3.18 3.19 3.20 3.21 3.22 3.23 3.24 3.25 3.26 3.27 3.28 3.29 3.30 4.1 4.2 4.3 4.4 4.5
4.6 4.7 4.8 4.9 4.10 4.11 4.12 4.13 4.14 4.15 4.16 4.17 4.18 4.19 4.20 4.21 4.22 4.23 4.24
4.25 4.26 4.27 4.28 4.29 4.30 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 5.9 5.10 5.11 5.12 5.13 5.14 5.15 5.16 5.17 5.18 5.19 5.20 5.21 5.22 5.23 5.24 5.25 5.26 5.27 5.28 5.29 5.30 5.31 5.32 6.1 6.2 6.3 6.4 6.5 6.6 6.7
6.8
6.9 6.10 6.11 6.12 6.13 6.14 6.15 6.16 6.17 6.18
6.19
6.20 6.21 6.22 6.23 6.24 6.25 6.26 6.27 6.28 6.29 6.30 7.1 7.2 7.3 7.4 7.5 7.6 7.7 7.8 7.9 7.10 7.11 7.12 7.13 7.14 7.15 7.16 7.17 7.18 7.19 7.20 7.21 7.22 7.23 7.24 7.25 7.26 7.27 7.28 7.29
7.30
8.1 8.2 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.11 8.12 8.13 8.14 8.15 8.16 8.17 8.18 8.19 8.20 8.21 8.22 8.23 8.24 8.25 8.26 8.27 8.28 8.29 8.30 8.31
8.32
9.1 9.2 9.3 9.4 9.5 9.6 9.7 9.8 9.9 9.10 9.11 9.12 9.13 9.14 9.15 9.16 9.17 9.18 9.19 9.20 9.21 9.22 9.23 9.24 9.25 9.26 9.27 9.28 9.29 9.30 9.31 9.32 10.1 10.2 10.3 10.4 10.5 10.6 10.7 10.8 10.9 10.10 10.11 10.12 10.13 10.14 10.15 10.16 10.17 10.18 10.19 10.20 10.21 10.22
10.23
10.24 10.25 10.26 10.27 10.28 10.29 10.30 10.31 10.32 11.1 11.2 11.3 11.4 11.5 11.6 11.7 11.8 11.9
11.10
11.11 11.12 11.13 11.14 11.15 11.16 11.17 11.18 11.19 11.20 11.21 11.22 11.23 11.24 11.25 11.26 11.27 11.28 11.29 11.30 11.31 11.32 12.1 12.2 12.3 12.4 12.5 12.6 12.7 12.8 12.9 12.10 12.11 12.12 12.13 12.14 12.15 12.16
12.17
12.18 12.19 12.20 12.21 12.22 12.23 12.24 12.25 12.26 12.27 12.28 12.29 12.30 12.31 13.1 13.2 13.3 13.4 13.5 13.6 13.7 13.8
13.9
13.10 13.11 13.12 13.13 13.14 13.15 13.16 13.17 13.18 13.19
13.20
13.21 13.22 13.23 13.24 13.25 13.26 13.27 13.28 13.29 13.30 14.1 14.2 14.3 14.4 14.5 14.6 14.7 14.8 14.9 14.10 14.11 14.12 14.13 14.14 14.15 14.16 14.17 14.18 14.19 14.20 14.21 14.22 14.23 14.24 14.25 14.26 14.27 14.28
15.1
15.2 15.3 15.4 15.5
15.6
15.7 15.8 15.9 15.10 15.11 15.12 15.13 15.14 15.15 15.16 15.17 15.18 15.19 15.20 15.21
15.22
15.23 15.24 15.25 15.26 15.27 15.28 15.29 15.30
15.31
16.1 16.2 16.3 16.4 16.5 16.6 16.7 16.8 16.9 16.10 16.11 16.12 16.13 16.14 16.15 16.16 16.17 16.18 16.19 16.20 16.21 16.22 16.23 16.24 16.25 16.26 16.27 16.28 16.29 16.30 16.31 16.32 16.33 17.1 17.2 17.3 17.4 17.5 17.6 17.7 17.8 17.9 17.10 17.11 17.12 17.13 17.14
17.15
17.16 17.17 17.18 17.19 17.20 17.21 17.22 17.23 17.24 17.25 17.26 17.27 17.28 17.29 17.30 17.31 17.32 18.1 18.2 18.3 18.4 18.5 18.6 18.7 18.8 18.9 18.10 18.11 18.12
18.13
18.14 18.15 18.16 18.17 18.18 18.19 18.20 18.21 18.22 18.23
18.24
18.25 18.26 18.27 18.28 18.29 18.30 18.31 19.1 19.2 19.3 19.4 19.5 19.6 19.7 19.8 19.9 19.10 19.11 19.12 19.13
19.14
19.15 19.16 19.17 19.18 19.19 19.20 19.21 19.22 19.23 19.24 19.25 19.26 19.27 19.28 19.29 19.30 19.31 20.1 20.2 20.3 20.4 20.5 20.6 20.7 20.8 20.9 20.10 20.11 20.12 20.13 20.14 20.15 20.16 20.17 20.18
20.19
20.20 20.21 20.22 20.23 20.24 20.25 20.26 20.27 20.28 20.29 20.30 20.31 21.1 21.2 21.3 21.4 21.5 21.6 21.7 21.8 21.9 21.10 21.11 21.12 21.13 21.14 21.15 21.16 21.17 21.18 21.19 21.20
21.21
21.22 21.23 21.24 21.25 21.26 21.27 21.28 21.29
21.30
22.1 22.2 22.3 22.4 22.5 22.6 22.7 22.8 22.9 22.10 22.11 22.12 22.13 22.14 22.15 22.16 22.17 22.18 22.19 22.20 22.21 22.22 22.23 22.24 22.25 22.26 22.27 22.28 22.29 22.30 22.31 23.1 23.2 23.3 23.4 23.5 23.6 23.7 23.8 23.9 23.10 23.11 23.12 23.13 23.14 23.15 23.16 23.17 23.18 23.19 23.20 23.21 23.22 23.23 23.24 23.25
23.26
23.27 23.28 23.29 23.30 23.31 24.1 24.2 24.3 24.4 24.5 24.6 24.7
24.8
24.9 24.10 24.11 24.12 24.13
24.14 24.15 24.16 24.17 24.18 24.19 24.20
24.21 24.22 24.23 24.24 24.25 24.26 24.27 24.28 24.29 24.30 25.1 25.2 25.3 25.4 25.5 25.6
25.7 25.8 25.9 25.10 25.11 25.12 25.13 25.14 25.15 25.16 25.17 25.18 25.19 25.20
25.21 25.22 25.23 25.24 25.25 25.26 25.27 25.28 25.29 25.30 26.1 26.2 26.3 26.4 26.5 26.6 26.7 26.8 26.9 26.10 26.11 26.12 26.13 26.14 26.15 26.16 26.17 26.18 26.19 26.20 26.21 26.22 26.23 26.24
26.25 26.26 26.27 26.28 26.29
27.1 27.2 27.3 27.4 27.5 27.6 27.7 27.8 27.9 27.10 27.11 27.12 27.13 27.14 27.15 27.16 27.17 27.18
27.19 27.20 27.21 27.22 27.23
27.24 27.25 27.26 27.27 27.28 28.1 28.2
28.3 28.4 28.5 28.6
28.7 28.8 28.9 28.10 28.11 28.12 28.13 28.14 28.15 28.16 28.17 28.18 28.19 28.20 28.21 28.22 28.23 28.24 28.25 28.26
29.1 29.2 29.3 29.4 29.5 29.6 29.7 29.8 29.9 29.10 29.11 29.12 29.13 29.14 29.15 29.16 29.17 29.18 29.19 29.20 29.21 29.22 29.23 29.24 29.25 29.26 29.27 29.28 29.29 29.30 29.31 30.1 30.2 30.3 30.4 30.5 30.6 30.7 30.8 30.9 30.10 30.11
30.12 30.13 30.14 30.15 30.16 30.17 30.18 30.19 30.20 30.21 30.22 30.23 30.24 30.25 30.26 30.27 30.28 30.29 30.30 30.31 31.1 31.2 31.3
31.4 31.5 31.6 31.7 31.8 31.9 31.10 31.11 31.12
31.13 31.14 31.15 31.16 31.17 31.18 31.19 31.20 31.21 31.22 31.23 31.24 31.25 31.26 31.27 31.28 31.29 32.1 32.2 32.3 32.4 32.5 32.6 32.7 32.8 32.9 32.10 32.11 32.12 32.13 32.14 32.15 32.16 32.17 32.18 32.19 32.20
32.21
32.22 32.23 32.24 32.25 32.26 32.27 32.28 33.1 33.2 33.3 33.4 33.5 33.6
33.7 33.8 33.9 33.10 33.11 33.12 33.13 33.14 33.15 33.16
33.17 33.18 33.19 33.20 33.21 33.22
33.23 33.24 33.25 33.26 33.27
33.28 33.29 33.30 34.1 34.2 34.3 34.4 34.5 34.6 34.7 34.8 34.9 34.10 34.11 34.12 34.13 34.14 34.15 34.16 34.17 34.18 34.19 34.20 34.21 34.22 34.23 34.24 34.25 34.26 34.27 34.28 34.29 34.30 34.31 34.32 35.1 35.2 35.3 35.4 35.5 35.6 35.7 35.8 35.9 35.10 35.11 35.12 35.13 35.14 35.15 35.16 35.17 35.18 35.19 35.20 35.21 35.22 35.23 35.24 35.25 35.26 35.27 35.28 35.29 35.30 35.31 35.32 35.33 36.1 36.2
36.3 36.4 36.5 36.6 36.7 36.8 36.9 36.10 36.11 36.12 36.13 36.14 36.15 36.16 36.17 36.18 36.19 36.20 36.21 36.22 36.23 36.24 36.25 36.26 36.27 36.28 36.29 36.30
37.1 37.2 37.3 37.4 37.5 37.6 37.7 37.8 37.9 37.10 37.11 37.12 37.13 37.14 37.15 37.16 37.17 37.18
37.19 37.20 37.21 37.22 37.23 37.24 37.25 37.26 37.27 37.28 37.29 37.30 38.1 38.2 38.3 38.4 38.5 38.6 38.7 38.8 38.9 38.10 38.11 38.12 38.13 38.14 38.15 38.16 38.17 38.18 38.19 38.20 38.21 38.22 38.23 38.24 38.25 38.26 38.27 38.28 39.1 39.2 39.3 39.4 39.5 39.6 39.7 39.8 39.9 39.10 39.11 39.12 39.13 39.14 39.15 39.16 39.17 39.18 39.19 39.20 39.21 39.22 39.23 39.24 39.25 39.26 39.27
40.1 40.2 40.3 40.4 40.5 40.6 40.7 40.8 40.9 40.10 40.11 40.12 40.13 40.14
40.15 40.16 40.17 40.18 40.19 40.20 40.21 40.22 40.23 40.24 40.25 40.26 40.27 40.28 40.29 40.30 40.31 41.1 41.2 41.3 41.4 41.5 41.6 41.7 41.8 41.9 41.10 41.11 41.12 41.13 41.14 41.15 41.16 41.17 41.18 41.19 41.20 41.21 41.22 41.23 41.24 41.25 41.26 41.27 41.28 41.29 41.30 41.31 42.1 42.2 42.3 42.4
42.5 42.6 42.7 42.8 42.9 42.10 42.11 42.12 42.13 42.14 42.15 42.16 42.17 42.18 42.19 42.20 42.21 42.22 42.23 42.24 42.25 42.26 42.27 42.28 42.29 42.30 42.31 42.32 43.1 43.2
43.3 43.4 43.5 43.6 43.7 43.8 43.9
43.10 43.11 43.12 43.13 43.14 43.15 43.16 43.17 43.18 43.19 43.20 43.21 43.22 43.23 43.24 43.25 43.26 43.27 43.28
44.1 44.2 44.3 44.4 44.5 44.6 44.7 44.8 44.9 44.10 44.11 44.12 44.13 44.14 44.15 44.16 44.17 44.18 44.19 44.20 44.21 44.22 44.23 44.24 44.25 44.26 44.27 44.28 44.29 45.1 45.2 45.3 45.4 45.5 45.6 45.7 45.8 45.9 45.10 45.11 45.12 45.13 45.14 45.15 45.16 45.17 45.18 45.19 45.20 45.21 45.22 45.23 45.24 45.25 45.26 45.27 46.1 46.2 46.3 46.4 46.5 46.6 46.7 46.8 46.9 46.10 46.11 46.12 46.13 46.14 46.15 46.16 46.17
46.18 46.19 46.20 46.21 46.22 46.23 46.24 46.25 46.26 46.27 46.28 47.1 47.2 47.3 47.4 47.5 47.6 47.7 47.8 47.9 47.10 47.11 47.12 47.13 47.14 47.15 47.16 47.17 47.18 47.19 47.20 47.21
47.22 47.23 47.24 47.25 47.26 47.27 47.28 47.29 47.30 48.1 48.2 48.3 48.4 48.5 48.6 48.7 48.8 48.9 48.10 48.11 48.12 48.13 48.14 48.15 48.16 48.17 48.18 48.19 48.20 48.21 48.22 48.23 48.24 48.25 48.26 48.27 48.28 48.29 49.1 49.2 49.3 49.4 49.5 49.6 49.7 49.8 49.9 49.10 49.11 49.12 49.13 49.14 49.15 49.16 49.17 49.18 49.19 49.20 49.21 49.22 49.23 49.24 49.25 49.26 49.27 49.28 49.29 49.30 50.1 50.2 50.3 50.4 50.5 50.6 50.7 50.8 50.9 50.10 50.11 50.12 50.13 50.14 50.15 50.16 50.17 50.18 50.19 50.20 50.21 50.22 50.23 50.24 50.25 50.26 50.27 50.28 50.29 50.30 51.1 51.2 51.3 51.4 51.5 51.6 51.7 51.8 51.9 51.10 51.11 51.12 51.13 51.14 51.15 51.16 51.17 51.18 51.19 51.20 51.21 51.22 51.23 51.24 51.25 51.26 51.27 51.28 51.29 51.30 51.31 52.1 52.2 52.3 52.4 52.5 52.6 52.7 52.8 52.9 52.10 52.11 52.12 52.13 52.14 52.15 52.16 52.17 52.18 52.19 52.20 52.21 52.22 52.23 52.24 52.25 52.26 52.27 52.28
53.1 53.2 53.3 53.4 53.5 53.6 53.7 53.8 53.9 53.10 53.11 53.12 53.13 53.14 53.15 53.16 53.17 53.18 53.19 53.20 53.21 53.22 53.23 53.24 53.25 53.26 53.27 53.28 53.29 53.30 53.31 53.32 53.33 54.1 54.2 54.3 54.4 54.5 54.6 54.7 54.8 54.9 54.10 54.11 54.12 54.13 54.14 54.15 54.16 54.17 54.18 54.19 54.20 54.21 54.22 54.23 54.24 54.25 54.26 54.27 54.28 54.29 54.30 54.31 54.32 54.33 54.34 55.1 55.2
55.3 55.4 55.5 55.6 55.7 55.8 55.9 55.10 55.11 55.12 55.13 55.14 55.15 55.16 55.17 55.18 55.19 55.20 55.21 55.22 55.23 55.24 55.25 55.26 55.27 55.28 55.29 55.30 55.31 56.1 56.2 56.3 56.4 56.5 56.6 56.7 56.8 56.9 56.10 56.11 56.12 56.13 56.14 56.15 56.16 56.17 56.18 56.19 56.20 56.21 56.22 56.23 56.24 56.25 56.26 56.27 56.28 56.29 56.30 57.1 57.2 57.3 57.4 57.5 57.6 57.7 57.8 57.9 57.10 57.11 57.12 57.13 57.14 57.15 57.16 57.17 57.18 57.19 57.20 57.21 57.22 57.23 57.24 57.25 57.26
57.27 57.28 57.29 57.30 57.31 57.32 58.1 58.2 58.3 58.4
58.5 58.6 58.7 58.8 58.9 58.10 58.11 58.12 58.13 58.14 58.15 58.16 58.17 58.18 58.19 58.20 58.21 58.22 58.23 58.24 58.25
58.26 58.27 58.28 59.1 59.2 59.3 59.4 59.5 59.6 59.7 59.8 59.9 59.10 59.11 59.12 59.13 59.14 59.15 59.16 59.17 59.18 59.19 59.20 59.21 59.22 59.23 59.24 59.25 59.26 59.27
59.28 59.29 59.30 59.31 59.32 60.1 60.2 60.3
60.4 60.5 60.6 60.7 60.8 60.9 60.10 60.11 60.12
60.13 60.14 60.15 60.16 60.17 60.18 60.19 60.20 60.21 60.22 60.23 60.24 60.25 60.26 60.27 60.28 60.29 60.30 61.1 61.2 61.3 61.4 61.5 61.6 61.7 61.8 61.9 61.10 61.11 61.12 61.13 61.14 61.15 61.16 61.17 61.18 61.19
61.20 61.21 61.22 61.23 61.24 61.25 61.26 61.27 61.28 61.29 61.30 61.31 61.32 61.33 61.34 62.1 62.2 62.3 62.4 62.5 62.6 62.7 62.8 62.9 62.10 62.11 62.12 62.13 62.14 62.15 62.16 62.17 62.18 62.19 62.20 62.21 62.22 62.23 62.24 62.25 62.26 62.27 62.28 62.29 62.30 62.31 63.1 63.2 63.3 63.4 63.5 63.6 63.7 63.8 63.9 63.10 63.11 63.12 63.13
63.14 63.15 63.16 63.17 63.18 63.19 63.20 63.21 63.22 63.23 63.24 63.25 63.26 63.27 63.28 63.29 63.30 63.31 63.32
64.1 64.2 64.3 64.4 64.5 64.6 64.7 64.8 64.9 64.10 64.11 64.12 64.13 64.14 64.15 64.16 64.17 64.18 64.19 64.20 64.21 64.22 64.23 64.24 64.25 64.26 64.27 64.28 64.29 64.30 64.31 64.32 64.33 65.1 65.2 65.3 65.4 65.5 65.6 65.7 65.8 65.9 65.10 65.11 65.12 65.13 65.14 65.15 65.16 65.17 65.18 65.19 65.20 65.21
65.22 65.23 65.24 65.25 65.26 65.27 65.28 65.29 65.30 65.31 65.32 66.1 66.2 66.3 66.4 66.5 66.6 66.7 66.8 66.9 66.10 66.11 66.12 66.13 66.14 66.15 66.16 66.17 66.18 66.19 66.20 66.21 66.22 66.23 66.24 66.25 66.26 66.27 66.28 66.29 66.30 66.31 66.32 67.1 67.2 67.3 67.4 67.5 67.6 67.7 67.8 67.9 67.10 67.11 67.12 67.13 67.14 67.15 67.16 67.17 67.18 67.19 67.20 67.21 67.22 67.23 67.24 67.25 67.26 67.27 67.28 67.29 67.30 67.31 67.32 67.33 67.34 68.1 68.2 68.3 68.4 68.5 68.6
68.7 68.8 68.9 68.10 68.11 68.12 68.13 68.14 68.15 68.16 68.17 68.18 68.19 68.20
68.21 68.22 68.23 68.24 68.25 68.26 68.27 68.28 68.29 68.30 68.31 69.1 69.2 69.3 69.4 69.5 69.6 69.7
69.8 69.9 69.10 69.11 69.12 69.13 69.14 69.15 69.16 69.17
69.18 69.19 69.20 69.21 69.22 69.23 69.24 69.25 69.26 69.27 69.28 69.29 69.30 69.31 69.32 69.33 70.1 70.2 70.3 70.4 70.5 70.6 70.7 70.8 70.9 70.10
70.11 70.12 70.13 70.14 70.15 70.16 70.17 70.18 70.19 70.20
70.21 70.22 70.23 70.24 70.25 70.26 70.27 70.28 70.29 70.30 70.31
71.1 71.2 71.3 71.4 71.5 71.6 71.7 71.8 71.9 71.10
71.11 71.12 71.13 71.14 71.15 71.16 71.17 71.18 71.19 71.20 71.21 71.22 71.23 71.24 71.25 71.26
71.27 71.28 71.29 71.30 71.31 71.32 72.1 72.2 72.3 72.4 72.5 72.6 72.7 72.8 72.9 72.10
72.11 72.12 72.13 72.14 72.15 72.16 72.17 72.18 72.19 72.20 72.21 72.22 72.23 72.24
72.25 72.26 72.27 72.28 72.29 72.30 72.31 72.32 73.1 73.2 73.3 73.4 73.5
73.6 73.7 73.8 73.9 73.10 73.11 73.12 73.13 73.14 73.15
73.16 73.17 73.18 73.19 73.20 73.21 73.22 73.23 73.24 73.25 73.26 73.27 73.28 73.29 73.30 73.31 74.1 74.2 74.3 74.4 74.5 74.6 74.7 74.8 74.9 74.10 74.11 74.12 74.13 74.14 74.15 74.16 74.17 74.18 74.19 74.20 74.21 74.22 74.23 74.24 74.25 74.26 74.27 74.28 74.29 74.30 74.31 74.32 75.1 75.2 75.3 75.4 75.5
75.6 75.7 75.8 75.9 75.10 75.11 75.12 75.13 75.14 75.15 75.16 75.17 75.18 75.19 75.20
75.21 75.22 75.23 75.24 75.25 75.26 75.27 75.28 75.29 75.30 76.1 76.2 76.3 76.4 76.5 76.6 76.7 76.8 76.9 76.10 76.11 76.12 76.13 76.14 76.15 76.16 76.17 76.18 76.19 76.20 76.21 76.22 76.23 76.24 76.25 76.26
76.27 76.28 76.29
77.1 77.2 77.3 77.4 77.5 77.6 77.7 77.8 77.9 77.10 77.11 77.12 77.13 77.14 77.15 77.16 77.17 77.18 77.19 77.20 77.21 77.22 77.23 77.24 77.25 77.26 77.27 77.28 77.29 78.1 78.2 78.3 78.4 78.5 78.6 78.7 78.8 78.9 78.10 78.11 78.12 78.13 78.14 78.15 78.16 78.17 78.18 78.19 78.20 78.21 78.22 78.23 78.24 78.25 78.26 78.27 78.28 78.29 78.30 78.31 78.32 79.1 79.2 79.3 79.4 79.5 79.6 79.7 79.8 79.9 79.10 79.11 79.12 79.13 79.14 79.15 79.16 79.17 79.18 79.19 79.20 79.21 79.22 79.23 79.24 79.25 79.26 79.27 79.28 79.29 79.30 79.31 79.32 80.1 80.2 80.3 80.4 80.5 80.6 80.7 80.8 80.9 80.10 80.11 80.12 80.13 80.14 80.15 80.16 80.17 80.18 80.19 80.20 80.21 80.22 80.23 80.24 80.25 80.26 80.27 80.28 80.29 80.30 80.31 80.32 81.1 81.2 81.3 81.4 81.5 81.6 81.7 81.8 81.9 81.10 81.11 81.12 81.13 81.14 81.15 81.16
81.17
81.18 81.19 81.20 81.21 81.22 81.23 81.24 81.25 81.26 81.27 81.28 81.29 81.30 81.31 82.1 82.2 82.3 82.4 82.5 82.6 82.7 82.8 82.9 82.10 82.11 82.12 82.13 82.14 82.15 82.16 82.17 82.18 82.19 82.20 82.21 82.22 82.23 82.24 82.25 82.26 82.27 82.28 82.29 82.30 82.31 82.32
83.1 83.2 83.3 83.4 83.5 83.6 83.7 83.8 83.9 83.10
83.11 83.12 83.13 83.14
83.15
83.16 83.17 83.18 83.19 83.20 83.21 83.22 83.23 83.24 83.25 83.26 83.27 83.28 83.29 83.30 84.1 84.2 84.3 84.4 84.5 84.6 84.7 84.8 84.9 84.10 84.11 84.12 84.13 84.14 84.15 84.16 84.17 84.18 84.19 84.20 84.21 84.22 84.23 84.24
84.25
84.26 84.27 84.28 84.29 84.30 84.31 84.32 84.33 85.1 85.2 85.3 85.4 85.5 85.6 85.7
85.8
85.9 85.10 85.11 85.12 85.13 85.14 85.15 85.16 85.17 85.18 85.19 85.20 85.21 85.22 85.23 85.24 85.25 85.26 85.27 85.28 85.29 85.30 85.31 86.1 86.2 86.3 86.4 86.5 86.6 86.7 86.8 86.9 86.10 86.11 86.12 86.13 86.14
86.15
86.16 86.17 86.18 86.19 86.20 86.21 86.22 86.23 86.24 86.25 86.26 86.27 86.28
86.29
87.1 87.2 87.3 87.4 87.5 87.6 87.7 87.8 87.9 87.10 87.11 87.12 87.13 87.14 87.15 87.16 87.17 87.18 87.19 87.20 87.21 87.22 87.23 87.24 87.25 87.26 87.27 87.28 87.29 87.30 87.31 87.32 87.33 88.1 88.2
88.3
88.4 88.5 88.6 88.7 88.8 88.9
88.10
88.11 88.12 88.13 88.14 88.15 88.16 88.17 88.18 88.19 88.20 88.21 88.22 88.23 88.24 88.25 88.26 88.27
88.28
89.1 89.2 89.3 89.4 89.5 89.6 89.7 89.8 89.9 89.10 89.11 89.12 89.13 89.14 89.15 89.16 89.17 89.18 89.19 89.20 89.21 89.22 89.23 89.24 89.25 89.26 89.27 89.28 89.29 89.30 89.31 89.32 90.1 90.2 90.3 90.4 90.5 90.6 90.7 90.8 90.9 90.10 90.11 90.12 90.13 90.14 90.15 90.16 90.17 90.18 90.19 90.20 90.21 90.22 90.23 90.24 90.25
90.26
90.27 90.28 90.29 90.30 90.31 90.32 90.33 91.1 91.2 91.3 91.4 91.5 91.6 91.7 91.8 91.9 91.10
91.11
91.12 91.13 91.14 91.15 91.16 91.17 91.18 91.19 91.20 91.21 91.22 91.23 91.24 91.25 91.26 91.27
91.28
92.1 92.2 92.3 92.4 92.5 92.6 92.7 92.8 92.9 92.10 92.11 92.12 92.13 92.14 92.15 92.16 92.17 92.18 92.19 92.20 92.21 92.22 92.23 92.24 92.25 92.26 92.27
92.28
93.1 93.2 93.3 93.4 93.5 93.6 93.7 93.8 93.9 93.10 93.11 93.12 93.13 93.14 93.15 93.16 93.17 93.18 93.19 93.20 93.21 93.22 93.23 93.24 93.25 93.26 93.27 93.28 93.29 93.30 93.31 93.32 93.33 93.34 94.1 94.2 94.3 94.4 94.5 94.6 94.7 94.8 94.9 94.10 94.11
94.12
94.13 94.14 94.15 94.16 94.17 94.18 94.19 94.20 94.21 94.22
94.23
94.24 94.25 94.26 94.27 94.28 94.29 94.30 94.31 95.1 95.2 95.3 95.4 95.5 95.6 95.7 95.8 95.9 95.10 95.11 95.12 95.13 95.14 95.15 95.16 95.17 95.18 95.19 95.20 95.21 95.22 95.23 95.24 95.25 95.26 95.27 95.28 95.29 95.30 95.31 95.32 95.33 96.1 96.2 96.3 96.4 96.5 96.6 96.7 96.8 96.9
96.10
96.11 96.12 96.13 96.14 96.15 96.16 96.17
96.18
96.19 96.20 96.21 96.22 96.23 96.24 96.25 96.26 96.27 96.28
96.29
97.1 97.2 97.3 97.4 97.5 97.6 97.7 97.8 97.9 97.10 97.11 97.12 97.13 97.14 97.15 97.16 97.17 97.18 97.19 97.20
97.21 97.22 97.23 97.24 97.25 97.26 97.27 97.28 97.29 97.30 97.31 97.32 97.33 98.1 98.2 98.3 98.4 98.5 98.6 98.7 98.8 98.9 98.10 98.11 98.12 98.13 98.14 98.15 98.16
98.17 98.18 98.19 98.20 98.21 98.22 98.23 98.24 98.25 98.26 98.27 98.28 98.29 98.30 98.31 98.32 98.33 98.34 99.1 99.2 99.3 99.4 99.5 99.6 99.7 99.8 99.9 99.10 99.11
99.12 99.13 99.14 99.15 99.16
99.17 99.18 99.19 99.20 99.21 99.22 99.23 99.24 99.25 99.26 99.27 99.28 99.29 99.30 99.31 99.32 100.1 100.2 100.3 100.4 100.5 100.6 100.7 100.8
100.9 100.10 100.11 100.12 100.13 100.14 100.15 100.16 100.17 100.18 100.19 100.20 100.21 100.22 100.23 100.24 100.25 100.26 100.27 100.28 100.29 100.30 100.31 100.32 101.1 101.2 101.3 101.4 101.5 101.6 101.7 101.8 101.9 101.10 101.11 101.12 101.13 101.14 101.15 101.16 101.17 101.18 101.19 101.20 101.21 101.22 101.23 101.24 101.25 101.26
102.1 102.2 102.3 102.4 102.5 102.6 102.7 102.8 102.9 102.10 102.11 102.12 102.13 102.14 102.15 102.16 102.17 102.18 102.19 102.20 102.21 102.22 102.23 102.24 102.25 102.26 102.27 102.28 102.29 102.30
103.1 103.2 103.3 103.4 103.5 103.6 103.7 103.8 103.9 103.10 103.11 103.12 103.13 103.14 103.15 103.16 103.17 103.18 103.19 103.20 103.21
103.22 103.23 103.24 103.25 103.26 103.27 103.28 103.29 103.30 104.1 104.2 104.3 104.4 104.5 104.6 104.7 104.8 104.9 104.10 104.11 104.12 104.13 104.14 104.15 104.16 104.17 104.18 104.19 104.20 104.21
104.22 104.23 104.24 104.25 104.26 104.27 104.28 104.29 104.30 105.1 105.2 105.3 105.4 105.5 105.6
105.7 105.8
105.9 105.10
105.11 105.12
105.13
105.14 105.15
105.16 105.17
105.18 105.19
105.20
105.21 105.22
105.23
105.24 105.25
105.26
106.1 106.2
106.3
106.4 106.5
106.6
106.7 106.8
106.9
106.10 106.11
106.12
106.13 106.14
106.15
106.16 106.17
106.18
106.19 106.20
106.21 106.22
106.23 106.24 106.25 106.26 107.1 107.2 107.3 107.4 107.5 107.6 107.7 107.8 107.9 107.10 107.11 107.12 107.13 107.14 107.15 107.16 107.17 107.18 107.19 107.20 107.21
107.22
107.23 107.24 107.25 107.26 107.27 107.28 107.29 107.30
107.31
108.1 108.2 108.3 108.4 108.5 108.6 108.7 108.8 108.9 108.10 108.11 108.12 108.13 108.14 108.15 108.16 108.17 108.18 108.19 108.20 108.21 108.22 108.23 108.24 108.25 108.26 108.27 108.28 108.29 108.30 108.31 108.32 108.33 108.34 108.35 109.1 109.2 109.3
109.4 109.5 109.6 109.7 109.8 109.9 109.10
109.11 109.12
109.13 109.14

A bill for an act
 relating to cannabis; transferring enforcement of edible cannabinoid products to
the Office of Cannabis Management; clarifying workplace testing for cannabis;
making technical changes related to the taxation of cannabis and related products;
replacing medical cannabis licenses with endorsements; establishing a petition
process to designate cannabinoids as nonintoxicating or approved for use in
lower-potency hemp edibles; authorizing lower-potency hemp edibles to contain
certain artificially derived cannabinoids created in making delta-9
tetrahydrocannabinol; allowing testing of certain hemp products to be performed
by labs meeting accreditation standards regardless of licensing status; authorizing
patients enrolled in the registry program to obtain cannabis flower from registered
designated caregivers; authorizing registered designated caregivers to cultivate
cannabis plants on behalf of patients enrolled in the registry program; authorizing
the Office of Cannabis Management to recall certain cannabis and related products;
transferring the duties of the medical cannabis program to the Office of Cannabis
Management on July 1, 2025; authorizing the appointment of deputy directors;
clarifying the process for transfer of certain licenses; providing for license
preapproval; removing the requirement that local governments perform certain
inspections; removing the requirement that license applications be scored based
on identified criteria and requiring that license applications be assessed based on
certain minimum criteria; requiring employees of cannabis businesses to meet
certain background check requirements; establishing social equity licenses; limiting
the number of certain licenses that can be made available in an application period;
providing for the conversion of a registration to sell certain hemp-derived products
into a hemp business license; providing for a cannabis research license
classification; authorizing the Office of Cannabis Management to adjust limits on
cultivation area; permitting certain businesses to transport cannabis and related
products between facilities operated by the business; replacing the prohibition on
certain sales of lower-potency hemp products with a prohibition on selling to an
obviously intoxicated person; providing for enforcement of unlicensed businesses
engaging in activities that require a license; making technical and conforming
changes; amending Minnesota Statutes 2022, sections 17.133, subdivision 1;
152.22, subdivisions 11, 14, by adding a subdivision; 152.25, subdivision 2; 152.27,
subdivisions 1, 2, 3, 4, 6, by adding a subdivision; 152.28, subdivision 2; 152.29,
subdivision 3; 181.950, subdivision 10; 181.952, as amended; Minnesota Statutes
2023 Supplement, sections 3.9224, subdivision 1; 151.72, subdivisions 1, 2, 3, 4,
5a, 5b, 6, 7; 152.28, subdivision 1; 152.30; 181.951, subdivisions 4, 5, 8; 181.954,
subdivision 1; 342.01, subdivisions 14, 17, 19, 48, 50, 52, 54, 63, 64, 65, 66, by
adding subdivisions; 342.02, subdivisions 2, 3, 6; 342.03, subdivisions 1, 4; 342.06;
342.07, subdivision 3; 342.09, subdivision 3; 342.10; 342.11; 342.12; 342.13;
342.14; 342.15, by adding a subdivision; 342.17; 342.18, subdivisions 2, 3, by
adding subdivisions; 342.19, by adding a subdivision; 342.22; 342.24, subdivisions
1, 2; 342.28, subdivision 2, by adding subdivisions; 342.29, subdivision 4, by
adding a subdivision; 342.30, subdivision 4; 342.31, subdivision 4; 342.32,
subdivision 4; 342.35, subdivision 1; 342.37, subdivision 1; 342.40, subdivision
7; 342.41, subdivision 3; 342.46, subdivision 8; 342.51; 342.515, subdivision 1,
by adding a subdivision; 342.52, subdivisions 1, 2, 3, 4, 5, 9, 11; 342.53; 342.54;
342.55, subdivisions 1, 2; 342.56, subdivisions 1, 2; 342.57, subdivisions 1, 2, 4;
342.60; 342.61, subdivisions 1, 4, 5; 342.62, by adding a subdivision; 342.63,
subdivisions 2, 3, 6; 342.64, subdivision 1; 342.73, subdivision 4; 342.80; Laws
2023, chapter 63, article 1, sections 2; 51; 52; 53; 54; 55; 56; 57; 58; 59; 61; article
6, sections 10; 73; proposing coding for new law in Minnesota Statutes, chapter
342; repealing Minnesota Statutes 2022, sections 152.22, subdivision 3; 152.36;
Minnesota Statutes 2023 Supplement, sections 342.01, subdivision 28; 342.18,
subdivision 1; 342.27, subdivision 13; 342.29, subdivision 9; 342.47; 342.48;
342.49; 342.50; Laws 2023, chapter 63, article 7, sections 4; 6.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

Minnesota Statutes 2023 Supplement, section 3.9224, subdivision 1, is amended
to read:


Subdivision 1.

Definitions.

(a) As used in this section, the following terms have the
meanings given.

(b) "Medical cannabis law" or "medical cannabis program" means the regulatory
framework for cultivation, production, distribution, and sale of cannabis to qualifying
patients for therapeutic use in the treatment of a qualifying condition.

(c) "Medical cannabis flower" means cannabis flower approved for sale under the medical
cannabis law of a Minnesota Tribal government or under a compact entered into under this
section.

(d) "Medical cannabis product" means a cannabis product approved for sale under the
medical cannabis law of a Minnesota Tribal government or under a compact entered into
under this section.

(e) "Medical cannabis business" means a deleted text begin medicaldeleted text end cannabis deleted text begin cultivator, processor, or
retailerdeleted text end new text begin business with a medical cannabis endorsementnew text end .

(f) "Medical cannabis industry" means every item, product, person, process, action,
business, or other thing or activity related to medical cannabis flower or medical cannabis
products and subject to regulation under the law of a Minnesota Tribal government or under
a compact entered into under this section.

(g) "Cannabis product" means any of the following:

(1) cannabis concentrate;

(2) a product infused with cannabinoids, whether artificially derived, or extracted or
derived from cannabis plants or cannabis flower, including but not limited to
tetrahydrocannabinol; or

(3) any other product that contains cannabis concentrate.

(h) "Minnesota Tribal governments" means the following federally recognized Indian
Tribes located in Minnesota:

(1) Bois Forte Band;

(2) Fond Du Lac Band;

(3) Grand Portage Band;

(4) Leech Lake Band;

(5) Mille Lacs Band;

(6) White Earth Band;

(7) Red Lake Nation;

(8) Lower Sioux Indian Community;

(9) Prairie Island Indian Community;

(10) Shakopee Mdewakanton Sioux Community; and

(11) Upper Sioux Indian Community.

(i) "Tribal medical cannabis business" means a medical cannabis business licensed by
a Minnesota Tribal government, including the business categories identified in paragraph
(e), as well as any others that may be provided under the law of a Minnesota Tribal
government.

(j) "Tribally regulated land" means:

(1) all land held in trust by the United States for the benefit of a Minnesota Tribal
government ("trust land");

(2) all land held by a Minnesota Tribal government in restricted fee status; and

(3) all land within the exterior boundaries of the reservation of a Minnesota Tribal
government that is subject to the civil regulatory jurisdiction of the Tribal government. For
the purposes of this section, land that is subject to the civil regulatory jurisdiction of the
Tribal government includes:

(i) trust land, or fee land held, including leased land, by the Tribe, entities organized
under Tribal law, or individual Indians; and

(ii) land held, including leased land, by non-Indian entities or individuals who consent
to the civil regulation of the Tribal government or are otherwise subject to such regulation
under federal law.

Sec. 2.

Minnesota Statutes 2022, section 17.133, subdivision 1, is amended to read:


Subdivision 1.

Definitions.

(a) For purposes of this section, the following terms have
the meanings given.

(b) "Eligible farmer" means an individual who at the time that the grant is awarded:

(1) is a resident of Minnesota who intends to acquire farmland located within the state
and provide the majority of the day-to-day physical labor and management of the farm;

(2) grosses no more than $250,000 per year from the sale of farm products; and

(3) has not, and whose spouse has not, at any time had a direct or indirect ownership
interest in farmland.

new text begin (c) "Emerging farmer" means a farmer experiencing limited land access or limited market
access.
 new text end

deleted text begin (c)deleted text end new text begin (d)new text end "Farm down payment" means an initial, partial payment required by a lender or
seller to purchase farmland.

new text begin (e) "Limited land access" means farming (1) under a lease or other rental arrangement
of no more than three years in duration when the person leasing or renting the land to the
farmer is not related to the farmer by blood or marriage, or (2) by renting land from an
incubator farm.
 new text end

new text begin (f) "Limited market access" means the majority of a farmer's annual farm product sales
are direct sales to the consumer.
 new text end

Sec. 3.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 1, is amended
to read:


Subdivision 1.

Definitions.

For the purposes of this section, the following terms have
the meanings given.

(a) "Artificially derived cannabinoid" means a cannabinoid extracted from a hemp plant
or hemp plant parts with a chemical makeup that is changed after extraction to create a
different cannabinoid or other chemical compound by applying a catalyst other than heat
or light. Artificially derived cannabinoid includes but is not limited to any
tetrahydrocannabinol created from cannabidiol.

(b) "Batch" means a specific quantity of a specific product containing cannabinoids
derived from hemp, including an edible cannabinoid product, that is manufactured at the
same time and using the same methods, equipment, and ingredients that is uniform and
intended to meet specifications for identity, strength, purity, and composition, and that is
manufactured, packaged, and labeled according to a single batch production record executed
and documented.

(c) "Certified hemp" means hemp plants that have been tested and found to meet the
requirements of chapter 18K and the rules adopted thereunder.

deleted text begin (d) "Commissioner" means the commissioner of health.
 deleted text end

deleted text begin (e)deleted text end new text begin (d)new text end "Distributor" means a person who sells, arranges a sale, or delivers a product
containing cannabinoids derived from hemp, including an edible cannabinoid product, that
the person did not manufacture to a retail establishment for sale to consumers. Distributor
does not include a common carrier used only to complete delivery to a retailer.

deleted text begin (f)deleted text end new text begin (e)new text end "Edible cannabinoid product" means any product that is intended to be eaten or
consumed as a beverage by humans, contains a cannabinoid in combination with food
ingredients, and is not a drug.

deleted text begin (g)deleted text end new text begin (f)new text end "Hemp" has the meaning given to "industrial hemp" in section 18K.02, subdivision
3.

deleted text begin (h)deleted text end new text begin (g)new text end "Label" has the meaning given in section 151.01, subdivision 18.

deleted text begin (i)deleted text end new text begin (h)new text end "Labeling" means all labels and other written, printed, or graphic matter that are:

(1) affixed to the immediate container in which a product regulated under this section
is sold;

(2) provided, in any manner, with the immediate container, including but not limited to
outer containers, wrappers, package inserts, brochures, or pamphlets; or

(3) provided on that portion of a manufacturer's website that is linked by a scannable
barcode or matrix barcode.

deleted text begin (j)deleted text end new text begin (i)new text end "Matrix barcode" means a code that stores data in a two-dimensional array of
geometrically shaped dark and light cells capable of being read by the camera on a
smartphone or other mobile device.

deleted text begin (k)deleted text end new text begin (j)new text end "Nonintoxicating cannabinoid" means substances extracted from certified hemp
plants that do not produce intoxicating effects when consumed by any route of administration.

new text begin (k) "Office" means the Office of Cannabis Management.
 new text end

(l) "Synthetic cannabinoid" means a substance with a similar chemical structure and
pharmacological activity to a cannabinoid, but which is not extracted or derived from hemp
plants, or hemp plant parts and is instead created or produced by chemical or biochemical
synthesis.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 4.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 2, is amended
to read:


Subd. 2.

Scope.

(a) This section applies to the sale of any product that contains
cannabinoids extracted from hemp and that is an edible cannabinoid product or is intended
for human or animal consumption by any route of administration.

(b) This section does not apply to any product dispensed by a registered medical cannabis
manufacturer pursuant to sections 152.22 to 152.37.

(c) The deleted text begin commissionerdeleted text end new text begin officenew text end must have no authority over food products, as defined in
section 34A.01, subdivision 4, that do not contain cannabinoids extracted or derived from
hemp.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 5.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 3, is amended
to read:


Subd. 3.

Sale of cannabinoids derived from hemp.

(a) Notwithstanding any other
section of this chapter, a product containing nonintoxicating cannabinoids, including an
edible cannabinoid product, may be sold for human or animal consumption only if all of
the requirements of this section are metdeleted text begin , provided thatdeleted text end new text begin .new text end A product sold for human or animal
consumption deleted text begin doesdeleted text end new text begin mustnew text end not contain more than 0.3 percent of any tetrahydrocannabinol and
an edible cannabinoid product deleted text begin doesdeleted text end new text begin mustnew text end not contain an amount of any tetrahydrocannabinol
that exceeds the limits established in subdivision 5a, paragraph (f).

(b) A product containing nonintoxicating cannabinoids, other than an edible cannabinoid
product, may be sold for human or animal consumption only if it is intended for application
externally to a part of the body of a human or animal. Such a product must not be
manufactured, marketed, distributed, or intended to be consumed:

(1) by combustion or vaporization of the product and inhalation of smoke, aerosol, or
vapor from the product;

(2) through chewing, drinking, or swallowing; or

(3) through injection or application to a mucous membrane or nonintact skin.

(c) No other substance extracted or otherwise derived from hemp may be sold for human
consumption if the substance is intended:

(1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention
of disease in humans or other animals; or

(2) to affect the structure or any function of the bodies of humans or other animals.

(d) No product containing any cannabinoid or tetrahydrocannabinol extracted or otherwise
derived from hemp may be sold to any individual who is under the age of 21.

(e) Products that meet the requirements of this section are not controlled substances
under section 152.02.

(f) Products may be sold for on-site consumption deleted text begin provided thatdeleted text end new text begin ifnew text end all of the following
conditions are met:

(1) the retailer must also hold an on-sale license issued under chapter 340A;

(2) productsnew text begin , other than products that are intended to be consumed as a beverage,new text end must
be served in original packaging, but may be removed from the products' packaging by
customers and consumed on site;

(3) products must not be sold to a customer who the retailer knows or reasonably should
know is intoxicated;

(4) products must not be permitted to be mixed with an alcoholic beverage; and

(5) products that have been removed from packaging must not be removed from the
premises.

new text begin (g) Edible cannabinoid products that are intended to be consumed as a beverage may be
served outside of the products' packaging if the information that is required to be contained
on the label of an edible cannabinoid product is posted or otherwise displayed by the retailer.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 6.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 4, is amended
to read:


Subd. 4.

Testing requirements.

(a) A manufacturer of a product regulated under this
section must submit representative samples of each batch of the product to an independent,
accredited laboratory in order to certify that the product complies with the standards deleted text begin adopted
by the board on or before July 1, 2023, or the standardsdeleted text end adopted by the deleted text begin commissionerdeleted text end new text begin officenew text end .
Testing must be consistent with generally accepted industry standards for herbal and botanical
substances, and, at a minimum, the testing must confirm that the product:

(1) contains the amount or percentage of cannabinoids that is stated on the label of the
product;

(2) does not contain more than trace amounts of any mold, residual solvents or other
catalysts, pesticides, fertilizers, or heavy metals; and

(3) does not contain more than 0.3 percent of any tetrahydrocannabinol.

(b) A manufacturer of a product regulated under this section must disclose all known
information regarding pesticides, fertilizers, solvents, or other foreign materials applied to
industrial hemp or added to industrial hemp during any production or processing stages of
any batch from which a representative sample has been sent for testing, including any
catalysts used to create artificially derived cannabinoids. The disclosure must be made to
the laboratory performing testing or sampling and, upon request, to the deleted text begin commissionerdeleted text end new text begin officenew text end .
The disclosure must include all information known to the deleted text begin licenseedeleted text end new text begin manufacturernew text end regardless
of whether the application or addition was made intentionally or accidentally, or by the
manufacturer or any other person.

(c) Upon the request of the deleted text begin commissionerdeleted text end new text begin officenew text end , the manufacturer of the product must
provide the deleted text begin commissionerdeleted text end new text begin officenew text end with the results of the testing required in this section.

(d) The deleted text begin commissionerdeleted text end new text begin officenew text end may determine that any testing laboratory that does not
operate formal management systems under the International Organization for Standardization
is not an accredited laboratory and require that a representative sample of a batch of the
product be retested by a testing laboratory that meets this requirement.

(e) Testing of the hemp from which the nonintoxicating cannabinoid was derived, or
possession of a certificate of analysis for such hemp, does not meet the testing requirements
of this section.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 7.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 5a, is amended
to read:


Subd. 5a.

Additional requirements for edible cannabinoid products.

(a) In addition
to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid
must meet the requirements of this subdivision.

(b) An edible cannabinoid product must not:

(1) bear the likeness or contain cartoon-like characteristics of a real or fictional person,
animal, or fruit that appeals to children;

(2) be modeled after a brand of products primarily consumed by or marketed to children;

(3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a
commercially available candy or snack food item;

(4) be substantively similar to a meat food product; poultry food product as defined in
section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision
7;

(5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved
by the United States Food and Drug Administration for use in food;

(6) be packaged in a way that resembles the trademarked, characteristic, or
product-specialized packaging of any commercially available food product; or

(7) be packaged in a container that includes a statement, artwork, or design that could
reasonably mislead any person to believe that the package contains anything other than an
edible cannabinoid product.

(c) An edible cannabinoid product must be prepackaged in packaging or a container that
is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is
child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The
requirement that packaging be child-resistant does not apply to an edible cannabinoid product
that is intended to be consumed as a beverage.

(d) If an edible cannabinoid product, other than a product that is intended to be consumed
as a beverage, is intended for more than a single use or contains multiple servings, each
serving must be indicated by scoring, wrapping, or other indicators designating the individual
serving size that appear on the edible cannabinoid product.

(e) A label containing at least the following information must be affixed to the packaging
or container of all edible cannabinoid products sold to consumers:

(1) the serving size;

(2) the cannabinoid profile per serving and in total;

(3) a list of ingredients, including identification of any major food allergens declared
by name; and

(4) the following statement: "Keep this product out of reach of children."

(f) An edible cannabinoid product must not contain more than five milligrams of any
tetrahydrocannabinol in a single serving. An edible cannabinoid product, other than a product
that is intended to be consumed as a beverage, may not contain more than a total of 50
milligrams of any tetrahydrocannabinol per package. An edible cannabinoid product that
is intended to be consumed as a beverage may not contain more than two servings per
container.

(g) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9
tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is an
artificially derived cannabinoid. Edible cannabinoid products are prohibited from containing
any other artificially derived cannabinoid, including but not limited to THC-P, THC-O, and
HHC, unless the deleted text begin commissionerdeleted text end new text begin officenew text end authorizes use of the artificially derived cannabinoid
in edible cannabinoid products. Edible cannabinoid products are prohibited from containing
synthetic cannabinoids.

(h) Every person selling edible cannabinoid products to consumers, other than products
that are intended to be consumed as a beverage, must ensure that all edible cannabinoid
products are displayed behind a checkout counter where the public is not permitted or in a
locked case.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 8.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 5b, is amended
to read:


Subd. 5b.

Registration; prohibitions.

deleted text begin (a) On or before October 1, 2023, every person
selling edible cannabinoid products to consumers must register with the commissioner in
a form and manner established by the commissioner. After October 1, 2023, the sale of
edible cannabinoid products by a person that is not registered is prohibited.
 deleted text end

new text begin (a) Every person selling an edible cannabinoid product to a consumer must be registered
with the office. Existing registrations through the Department of Health must be transferred
to the office by July 1, 2024. All other persons required to register must register in a form
and manner established by the office. The sale of edible cannabinoid products by a person
who is not registered with the office is prohibited and subject to the penalties in section
342.09, subdivision 6; any applicable criminal penalty; and any other applicable civil or
administrative penalty.
 new text end

(b) The registration form must contain an attestation of compliance and each registrant
must affirm that it is operating and will continue to operate in compliance with the
requirements of this section and all other applicable state and local laws and ordinances.

(c) The deleted text begin commissioner shalldeleted text end new text begin office mustnew text end not charge a fee for registration under this
subdivision.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 9.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 6, is amended
to read:


Subd. 6.

Noncompliant products; enforcement.

(a) A product regulated under this
section, including an edible cannabinoid product, shall be considered a noncompliant product
if the product is offered for sale in this state or if the product is manufactured, imported,
distributed, or stored with the intent to be offered for sale in this state in violation of any
provision of this section, including but not limited to if:

(1) it consists, in whole or in part, of any filthy, putrid, or decomposed substance;

(2) it has been produced, prepared, packed, or held under unsanitary conditions where
it may have been rendered injurious to health, or where it may have been contaminated with
filth;

(3) its container is composed, in whole or in part, of any poisonous or deleterious
substance that may render the contents injurious to health;

(4) it contains any food additives, color additives, or excipients that have been found by
the FDA to be unsafe for human or animal consumption;

(5) it contains an amount or percentage of nonintoxicating cannabinoids that is different
than the amount or percentage stated on the label;

(6) it contains more than 0.3 percent of any tetrahydrocannabinol or, if the product is
an edible cannabinoid product, an amount of tetrahydrocannabinol that exceeds the limits
established in subdivision 5a, paragraph (f); or

(7) it contains more than trace amounts of mold, residual solvents, pesticides, fertilizers,
or heavy metals.

(b) A product regulated under this section shall be considered a noncompliant product
if the product's labeling is false or misleading in any manner or in violation of the
requirements of this section.

(c) The deleted text begin commissionerdeleted text end new text begin officenew text end may assume that any product regulated under this section
that is present in the state, other than a product lawfully possessed for personal use, has
been manufactured, imported, distributed, or stored with the intent to be offered for sale in
this state if a product of the same type and brand was sold in the state on or after July 1,
2023, or if the product is in the possession of a person who has sold any product in violation
of this section.

(d) The deleted text begin commissionerdeleted text end new text begin officenew text end may enforce this section, including enforcement against a
manufacturer or distributor of a product regulated under this section, under deleted text begin sections 144.989
to 144.993deleted text end new text begin section 342.19new text end .

(e) deleted text begin The commissioner may enter into an interagency agreement withdeleted text end The office deleted text begin of
Cannabis Management anddeleted text end new text begin may enter into an interagency agreement withnew text end the commissioner
of agriculture to perform inspections and take other enforcement actions on behalf of the
deleted text begin commissionerdeleted text end new text begin officenew text end .

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 10.

Minnesota Statutes 2023 Supplement, section 151.72, subdivision 7, is amended
to read:


Subd. 7.

Violations; criminal penalties.

(a) deleted text begin Notwithstanding section 144.99, subdivision
11,deleted text end A person who does any of the following regarding a product regulated under this section
is guilty of a gross misdemeanor and may be sentenced to imprisonment for not more than
364 days or to payment of a fine of not more than $3,000, or both:

(1) knowingly alters or otherwise falsifies testing results;

(2) intentionally alters or falsifies any information required to be included on the label
of an edible cannabinoid product; or

(3) intentionally makes a false material statement to the deleted text begin commissionerdeleted text end new text begin officenew text end .

(b) deleted text begin Notwithstanding section 144.99, subdivision 11,deleted text end A person who does any of the
following on the premises of a registered retailer or another business that sells retail goods
to customers is guilty of a gross misdemeanor and may be sentenced to imprisonment for
not more than 364 days or to payment of a fine of not more than $3,000, or both:

(1) sells an edible cannabinoid product knowing that the product does not comply with
the limits on the amount or types of cannabinoids that a product may contain;

(2) sells an edible cannabinoid product knowing that the product does not comply with
the applicable testing, packaging, or labeling requirements; or

(3) sells an edible cannabinoid product to a person under the age of 21, except that it is
an affirmative defense to a charge under this clause if the defendant proves by a
preponderance of the evidence that the defendant reasonably and in good faith relied on
proof of age as described in subdivision 5c.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 11.

Minnesota Statutes 2022, section 152.22, subdivision 11, is amended to read:


Subd. 11.

Registered designated caregiver.

"Registered designated caregiver" means
a person who:

(1) is at least 18 years old;

deleted text begin (2) does not have a conviction for a disqualifying felony offense;
 deleted text end

deleted text begin (3)deleted text end new text begin (2)new text end has been approved by the deleted text begin commissionerdeleted text end new text begin officenew text end to assist a patient who requires
assistance in administering medical cannabis or obtaining medical cannabis from a
distribution facility; and

deleted text begin (4)deleted text end new text begin (3)new text end is authorized by the deleted text begin commissionerdeleted text end new text begin officenew text end to assist the patient with the use of
medical cannabis.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 12.

Minnesota Statutes 2022, section 152.22, subdivision 14, is amended to read:


Subd. 14.

Qualifying medical condition.

"Qualifying medical condition" means a
diagnosis of any of the following conditions:

new text begin (1) Alzheimer's disease;
 new text end

new text begin (2) autism spectrum disorder that meets the requirements of the fifth edition of the
Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric
Association;
 new text end

deleted text begin (1)deleted text end new text begin (3)new text end cancer, if the underlying condition or treatment produces one or more of the
following:

(i) severe or chronic pain;

(ii) nausea or severe vomiting; or

(iii) cachexia or severe wasting;

new text begin (4) chronic motor or vocal tic disorder;
 new text end

new text begin (5) chronic pain;
 new text end

deleted text begin (2)deleted text end new text begin (6)new text end glaucoma;

deleted text begin (3)deleted text end new text begin (7)new text end human immunodeficiency virus or acquired immune deficiency syndrome;

new text begin (8) intractable pain as defined in section 152.125, subdivision 1, paragraph (c);
 new text end

new text begin (9) obstructive sleep apnea;
 new text end

new text begin (10) post-traumatic stress disorder;
 new text end

deleted text begin (4)deleted text end new text begin (11)new text end Tourette's syndrome;

deleted text begin (5)deleted text end new text begin (12)new text end amyotrophic lateral sclerosis;

deleted text begin (6)deleted text end new text begin (13)new text end seizures, including those characteristic of epilepsy;

deleted text begin (7)deleted text end new text begin (14)new text end severe and persistent muscle spasms, including those characteristic of multiple
sclerosis;

deleted text begin (8)deleted text end new text begin (15)new text end inflammatory bowel disease, including Crohn's disease;

new text begin (16) irritable bowel syndrome;
 new text end

new text begin (17) obsessive-compulsive disorder;
 new text end

new text begin (18) sickle cell disease;
 new text end

deleted text begin (9)deleted text end new text begin (19)new text end terminal illness, with a probable life expectancy of under one year, if the illness
or its treatment produces one or more of the following:

(i) severe or chronic pain;

(ii) nausea or severe vomiting; or

(iii) cachexia or severe wasting; or

deleted text begin (10)deleted text end new text begin (20)new text end any other medical condition deleted text begin or its treatment approved by the commissioner.deleted text end new text begin
that is:
new text end

new text begin (i) approved by a patient's health care practitioner; or
 new text end

new text begin (ii) if the patient is a veteran receiving care from the United States Department of Veterans
Affairs, certified under section 152.27, subdivision 3a.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 13.

Minnesota Statutes 2022, section 152.22, is amended by adding a subdivision to
read:


new text begin Subd. 19. new text end

new text begin Veteran. new text end

new text begin "Veteran" means an individual who satisfies the requirements in
section 197.447 and is receiving care from the United States Department of Veterans Affairs.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 14.

Minnesota Statutes 2022, section 152.25, subdivision 2, is amended to read:


Subd. 2.

Range of compounds and dosages; report.

The deleted text begin commissionerdeleted text end new text begin officenew text end shall
review and publicly report the existing medical and scientific literature regarding the range
of recommended dosages for each qualifying condition and the range of chemical
compositions of any plant of the genus cannabis that will likely be medically beneficial for
each of the qualifying medical conditions. The deleted text begin commissionerdeleted text end new text begin officenew text end shall make this
information available to patients with qualifying medical conditions beginning December
1, 2014, and update the information deleted text begin annuallydeleted text end new text begin every three yearsnew text end . The deleted text begin commissionerdeleted text end new text begin officenew text end
may consult with the independent laboratory under contract with the manufacturer or other
experts in reporting the range of recommended dosages for each qualifying medical condition,
the range of chemical compositions that will likely be medically beneficial, and any risks
of noncannabis drug interactions. The deleted text begin commissionerdeleted text end new text begin officenew text end shall consult with each
manufacturer on an annual basis on medical cannabis offered by the manufacturer. The list
of medical cannabis offered by a manufacturer shall be published on the deleted text begin Department of
Healthdeleted text end new text begin Office of Cannabis Managementnew text end website.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 15.

Minnesota Statutes 2022, section 152.27, subdivision 1, is amended to read:


Subdivision 1.

Patient registry program; establishment.

deleted text begin (a)deleted text end The deleted text begin commissionerdeleted text end new text begin officenew text end
shall establish a patient registry program to evaluate data on patient demographics, effective
treatment options, clinical outcomes, and quality-of-life outcomes for the purpose of reporting
on the benefits, risks, and outcomes regarding patients with a qualifying medical condition
engaged in the therapeutic use of medical cannabis.

deleted text begin (b) The establishment of the registry program shall not be construed or interpreted to
condone or promote the illicit recreational use of marijuana.
 deleted text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 16.

Minnesota Statutes 2022, section 152.27, subdivision 2, is amended to read:


Subd. 2.

deleted text begin Commissionerdeleted text end new text begin Officenew text end duties.

(a) The deleted text begin commissionerdeleted text end new text begin officenew text end shall:

(1) give notice of the program to health care practitioners in the state who are eligible
to serve as health care practitioners and explain the purposes and requirements of the
program;

(2) allow each health care practitioner who meets or agrees to meet the program's
requirements and who requests to participate, to be included in the registry program to
collect data for the patient registry;

(3) provide explanatory information and assistance to each health care practitioner in
understanding the nature of therapeutic use of medical cannabis within program requirements;

(4) create and provide a certification to be used by a health care practitioner for the
practitioner to certify whether a patient has been diagnosed with a qualifying medical
condition deleted text begin and include in the certification an option for the practitioner to certify whether
the patient, in the health care practitioner's medical opinion, is developmentally or physically
disabled and, as a result of that disability, the patient requires assistance in administering
medical cannabis or obtaining medical cannabis from a distribution facilitydeleted text end ;

(5) supervise the participation of the health care practitioner in conducting patient
treatment and health records reporting in a manner that ensures stringent security and
record-keeping requirements and that prevents the unauthorized release of private data on
individuals as defined by section 13.02;

(6) develop safety criteria for patients with a qualifying medical condition as a
requirement of the patient's participation in the program, to prevent the patient from
undertaking any task under the influence of medical cannabis that would constitute negligence
or professional malpractice on the part of the patient; and

(7) conduct research and studies based on data from health records submitted to the
registry program and submit reports on intermediate or final research results to the legislature
and major scientific journals. The deleted text begin commissionerdeleted text end new text begin officenew text end may contract with a third party to
complete the requirements of this clause. Any reports submitted must comply with section
152.28, subdivision 2.

(b) The deleted text begin commissionerdeleted text end new text begin officenew text end may add a delivery method under section 152.22, subdivision
6, deleted text begin or add, remove, or modify a qualifying medical condition under section 152.22, subdivision
14,deleted text end upon a petition from a member of the public or the deleted text begin task force on medical cannabis
therapeutic researchdeleted text end new text begin Cannabis Advisory Council under section 342.03new text end or as directed by law.
deleted text begin The commissioner shall evaluate all petitions to add a qualifying medical condition or to
remove or modify an existing qualifying medical condition submitted by the task force on
medical cannabis therapeutic research or as directed by law and may make the addition,
removal, or modification if the commissioner determines the addition, removal, or
modification is warranted based on the best available evidence and research.deleted text end If the
deleted text begin commissionerdeleted text end new text begin officenew text end wishes to add a delivery method under section 152.22, subdivision 6,
deleted text begin or add or remove a qualifying medical condition under section 152.22, subdivision 14,deleted text end the
deleted text begin commissionerdeleted text end new text begin officenew text end must notify the chairs and ranking minority members of the legislative
policy committees having jurisdiction over health and public safety of the addition deleted text begin or removaldeleted text end
and the reasons for its addition deleted text begin or removaldeleted text end , including any written comments received by
the deleted text begin commissionerdeleted text end new text begin officenew text end from the public and any guidance received from the deleted text begin task force on
medical cannabis researchdeleted text end new text begin Cannabis Advisory Council under section 342.03new text end , by January
15 of the year in which the deleted text begin commissionerdeleted text end new text begin officenew text end wishes to make the change. The change
shall be effective on August 1 of that year, unless the legislature by law provides otherwise.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 17.

Minnesota Statutes 2022, section 152.27, subdivision 3, is amended to read:


Subd. 3.

Patient application.

(a) The deleted text begin commissionerdeleted text end new text begin officenew text end shall develop a patient
application for enrollment into the registry program. The application shall be available to
the patient and given to health care practitioners in the state who are eligible to serve as
health care practitioners. The application must include:

(1) the name, mailing address, and date of birth of the patient;

(2) the name, mailing address, and telephone number of the patient's health care
practitioner;

(3) the name, mailing address, and date of birth of the patient's designated caregiver, if
any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian, or spouse
will be acting as a caregiver;

(4) a copy of the certification from the patient's health care practitioner that is dated
within 90 days prior to submitting the application that certifies that the patient has been
diagnosed with a qualifying medical condition; and

(5) all other signed affidavits and enrollment forms required by the deleted text begin commissionerdeleted text end new text begin officenew text end
under sections 152.22 to 152.37, including, but not limited to, the disclosure form required
under paragraph deleted text begin (c)deleted text end new text begin (b)new text end .

deleted text begin (b) The commissioner shall require a patient to resubmit a copy of the certification from
the patient's health care practitioner on a yearly basis and shall require that the recertification
be dated within 90 days of submission.
 deleted text end

deleted text begin (c)deleted text end new text begin (b)new text end The deleted text begin commissionerdeleted text end new text begin officenew text end shall develop a disclosure form and require, as a condition
of enrollment, all patients to sign a copy of the disclosure. The disclosure must include:

(1) a statement that, notwithstanding any law to the contrary, the deleted text begin commissionerdeleted text end new text begin officenew text end ,
or an employee of any state agency, may not be held civilly or criminally liable for any
injury, loss of property, personal injury, or death caused by any act or omission while acting
within the scope of office or employment under sections 152.22 to 152.37; and

(2) the patient's acknowledgment that enrollment in the patient registry program is
conditional on the patient's agreement to meet all of the requirements of sections 152.22 to
152.37.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 18.

Minnesota Statutes 2022, section 152.27, is amended by adding a subdivision to
read:


new text begin Subd. 3a. new text end

new text begin Application procedure for veterans. new text end

new text begin (a) Beginning July 1, 2024, the office
shall establish an alternative certification procedure for veterans to enroll in the patient
registry program.
 new text end

new text begin (b) A patient who is a veteran receiving care from the United States Department of
Veterans Affairs and is seeking to enroll in the registry program must submit a copy of the
patient's veteran health identification card issued by the United States Department of Veterans
Affairs and an application established by the office to confirm that the veteran has been
diagnosed with a condition that may benefit from the therapeutic use of medical cannabis.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 19.

Minnesota Statutes 2022, section 152.27, subdivision 4, is amended to read:


Subd. 4.

Registered designated caregiver.

(a) The deleted text begin commissionerdeleted text end new text begin officenew text end shall register
a designated caregiver for a patient if the patient requires assistance in administering medical
cannabis or obtaining medical cannabis from a distribution facility and the caregiver has
agreed, in writing, to be the patient's designated caregiver. As a condition of registration as
a designated caregiver, the commissioner shall require the person to:

(1) be at least 18 years of age;

(2) agree to only possess the patient's medical cannabis for purposes of assisting the
patient; and

(3) agree that if the application is approved, the person will not be a registered designated
caregiver for more than six registered patients at one time. Patients who reside in the same
residence shall count as one patient.

deleted text begin (b) The commissioner shall conduct a criminal background check on the designated
caregiver prior to registration to ensure that the person does not have a conviction for a
disqualifying felony offense. Any cost of the background check shall be paid by the person
seeking registration as a designated caregiver. A designated caregiver must have the criminal
background check renewed every two years.
 deleted text end

deleted text begin (c)deleted text end new text begin (b)new text end Nothing in sections 152.22 to 152.37 shall be construed to prevent a person
registered as a designated caregiver from also being enrolled in the registry program as a
patient and possessing and using medical cannabis as a patient.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 20.

Minnesota Statutes 2022, section 152.27, subdivision 6, is amended to read:


Subd. 6.

Patient enrollment.

(a) After receipt of a patient's applicationdeleted text begin , application fees,deleted text end
and signed disclosure, the deleted text begin commissionerdeleted text end new text begin officenew text end shall enroll the patient in the registry program
and issue the patient and patient's registered designated caregiver or parent, legal guardian,
or spouse, if applicable, a registry verification. The deleted text begin commissionerdeleted text end new text begin officenew text end shall approve or
deny a patient's application for participation in the registry program within 30 days after
the deleted text begin commissionerdeleted text end new text begin officenew text end receives the patient's application deleted text begin and application fee. The
commissioner may approve applications up to 60 days after the receipt of a patient's
application and application fees until January 1, 2016deleted text end . A patient's enrollment in the registry
program shall only be denied if the patient:

(1) does not have certification from a health care practitionernew text begin or, if the patient is a veteran
receiving care from the United States Department of Veterans Affairs, does not have the
documentation required under subdivision 3anew text end that the patient has been diagnosed with a
qualifying medical condition;

(2) has not signed and returned the disclosure form required under subdivision 3,
paragraph (c), to the deleted text begin commissionerdeleted text end new text begin officenew text end ;

(3) does not provide the information required;

(4) has previously been removed from the registry program for violations of section
152.30 or 152.33; or

(5) provides false information.

(b) The deleted text begin commissionerdeleted text end new text begin officenew text end shall give written notice to a patient of the reason for
denying enrollment in the registry program.

(c) Denial of enrollment into the registry program is considered a final decision of the
commissioner and is subject to judicial review under the Administrative Procedure Act
pursuant to chapter 14.

(d) A patient's enrollment in the registry program may only be revoked upon the death
of the patient or if a patient violates a requirement under section 152.30 or 152.33.

(e) The deleted text begin commissionerdeleted text end new text begin officenew text end shall develop a registry verification to provide to the patient,
the health care practitioner identified in the patient's application, and to the manufacturer.
The registry verification shall include:

(1) the patient's name and date of birth;

(2) the patient registry number assigned to the patient; and

(3) the name and date of birth of the patient's registered designated caregiver, if any, or
the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or
spouse will be acting as a caregiver.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 21.

Minnesota Statutes 2023 Supplement, section 152.28, subdivision 1, is amended
to read:


Subdivision 1.

Health care practitioner duties.

(a) Prior to a patient's enrollment in
the registry program, a health care practitioner shall:

(1) determine, in the health care practitioner's medical judgment, whether a patient suffers
from a qualifying medical condition, and, if so determined, provide the patient with a
certification of that diagnosis;

(2) advise patients, registered designated caregivers, and parents, legal guardians, or
spouses who are acting as caregivers of the existence of any nonprofit patient support groups
or organizations;

(3) provide explanatory information from the commissioner to patients with qualifying
medical conditions, including disclosure to all patients about the experimental nature of
therapeutic use of medical cannabis; the possible risks, benefits, and side effects of the
proposed treatment; the application and other materials from the commissioner; and provide
patients with the Tennessen warning as required by section 13.04, subdivision 2; and

(4) agree to continue treatment of the patient's qualifying medical condition and report
medical findings to the commissioner.

(b) Upon notification from the commissioner of the patient's enrollment in the registry
program, the health care practitioner shall:

(1) participate in the patient registry reporting system under the guidance and supervision
of the commissioner;

(2) report health records of the patient throughout the ongoing treatment of the patient
to the commissioner in a manner determined by the commissioner and in accordance with
subdivision 2;

(3) determine, deleted text begin on a yearly basisdeleted text end new text begin every three yearsnew text end , if the patient continues to suffer from
a qualifying medical condition and, if so, issue the patient a new certification of that
diagnosis; and

(4) otherwise comply with all requirements developed by the commissioner.

(c) A health care practitioner may utilize telehealth, as defined in section 62A.673,
subdivision 2, for certifications and recertifications.

(d) Nothing in this section requires a health care practitioner to participate in the registry
program.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 22.

Minnesota Statutes 2022, section 152.28, subdivision 2, is amended to read:


Subd. 2.

Data.

Data collected on patients by a health care practitioner and reported to
the patient registrynew text begin , including data on patients who are veterans who receive care from the
United States Department of Veterans Affairs,new text end are health records under section 144.291,
and are private data on individuals under section 13.02, but may be used or reported in an
aggregated, nonidentifiable form as part of a scientific, peer-reviewed publication of research
conducted under section 152.25 or in the creation of summary data, as defined in section
13.02, subdivision 19.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 23.

Minnesota Statutes 2022, section 152.29, subdivision 3, is amended to read:


Subd. 3.

Manufacturer; distribution.

(a) A manufacturer shall require that employees
licensed as pharmacists pursuant to chapter 151 be the only employees to give final approval
for the distribution of medical cannabis to a patient. A manufacturer may transport medical
cannabis or medical cannabis products that have been cultivated, harvested, manufactured,
packaged, and processed by that manufacturer to another registered manufacturer for the
other manufacturer to distribute.

(b) A manufacturer may distribute medical cannabis products, whether or not the products
have been manufactured by that manufacturer.

(c) Prior to distribution of any medical cannabis, the manufacturer shall:

(1) verify that the manufacturer has received the registry verification from the
deleted text begin commissionerdeleted text end new text begin officenew text end for that individual patient;

(2) verify that the person requesting the distribution of medical cannabis is the patient,
the patient's registered designated caregiver, or the patient's parent, legal guardian, or spouse
listed in the registry verification using the procedures described in section 152.11, subdivision
2d;

(3) assign a tracking number to any medical cannabis distributed from the manufacturer;

(4) ensure that any employee of the manufacturer licensed as a pharmacist pursuant to
chapter 151 has consulted with the patient to determine the proper dosage for the individual
patient after reviewing the ranges of chemical compositions of the medical cannabis and
the ranges of proper dosages reported by the deleted text begin commissionerdeleted text end new text begin officenew text end . For purposes of this
clause, a consultation may be conducted remotely by secure videoconference, telephone,
or other remote means, so long as the employee providing the consultation is able to confirm
the identity of the patient and the consultation adheres to patient privacy requirements that
apply to health care services delivered through telehealth. A pharmacist consultation under
this clause is deleted text begin not required when a manufacturer is distributing medical cannabis to a patient
according to a patient-specific dosage plan established with that manufacturer and is not
modifying the dosage or product being distributed under that plan and the medical cannabis
is distributed by a pharmacy technician;deleted text end new text begin only required:
new text end

new text begin (i) if the patient is purchasing the medical cannabis flower or medical cannabinoid
product for the first time;
 new text end

new text begin (ii) if the patient purchases medical cannabis flower or a medical cannabinoid product
that the patient must administer using a different method than the patient's previous method
of administration;
 new text end

new text begin (iii) if the patient purchases medical cannabis flower or a medical cannabinoid product
with a cannabinoid concentration of at least double the patient's prior dosage; or
 new text end

new text begin (iv) upon the request of the patient; and
 new text end

(5) properly package medical cannabis in compliance with the United States Poison
Prevention Packing Act regarding child-resistant packaging and exemptions for packaging
for elderly patients, and label distributed medical cannabis with a list of all active ingredients
and individually identifying information, including:

(i) the patient's name and date of birth;

(ii) the name and date of birth of the patient's registered designated caregiver or, if listed
on the registry verification, the name of the patient's parent or legal guardian, if applicable;

(iii) the patient's registry identification number;

(iv) the chemical composition of the medical cannabis; and

(v) the dosagedeleted text begin ; and
deleted text end

deleted text begin (6) ensure that the medical cannabis distributed contains a maximum of a 90-day supply
of the dosage determined for that patientdeleted text end .

(d) A manufacturer shall require any employee of the manufacturer who is transporting
medical cannabis or medical cannabis products to a distribution facility or to another
registered manufacturer to carry identification showing that the person is an employee of
the manufacturer.

(e) A manufacturer shall distribute medical cannabis in dried raw cannabis form only
to a patient age 21 or older, or to the registered designated caregiver, parent, legal guardian,
or spouse of a patient age 21 or older.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 24.

Minnesota Statutes 2023 Supplement, section 152.30, is amended to read:


152.30 PATIENT DUTIES.

(a) A patient shall apply to the deleted text begin commissionerdeleted text end new text begin officenew text end for enrollment in the registry program
by submitting an application as required in section 152.27 deleted text begin and an annual registration fee as
determined under section 152.35deleted text end .

(b) As a condition of continued enrollment, patients shall agree to:

(1) continue to receive regularly scheduled treatment for their qualifying medical
condition from their health care practitioner; and

(2) report changes in their qualifying medical condition to their health care practitioner.

(c) A patient shall only receive medical cannabis from a registered manufacturer or
Tribal medical cannabis program but is not required to receive medical cannabis products
from only a registered manufacturer or Tribal medical cannabis program.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 25.

Minnesota Statutes 2022, section 181.950, subdivision 10, is amended to read:


Subd. 10.

Positive test result.

"Positive test result" means a finding of the presence of
drugs, new text begin cannabis, new text end alcohol, or their metabolites in the sample tested in levels at or above the
threshold detection levels contained in the standards of one of the programs listed in section
181.953, subdivision 1.

Sec. 26.

Minnesota Statutes 2023 Supplement, section 181.951, subdivision 4, is amended
to read:


Subd. 4.

Random testing.

An employer may request or require employees to undergo
cannabis testing deleted text begin ordeleted text end new text begin andnew text end drug and alcohol testing on a random selection basis only if (1) they
are employed in safety-sensitive positions, or (2) they are employed as professional athletes
if the professional athlete is subject to a collective bargaining agreement permitting random
testing but only to the extent consistent with the collective bargaining agreement.

Sec. 27.

Minnesota Statutes 2023 Supplement, section 181.951, subdivision 5, is amended
to read:


Subd. 5.

Reasonable suspicion testing.

An employer may request or require an employee
to undergo cannabis testing and drug and alcohol testing if the employer has a reasonable
suspicion that the employee:

(1) is under the influence of drugsnew text begin , cannabis,new text end or alcohol;

(2) has violated the employer's written work rules prohibiting the use, possession,
new text begin impairment, new text end sale, or transfer of drugs or alcohol, cannabis flower, cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products while the employee is
working or while the employee is on the employer's premises or operating the employer's
vehicle, machinery, or equipment, deleted text begin provideddeleted text end new text begin ifnew text end the work rules are in writing and contained
in the employer's written cannabis testing or drug and alcohol testing policy;

(3) has sustained a personal injury, as that term is defined in section 176.011, subdivision
16, or has caused another employee to sustain a personal injury; or

(4) has caused a work-related accident or was operating or helping to operate machinery,
equipment, or vehicles involved in a work-related accident.

Sec. 28.

Minnesota Statutes 2023 Supplement, section 181.951, subdivision 8, is amended
to read:


Subd. 8.

Limitations on cannabis testing.

(a) An employer must not request or require
a job applicant to undergo cannabis testing deleted text begin solely for the purpose of determining the presence
or absence of cannabisdeleted text end as a condition of employment unless otherwise required by state or
federal law.

(b) Unless otherwise required by state or federal law, an employer must not refuse to
hire a job applicant solely because the job applicant submits to a cannabis test or a drug and
alcohol test authorized by this section and the results of the test indicate the presence of
cannabis.

(c) An employer must not request or require an employee or job applicant to undergo
cannabis testing on an arbitrary or capricious basis.

(d) Cannabis testing authorized under deleted text begin paragraph (d)deleted text end new text begin this sectionnew text end must comply with the
safeguards for testing employees provided in sections 181.953 and 181.954.

Sec. 29.

Minnesota Statutes 2022, section 181.952, as amended by Laws 2023, chapter
63, article 6, section 38, is amended to read:


181.952 POLICY CONTENTS; PRIOR WRITTEN NOTICE.

Subdivision 1.

Contents of the policy.

An employer's drug and alcohol new text begin and cannabis
new text end testing policy must, at a minimum, set forth the following information:

(1) the employees or job applicants subject to testing under the policy;

(2) the circumstances under which drug or alcohol new text begin and cannabis new text end testing may be requested
or required;

(3) the right of an employee or job applicant to refuse to undergo drug and alcohol new text begin and
cannabis new text end testing and the consequences of refusal;

(4) any disciplinary or other adverse personnel action that may be taken based on a
confirmatory test verifying a positive test result on an initial screening test;

(5) the right of an employee or job applicant to explain a positive test result on a
confirmatory test or request and pay for a confirmatory retest; and

(6) any other appeal procedures available.

Subd. 2.

Notice.

An employer shall provide written notice of its drug and alcohol testing
new text begin and cannabis testing new text end policy to all affected employees upon adoption of the policy, to a
previously nonaffected employee upon transfer to an affected position under the policy, and
to a job applicant upon hire and before any testing of the applicant if the job offer is made
contingent on the applicant passing drug and alcohol testing. An employer shall also post
notice in an appropriate and conspicuous location on the employer's premises that the
employer has adopted a drug and alcohol testing new text begin and cannabis testing new text end policy and that copies
of the policy are available for inspection during regular business hours by its employees or
job applicants in the employer's personnel office or other suitable locations.

Subd. 3.

Cannabis deleted text begin policydeleted text end new text begin work rulesnew text end .

(a) Unless otherwise provided by state or federal
law, an employer is not required to permit or accommodate cannabis flower, cannabis
product, lower-potency hemp edible, or hemp-derived consumer product use, possession,
impairment, sale, or transfer while an employee is working or while an employee is on the
employer's premises or operating the employer's vehicle, machinery, or equipment.

(b) An employer may only enact and enforce written work rules prohibiting cannabis
flower, cannabis product, lower-potency hemp edible, and hemp-derived consumer product
use, possession, impairment, sale, or transfer while an employee, is working or while an
employee is on the employer's premises or operating the employer's vehicle, machinery, or
equipment in a written policy that contains the minimum information required by this section.

Sec. 30.

Minnesota Statutes 2023 Supplement, section 181.954, subdivision 1, is amended
to read:


Subdivision 1.

Privacy limitations.

A laboratory may only disclose to the employer test
result data regarding the presence or absence of drugs,new text begin cannabis,new text end alcohol, or their metabolites
in a sample tested.

Sec. 31.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 14, is amended
to read:


Subd. 14.

Cannabis business.

"Cannabis business" means any of the following licensed
under this chapter:

(1) cannabis microbusiness;

(2) cannabis mezzobusiness;

(3) cannabis cultivator;

(4) cannabis manufacturer;

(5) cannabis retailer;

(6) cannabis wholesaler;

(7) cannabis transporter;

(8) cannabis testing facility;

(9) cannabis event organizer;

(10) cannabis delivery service;new text begin and
new text end

deleted text begin (11) medical cannabis cultivator;
 deleted text end

deleted text begin (12) medical cannabis processor;
 deleted text end

deleted text begin (13) medical cannabis retailer; and
 deleted text end

deleted text begin (14)deleted text end new text begin (11)new text end medical cannabis combination business.

Sec. 32.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 17, is amended
to read:


Subd. 17.

Cannabis industry.

"Cannabis industry" means every item, product, person,
process, action, business, or other thing related to new text begin cannabis plants, new text end cannabis flowernew text begin ,new text end and
cannabis products deleted text begin and subject to regulation under this chapterdeleted text end .

Sec. 33.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 19, is amended
to read:


Subd. 19.

Cannabis plant.

"Cannabis plant" means all parts of the plant of the genus
Cannabis that is growing or has not been harvested deleted text begin and has a delta-9 tetrahydrocannabinol
concentration of more than 0.3 percent on a dry weight basisdeleted text end new text begin , including but not limited to
a mother plant; a mature, flowering plant; an immature plant; or a seedling. Cannabis plant
does not include a hemp plantnew text end .

Sec. 34.

Minnesota Statutes 2023 Supplement, section 342.01, is amended by adding a
subdivision to read:


new text begin Subd. 31a. new text end

new text begin Endorsement. new text end

new text begin "Endorsement" means an authorization from the office to
conduct a specified operation activity.
 new text end

Sec. 35.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 48, is amended
to read:


Subd. 48.

License holder.

"License holder" means a person, cooperative, or business
that holds any of the following licenses:

(1) cannabis microbusiness;

(2) cannabis mezzobusiness;

(3) cannabis cultivator;

(4) cannabis manufacturer;

(5) cannabis retailer;

(6) cannabis wholesaler;

(7) cannabis transporter;

(8) cannabis testing facility;

(9) cannabis event organizer;

(10) cannabis delivery service;

(11) lower-potency hemp edible manufacturer;

(12) lower-potency hemp edible retailer;new text begin or
new text end

deleted text begin (13) medical cannabis cultivator;
 deleted text end

deleted text begin (14) medical cannabis processor;
 deleted text end

deleted text begin (15) medical cannabis retailer; or
 deleted text end

deleted text begin (16)deleted text end new text begin (13)new text end medical cannabis combination business.

Sec. 36.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 50, is amended
to read:


Subd. 50.

Lower-potency hemp edible.

new text begin (a) new text end "Lower-potency hemp edible" means any
product that:

(1) is intended to be eaten or consumed as a beverage by humans;

(2) contains hemp concentrate or an artificially derived cannabinoid, in combination
with food ingredients;

(3) is not a drug;

deleted text begin (4) consists of servings that contain no more than five milligrams of delta-9
tetrahydrocannabinol, 25 milligrams of cannabidiol, 25 milligrams of cannabigerol, or any
combination of those cannabinoids that does not exceed the identified amounts;
 deleted text end

deleted text begin (5) does not contain more than a combined total of 0.5 milligrams of all other
cannabinoids per serving;
 deleted text end

deleted text begin (6) does not contain an artificially derived cannabinoid other than delta-9
tetrahydrocannabinol;
 deleted text end

deleted text begin (7)deleted text end new text begin (4)new text end does not contain a cannabinoid derived from cannabis plants or cannabis flower;
deleted text begin and
deleted text end

deleted text begin (8)deleted text end new text begin (5)new text end is a type of product approved for sale by the office or is substantially similar to
a product approved by the office, including but not limited to products that resemble
nonalcoholic beverages, candy, and baked goodsdeleted text begin .deleted text end new text begin ; and
new text end

new text begin (6) meets either of the requirements in paragraph (b).
 new text end

new text begin (b) A lower-potency hemp edible includes:
 new text end

new text begin (1) a product that:
 new text end

new text begin (i) consists of servings that contain no more than five milligrams of delta-9
tetrahydrocannabinol; no more than 25 milligrams of cannabidiol, cannabigerol, cannabinol,
or cannabichromene; any other cannabinoid authorized by the office; or any combination
of those cannabinoids that does not exceed the identified amounts;
 new text end

new text begin (ii) does not contain more than a combined total of 0.5 milligrams of all other
cannabinoids per serving; and
 new text end

new text begin (iii) does not contain an artificially derived cannabinoid other than delta-9
tetrahydrocannabinol, except that a product may include artificially derived cannabinoids
created during the process of creating the delta-9 tetrahydrocannabinol that is added to the
product, if no artificially derived cannabinoid is added to the ingredient containing delta-9
tetrahydrocannabinol and the ratio of delta-9 tetrahydrocannabinol to all other artificially
derived cannabinoids is no less than 20 to one; or
 new text end

new text begin (2) a product that:
 new text end

new text begin (i) contains hemp concentrate processed or refined without increasing the percentage of
targeted cannabinoids or altering the ratio of cannabinoids in the extracts or resins of a hemp
plant or hemp plant parts beyond the variability generally recognized for the method used
for processing or refining or by an amount needed to reduce the total THC in the hemp
concentrate; and
 new text end

new text begin (ii) consists of servings that contain no more than five milligrams of total THC.
 new text end

Sec. 37.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 52, is amended
to read:


Subd. 52.

Medical cannabinoid product.

(a) "Medical cannabinoid product" means a
product that:

(1) consists of or contains cannabis concentrate or hemp concentrate or is infused with
cannabinoids, including but not limited to artificially derived cannabinoids; and

(2) is provided to a patient enrolled in the registry program; a registered designated
caregiver; or a parent, legal guardian, or spouse of an enrolled patient, by a new text begin registered
designated caregiver, new text end cannabis retailernew text begin ,new text end or deleted text begin medical cannabis retailerdeleted text end new text begin cannabis business with
a medical cannabis retail endorsementnew text end to treat or alleviate the symptoms of a qualifying
medical condition.

(b) A medical cannabinoid product must be in the form of:

(1) liquid, including but not limited to oil;

(2) pill;

(3) liquid or oil for use with a vaporized delivery method;

(4) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles;

(5) orally dissolvable product, including lozenges, gum, mints, buccal tablets, and
sublingual tablets;

(6) edible products in the form of gummies and chews;

(7) topical formulation; or

(8) any allowable form or delivery method approved by the office.

(c) Medical cannabinoid product does not include adult-use cannabis products or
hemp-derived consumer products.

Sec. 38.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 54, is amended
to read:


Subd. 54.

Medical cannabis flower.

"Medical cannabis flower" means cannabis flower
provided to a patient enrolled in the registry programnew text begin or a visiting patientnew text end ; a registered
designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient by a
new text begin registered designated caregiver, new text end cannabis retailernew text begin ,new text end or deleted text begin medical cannabis businessdeleted text end new text begin cannabis
business with a medical cannabis retail endorsementnew text end to treat or alleviate the symptoms of
a qualifying medical condition. Medical cannabis flower does not include adult-use cannabis
flower.

Sec. 39.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 63, is amended
to read:


Subd. 63.

Qualifying medical condition.

"Qualifying medical condition" means a
diagnosis of any of the following conditions:

(1) Alzheimer's disease;

(2) autism spectrum disorder that meets the requirements of the fifth edition of the
Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric
Association;

(3) cancer, if the underlying condition or treatment produces one or more of the following:

(i) severe or chronic pain;

(ii) nausea or severe vomiting; or

(iii) cachexia or severe wasting;

(4) chronic motor or vocal tic disorder;

(5) chronic pain;

(6) glaucoma;

(7) human immunodeficiency virus or acquired immune deficiency syndrome;

(8) intractable pain as defined in section 152.125, subdivision 1, paragraph (c);

(9) obstructive sleep apnea;

(10) post-traumatic stress disorder;

(11) Tourette's syndrome;

(12) amyotrophic lateral sclerosis;

(13) seizures, including those characteristic of epilepsy;

(14) severe and persistent muscle spasms, including those characteristic of multiple
sclerosis;

(15) inflammatory bowel disease, including Crohn's disease;

(16) irritable bowel syndrome;

(17) obsessive-compulsive disorder;

(18) sickle cell disease;

(19) terminal illness, with a probable life expectancy of under one year, if the illness or
its treatment produces one or more of the following:

(i) severe or chronic pain;

(ii) nausea or severe vomiting; or

(iii) cachexia or severe wasting; or

(20) any other medical condition deleted text begin or its treatment approved by the office.deleted text end new text begin that is:
new text end

new text begin (i) approved by a patient's health care practitioner; or
 new text end

new text begin (ii) if the patient is a veteran receiving care from the United States Department of Veterans
Affairs, certified under section 342.52, subdivision 3.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 40.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 64, is amended
to read:


Subd. 64.

Registered designated caregiver.

"Registered designated caregiver" means
an individual who:

(1) is at least 18 years old;

deleted text begin (2) is not disqualified for a criminal offense according to rules adopted pursuant to
section 342.15, subdivision 2;
 deleted text end

deleted text begin (3)deleted text end new text begin (2)new text end has been approved by the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end to assist a patient
with obtaining medical cannabis flower and medical cannabinoid products from a cannabis
deleted text begin retailer or medical cannabis retailerdeleted text end new text begin business with a medical cannabis retail endorsementnew text end
and with administering medical cannabis flower and medical cannabinoid products; and

deleted text begin (4)deleted text end new text begin (3)new text end is authorized by the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end to assist a patient with
the use of medical cannabis flower and medical cannabinoid products.

Sec. 41.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 65, is amended
to read:


Subd. 65.

Registry or registry program.

"Registry" or "registry program" means the
patient registry established under this chapter listing patientsnew text begin ; registered designated
caregivers; and any parent, legal guardian, or spouse of a patient who isnew text end authorized tonew text begin perform
the following acts either as a patient or to assist a patient:
new text end

new text begin (1)new text end obtain medical cannabis flower, medical cannabinoid products, and medical cannabis
paraphernalia from new text begin a new text end cannabis deleted text begin retailers and medical cannabis retailersdeleted text end new text begin business with a
medical cannabis retail endorsement;new text end and

new text begin (2)new text end administer medical cannabis flower and medical cannabinoid products.

Sec. 42.

Minnesota Statutes 2023 Supplement, section 342.01, subdivision 66, is amended
to read:


Subd. 66.

Registry verification.

"Registry verification" means the verification provided
by the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end that a patient is enrolled in the registry program
and that includes the patient's name, patient registry number, and, if applicable, the name
of the patient's registered designated caregiver or parent, legal guardian, or spouse.

Sec. 43.

Minnesota Statutes 2023 Supplement, section 342.01, is amended by adding a
subdivision to read:


new text begin Subd. 69a. new text end

new text begin Total THC. new text end

new text begin "Total THC" means the sum of the percentage by weight of
tetrahydrocannabinolic acid multiplied by 0.877 plus the percentage by weight of all
tetrahydrocannabinols.
 new text end

Sec. 44.

Minnesota Statutes 2023 Supplement, section 342.02, subdivision 2, is amended
to read:


Subd. 2.

Powers and duties.

(a) The office has the following powers and duties:

(1) to develop, maintain, and enforce an organized system of regulation for the cannabis
industry and hemp consumer industry;

(2) to establish programming, services, and notification to protect, maintain, and improve
the health of citizens;

(3) to prevent unauthorized access to cannabis flower, cannabis products, lower-potency
hemp edibles, and hemp-derived consumer products by individuals under 21 years of age;

(4) to establish and regularly update standards for product manufacturing, testing,
packaging, and labeling, including requirements for an expiration, sell-by, or best-used-by
date;

(5) to promote economic growth with an emphasis on growth in areas that experienced
a disproportionate, negative impact from cannabis prohibition;

(6) to issue and renew licenses;

(7) to require fingerprints from individuals determined to be subject to fingerprinting,
including the submission of fingerprints to the Federal Bureau of Investigation where
required by law and to obtain criminal conviction data for individuals seeking a license
from the office on the individual's behalf or as a cooperative member or director, manager,
or general partner of a business entity;

(8) to receive reports required by this chapter and inspect the premises, records, books,
and other documents of license holders to ensure compliance with all applicable laws and
rules;

(9) to authorize the use of unmarked motor vehicles to conduct seizures or investigations
pursuant to the office's authority;

(10) to impose and collect civil and administrative penalties as provided in this chapter;

(11) to publish such information as may be deemed necessary for the welfare of cannabis
businesses, cannabis workers, hemp businesses, and hemp workers and the health and safety
of citizens;

(12) to make loans and grants in aid to the extent that appropriations are made available
for that purpose;

(13) to authorize research and studies on cannabis flower, cannabis products, artificially
derived cannabinoids, lower-potency hemp edibles, hemp-derived consumer products, the
cannabis industry, and the hemp consumer industry;

(14) to provide reports as required by law;

(15) to develop a warning label regarding the effects of the use of cannabis flower and
cannabis products by persons 25 years of age or younger;

(16) to determine, based on a review of medical and scientific literature, whether it is
appropriate to require additional health and safety warnings containing information that is
both supported by credible science and helpful to consumers in considering potential health
risks from the use of cannabis flower, cannabis products, lower-potency hemp edibles, and
hemp-derived consumer products, including but not limited to warnings regarding any risks
associated with use by pregnant or breastfeeding individuals, or by individuals planning to
become pregnant, and the effects that use has on brain development for individuals under
the age of 25;

(17) to establish limits on the potency of cannabis flower and cannabis products that can
be sold to customers by licensed cannabis retailers, licensed cannabis microbusinesses, and
licensed cannabis mezzobusinesses with an endorsement to sell cannabis flower and cannabis
products to customers;

(18) to establish rules authorizing an increase in plant canopy limits and outdoor
cultivation limits to meet market demand and limiting cannabis manufacturing consistent
with the goals identified in subdivision 1; deleted text begin and
deleted text end

new text begin (19) to order a person or business that cultivates cannabis flower or manufactures or
produces cannabis products, medical cannabinoid products, artificially derived cannabinoids,
lower-potency hemp edibles, hemp-derived consumer products, or hemp-derived topical
products to recall any cannabis flower, product, or ingredient containing cannabinoids that
is used in a product if the office determines that the flower, product, or ingredient represents
a risk of causing a serious adverse incident; and
 new text end

deleted text begin (19)deleted text end new text begin (20)new text end to exercise other powers and authority and perform other duties required by
law.

(b) In addition to the powers and duties in paragraph (a), the office has the following
powers and duties until January 1, 2027:

(1) to establish limits on the potency of adult-use cannabis flower and adult-use cannabis
products that can be sold to customers by licensed cannabis retailers, licensed cannabis
microbusinesses, and licensed cannabis mezzobusinesses with an endorsement to sell
adult-use cannabis flower and adult-use cannabis products to customers; and

(2) to permit, upon application to the office in the form prescribed by the director of the
office, a licensee under this chapter to perform any activity if such permission is substantially
necessary for the licensee to perform any other activity permitted by the applicant's license
and is not otherwise prohibited by law.

Sec. 45.

Minnesota Statutes 2023 Supplement, section 342.02, subdivision 3, is amended
to read:


Subd. 3.

Medical cannabis program.

(a) The powers and duties of the Department of
Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections
152.22 to 152.37, are transferred to the Office of Cannabis Management under section
15.039.

(b) The following protections shall apply to employees who are transferred from the
Department of Health to the Office of Cannabis Management:

(1) the employment status and job classification of a transferred employee shall not be
altered as a result of the transfer;

(2) transferred employees who were represented by an exclusive representative prior to
the transfer shall continue to be represented by the same exclusive representative after the
transfer;

(3) the applicable collective bargaining agreements with exclusive representatives shall
continue in full force and effect for such transferred employees after the transfer;

(4) the state must meet and negotiate with the exclusive representatives of the transferred
employees about any proposed changes affecting or relating to the transferred employees'
terms and conditions of employment to the extent such changes are not addressed in the
applicable collective bargaining agreement; and

(5) for an employee in a temporary unclassified position transferred to the Office of
Cannabis Management, the total length of time that the employee has served in the
appointment shall include all time served in the appointment and the transferring agency
and the time served in the appointment at the Office of Cannabis Management. An employee
in a temporary unclassified position who was hired by a transferring agency through an
open competitive selection process in accordance with a policy enacted by Minnesota
Management and Budget shall be considered to have been hired through such process after
the transfer.

new text begin (c) This subdivision is effective July 1, 2024.
 new text end

Sec. 46.

Minnesota Statutes 2023 Supplement, section 342.02, subdivision 6, is amended
to read:


Subd. 6.

Director.

(a) The governor shall appoint a director of the office with the advice
and consent of the senate. The director must be in the unclassified service and must serve
at the pleasure of the governor.

deleted text begin (b) The salary of the director must not exceed the salary limit established under section
15A.0815, subdivision 3.
 deleted text end

new text begin (b) The director may appoint and employ no more than two deputy directors.
 new text end

new text begin (c) The director has administrative control of the office. The director has the powers
described in section 15.06, subdivision 6.
 new text end

new text begin (d) The director may apply for and accept on behalf of the state any grants, bequests,
gifts, or contributions for the purpose of carrying out the duties and responsibilities of the
director.
 new text end

new text begin (e) Pursuant to state law, the director may apply for and receive money made available
from federal sources for the purpose of carrying out the duties and responsibilities of the
director.
 new text end

new text begin (f) The director may make contracts with and grants to Tribal Nations, public and private
agencies, for-profit and nonprofit organizations, and individuals using appropriated money.
 new text end

Sec. 47.

Minnesota Statutes 2023 Supplement, section 342.03, subdivision 1, is amended
to read:


Subdivision 1.

Membership.

The Cannabis Advisory Council is created consisting of
the following members:

(1) the director of the Office of Cannabis Management or a designee;

(2) the commissioner of employment and economic development or a designee;

(3) the commissioner of revenue or a designee;

(4) the commissioner of health or a designee;

(5) the commissioner of human services or a designee;

(6) the commissioner of public safety or a designee;

(7) the commissioner of human rights or a designee;

(8) the commissioner of labor or a designee;

(9) the commissioner of agriculture or a designee;

(10) the commissioner of the Pollution Control Agency or a designee;

(11) the superintendent of the Bureau of Criminal Apprehension or a designee;

(12) the colonel of the State Patrol or a designee;

(13) the director of the Office of Traffic Safety in the Department of Public Safety or a
designee;

(14) a representative from the League of Minnesota Cities appointed by the league;

(15) a representative from the Association of Minnesota Counties appointed by the
association;

(16) an expert in minority business development appointed by the governor;

(17) an expert in economic development strategies for under-resourced communities
appointed by the governor;

(18) an expert in farming or representing the interests of farmers appointed by the
governor;

(19) an expert representing the interests of cannabis workers appointed by the governor;

(20) an expert representing the interests of employers appointed by the governor;

(21) an expert in municipal law enforcement with advanced training in impairment
detection and evaluation appointed by the governor;

(22) an expert in social welfare or social justice appointed by the governor;

(23) an expert in criminal justice reform to mitigate the disproportionate impact of drug
prosecutions on communities of color appointed by the governor;

(24) an expert in prevention, treatment, and recovery related to substance use disorders
appointed by the governor;

(25) an expert in minority business ownership appointed by the governor;

(26) an expert in women-owned businesses appointed by the governor;

(27) an expert in cannabis retailing appointed by the governor;

(28) an expert in cannabis product manufacturing appointed by the governor;

(29) an expert in laboratory sciences and toxicology appointed by the governor;

(30) an expert in providing legal services to cannabis businesses appointed by the
governor;

(31) an expert in cannabis cultivation appointed by the governor;

(32) an expert in pediatric medicine appointed by the governor;

(33) an expert in adult medicine appointed by the governor;

(34) new text begin an expert in clinical pharmacy appointed by the governor;
new text end

new text begin (35) new text end three patient advocates, one who is a patient enrolled in the medical cannabis
program; one who is a parent or caregiver of a patient in the medical cannabis program;
and one patient with experience in the mental health system or substance use disorder
treatment system appointed by the governor;

deleted text begin (35)deleted text end new text begin (36)new text end two licensed mental health professionals appointed by the governor;

deleted text begin (36)deleted text end new text begin (37)new text end a veteran appointed by the governor;

deleted text begin (37)deleted text end new text begin (38)new text end one member of each of the following federally recognized Tribes, designated
by the elected Tribal president or chairperson of the governing bodies of:

(i) the Fond du Lac Band;

(ii) the Grand Portage Band;

(iii) the Mille Lacs Band;

(iv) the White Earth Band;

(v) the Bois Forte Band;

(vi) the Leech Lake Band;

(vii) the Red Lake Nation;

(viii) the Upper Sioux Community;

(ix) the Lower Sioux Indian Community;

(x) the Shakopee Mdewakanton Sioux Community; and

(xi) the Prairie Island Indian Community; and

deleted text begin (38)deleted text end new text begin (39)new text end a representative from the Local Public Health Association of Minnesota
appointed by the association.

Sec. 48.

Minnesota Statutes 2023 Supplement, section 342.03, subdivision 4, is amended
to read:


Subd. 4.

Duties.

(a) The duties of the advisory council shall include:

(1) reviewing national cannabis policy;

(2) examining the effectiveness of state cannabis policy;

(3) reviewing developments in the cannabis industry and hemp consumer industry;

(4) reviewing developments in the study of cannabis flower, cannabis products, artificially
derived cannabinoids, lower-potency hemp edibles, and hemp-derived consumer products;

(5) taking public testimony; deleted text begin and
deleted text end

new text begin (6) studying the impact of legalized adult-use cannabis on the rate of cannabis use by
minors; and
 new text end

deleted text begin (6)deleted text end new text begin (7)new text end making recommendations to the Office of Cannabis Management.

(b) At its discretion, the advisory council may examine other related issues consistent
with this section.

Sec. 49.

Minnesota Statutes 2023 Supplement, section 342.06, is amended to read:


342.06 APPROVAL OF CANNABIS FLOWER, PRODUCTS, AND
CANNABINOIDS.

new text begin Subdivision 1. new text end

new text begin Approval of cannabis flower and products. new text end

(a) For the purposes of
this section, "product category" means a type of product that may be sold in different sizes,
distinct packaging, or at various prices but is still created using the same manufacturing or
agricultural processes. A new or additional stock keeping unit (SKU) or Universal Product
Code (UPC) shall not prevent a product from being considered the same type as another
unit. All other terms have the meanings provided in section 342.01.

(b) The office shall approve product categories of cannabis flower, cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products for retail sale.

(c) The office may establish limits on the total THC of cannabis flower, cannabis products,
and hemp-derived consumer products. As used in this paragraph, "total THC" means the
sum of the percentage by weight of tetrahydrocannabinolic acid multiplied by 0.877 plus
the percentage by weight of all tetrahydrocannabinols.

(d) The office shall not approve any cannabis product, lower-potency hemp edible, or
hemp-derived consumer product that:

(1) is or appears to be a lollipop or ice cream;

(2) bears the likeness or contains characteristics of a real or fictional person, animal, or
fruit;

(3) is modeled after a type or brand of products primarily consumed by or marketed to
children;

(4) is substantively similar to a meat food product; poultry food product as defined in
section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision
7;

(5) contains a synthetic cannabinoid;

(6) is made by applying a cannabinoid, including but not limited to an artificially derived
cannabinoid, to a finished food product that does not contain cannabinoids and is sold to
consumers, including but not limited to a candy or snack food; or

(7) if the product is an edible cannabis product or lower-potency hemp edible, contains
an ingredient, other than a cannabinoid, that is not approved by the United States Food and
Drug Administration for use in food.

new text begin Subd. 2. new text end

new text begin Approval of cannabinoids. new text end

new text begin (a) The office may designate any cannabinoid as
nonintoxicating and may approve the use of any cannabinoid in lower-potency hemp edibles.
The office may establish limits on the amount of an intoxicating cannabinoid that may be
present in a lower-potency hemp edible.
 new text end

new text begin (b) Beginning January 1, 2026, any person may petition the office to designate a
cannabinoid as nonintoxicating or to allow the use of any cannabinoid in lower-potency
hemp edibles. Petitions must be filed in the form and manner established by the office and
must:
 new text end

new text begin (1) specify the cannabinoid that is the subject of the petition;
 new text end

new text begin (2) indicate whether the petition seeks to have the cannabinoid designated as
nonintoxicating or approved for use in lower-potency hemp edibles;
 new text end

new text begin (3) indicate whether the cannabinoid has been identified in cannabis plants, cannabis
extract, hemp plant parts, or hemp extract; and
 new text end

new text begin (4) include verified data, validated studies, or other evidence that is generally relied
upon in the scientific community to support the petition.
 new text end

new text begin (c) The office must post all final determinations on the office's publicly facing website.
 new text end

new text begin (d) If the office denies a petition to designate a cannabinoid as nonintoxicating or to
allow the cannabinoid's use in lower-potency hemp edibles, that denial shall be in effect for
two years. Any petition filed under this subdivision within two years of a final determination
denying a petition for the same cannabinoid must be summarily denied.
 new text end

Sec. 50.

Minnesota Statutes 2023 Supplement, section 342.07, subdivision 3, is amended
to read:


Subd. 3.

Edible cannabinoid product handler endorsement.

(a) Any person seeking
to manufacture, process, sell, handle, or store an edible cannabis product or lower-potency
hemp edible, other than an edible cannabis product or lower-potency hemp edible that has
been placed in its final packaging, must first obtain an edible cannabinoid product handler
endorsement.

(b) In consultation with the commissioner of agriculture, the office shall establish an
edible cannabinoid product handler endorsement.

(c) The office must regulate edible cannabinoid product handlers deleted text begin and assess penalties
in the samedeleted text end new text begin in anew text end manner deleted text begin provided fordeleted text end new text begin consistent with Department of Agriculture regulation
ofnew text end food handlers under chapters 28A, 31, and 34A and associated rules, with the following
exceptions:

(1) the office must issue an edible cannabinoid product handler endorsement, rather than
a license;

(2) eligibility for an edible cannabinoid product handler endorsement is limited to persons
who possess a valid license issued by the office;

(3) the office may not charge a fee for issuing or renewing the endorsement;

(4) the office must align the term and renewal period for edible cannabinoid product
handler endorsements with the term and renewal period of the license issued by the office;
and

(5) an edible cannabis product or lower-potency hemp edible must not be considered
adulterated solely because the product or edible contains tetrahydrocannabinol, cannabis
concentrate, hemp concentrate, artificially derived cannabinoids, or any other material
extracted or derived from a cannabis plant, cannabis flower, hemp plant, or hemp plant
parts.

(d) The edible cannabinoid product handler endorsement must prohibit the manufacture
of edible cannabis products at the same premises where food is manufactured, except for
the limited production of edible products produced solely for product development, sampling,
or testing. This limitation does not apply to the manufacture of lower-potency hemp edibles.

Sec. 51.

Minnesota Statutes 2023 Supplement, section 342.09, subdivision 3, is amended
to read:


Subd. 3.

Home extraction of cannabis concentrate by use of volatile solvent
prohibited.

No person may use a volatile solvent to separate or extract cannabis concentrate
or hemp concentrate without a cannabis microbusiness, cannabis mezzobusiness, cannabis
manufacturer, medical cannabis deleted text begin processordeleted text end new text begin combination businessnew text end , or lower-potency hemp
edible manufacturer license issued under this chapter.

Sec. 52.

Minnesota Statutes 2023 Supplement, section 342.10, is amended to read:


342.10 LICENSES; TYPES.

The office shall issue the following types of license:

(1) cannabis microbusiness;

(2) cannabis mezzobusiness;

(3) cannabis cultivator;

(4) cannabis manufacturer;

(5) cannabis retailer;

(6) cannabis wholesaler;

(7) cannabis transporter;

(8) cannabis testing facility;

(9) cannabis event organizer;

(10) cannabis delivery service;

(11) lower-potency hemp edible manufacturer;

(12) lower-potency hemp edible retailer;new text begin and
new text end

deleted text begin (13) medical cannabis cultivator;
 deleted text end

deleted text begin (14) medical cannabis processor;
 deleted text end

deleted text begin (15) medical cannabis retailer; or
 deleted text end

deleted text begin (16)deleted text end new text begin (13)new text end medical cannabis combination business.

Sec. 53.

Minnesota Statutes 2023 Supplement, section 342.11, is amended to read:


342.11 LICENSES; FEES.

(a) The office shall require the payment of application fees, initial licensing fees, and
renewal licensing fees as provided in this section. The initial license fee shall include the
fee for initial issuance of the license and the first annual renewal. The renewal fee shall be
charged at the time of the second renewal and each subsequent annual renewal thereafter.
Nothing in this section prohibits a local unit of government from charging the retailer
registration fee established in section 342.22. Application fees, initial licensing fees, and
renewal licensing fees are nonrefundable.

(b) Application and licensing fees shall be as follows:

(1) for a cannabis microbusiness:

(i) an application fee of $500;

(ii) an initial license fee of $0; and

(iii) a renewal license fee of $2,000;

(2) for a cannabis mezzobusiness:

(i) an application fee of $5,000;

(ii) an initial license fee of $5,000; and

(iii) a renewal license fee of $10,000;

(3) for a cannabis cultivator:

(i) an application fee of $10,000;

(ii) an initial license fee of $20,000; and

(iii) a renewal license fee of $30,000;

(4) for a cannabis manufacturer:

(i) an application fee of $10,000;

(ii) an initial license fee of $10,000; and

(iii) a renewal license fee of $20,000;

(5) for a cannabis retailer:

(i) an application fee of $2,500;

(ii) an initial license fee of $2,500; and

(iii) a renewal license fee of $5,000;

(6) for a cannabis wholesaler:

(i) an application fee of $5,000;

(ii) an initial license fee of $5,000; and

(iii) a renewal license fee of $10,000;

(7) for a cannabis transporter:

(i) an application fee of $250;

(ii) an initial license fee of $500; and

(iii) a renewal license fee of $1,000;

(8) for a cannabis testing facility:

(i) an application fee of $5,000;

(ii) an initial license fee of $5,000; and

(iii) a renewal license fee of $10,000;

(9) for a cannabis delivery service:

(i) an application fee of $250;

(ii) an initial license fee of $500; and

(iii) a renewal license fee of $1,000;

(10) for a cannabis event organizer:

(i) an application fee of $750; and

(ii) an initial license fee of $750;

(11) for a lower-potency hemp edible manufacturer:

(i) an application fee of $250;

(ii) an initial license fee of $1,000; and

(iii) a renewal license fee of $1,000;

(12) for a lower-potency hemp edible retailer:

(i) an application fee of $250 per retail location;

(ii) an initial license fee of $250 per retail location; and

(iii) a renewal license fee of $250 per retail location;new text begin and
new text end

deleted text begin (13) for a medical cannabis cultivator:
 deleted text end

deleted text begin (i) an application fee of $250;
 deleted text end

deleted text begin (ii) an initial license fee of $0; and
 deleted text end

deleted text begin (iii) a renewal license fee of $0;
 deleted text end

deleted text begin (14) for a medical cannabis processor:
 deleted text end

deleted text begin (i) an application fee of $250;
 deleted text end

deleted text begin (ii) an initial license fee of $0; and
 deleted text end

deleted text begin (iii) a renewal license fee of $0;
 deleted text end

deleted text begin (15) for a medical cannabis retailer:
 deleted text end

deleted text begin (i) an application fee of $250;
 deleted text end

deleted text begin (ii) an initial license fee of $0; and
 deleted text end

deleted text begin (iii) a renewal license fee of $0; and
 deleted text end

deleted text begin (16)deleted text end new text begin (13)new text end for a medical cannabis combination business:

(i) an application fee of $10,000;

(ii) an initial license fee of $20,000; and

(iii) a renewal license fee of $70,000.

Sec. 54.

Minnesota Statutes 2023 Supplement, section 342.12, is amended to read:


342.12 LICENSES; TRANSFERS; ADJUSTMENTS.

(a) Licenses issued under this chapter new text begin that are available to all applicants pursuant to
section 342.18, subdivision 4, paragraph (g), new text end may be freely transferred subject to the prior
written approval of the officedeleted text begin , which approval may be given or withheld in the office's sole
discretion, provided that a social equity applicant may only transfer the applicant's license
to another social equity applicantdeleted text end .

new text begin (b) Licenses issued as social equity licenses pursuant to either section 342.18, subdivision
4, paragraph (f), or section 342.175, paragraph (b), may only be transferred to another social
equity applicant for three years after the date on which the office issues the license. Three
years after the date of issuance, a license holder may transfer a license to any entity. Transfer
of a license that was issued as a social equity license must be reviewed by the Division of
Social Equity and is subject to the prior written approval of the office.
 new text end

new text begin (c) License preapproval issued pursuant to section 342.125 may not be transferred.
 new text end

new text begin (d)new text end A new license must be obtained when:

(1) the form of the licensee's legal business structure converts or changes to a different
type of legal business structure; or

(2) the licensee dissolves; consolidates; reorganizes; undergoes bankruptcy, insolvency,
or receivership proceedings; merges with another legal organization; or assigns all or
substantially all of its assets for the benefit of creditors.

deleted text begin (b) Transfers between social equity applicants must be reviewed by the Division of
Social Equity.
 deleted text end

deleted text begin (c)deleted text end new text begin (e)new text end Licenses must be renewed annually.

deleted text begin (d)deleted text end new text begin (f)new text end License holders may petition the office to adjust the tier of a license issued within
a license category deleted text begin provided thatdeleted text end new text begin ifnew text end the license holder meets all applicable requirements.

deleted text begin (e)deleted text end new text begin (g)new text end The office by rule may permit new text begin the new text end relocation of a licensed cannabis businessdeleted text begin ,deleted text end new text begin ;
permit the relocation of an approved operational location, including a cultivation,
manufacturing, processing, or retail location;new text end adopt requirements for the submission of a
license relocation applicationdeleted text begin ,deleted text end new text begin ;new text end establish standards for the approval of a relocation
applicationdeleted text begin ,deleted text end new text begin ;new text end and charge a fee not to exceed $250 for reviewing and processing applications.
Relocation of a licensed premises pursuant to this paragraph does not extend or otherwise
modify the license term of the license subject to relocation.

Sec. 55.

new text begin [342.125] LICENSE PREAPPROVAL.
 new text end

new text begin Subdivision 1. new text end

new text begin Preapproval. new text end

new text begin (a) The office may establish a license preapproval process
for applicants who meet the requirements in section 342.17.
 new text end

new text begin (b) The office may issue up to the following number of license preapprovals:
 new text end

new text begin (1) cannabis microbusiness licenses, 100;
 new text end

new text begin (2) cannabis mezzobusiness licenses, 25;
 new text end

new text begin (3) cannabis cultivator licenses, 13;
 new text end

new text begin (4) cannabis manufacturer licenses, six;
 new text end

new text begin (5) cannabis retailer licenses, 50;
 new text end

new text begin (6) cannabis wholesaler licenses, 20;
 new text end

new text begin (7) cannabis transporter licenses, 20;
 new text end

new text begin (8) cannabis testing facility licenses, 50; and
 new text end

new text begin (9) cannabis delivery service licenses, ten.
 new text end

new text begin (c) License preapproval remains valid for 18 months from the date that the office adopts
initial rules pursuant to section 342.02, subdivision 5, unless the office revokes the
preapproval. If a person has not converted a preapproval into a license within 18 months,
the preapproval expires.
 new text end

new text begin (d) By August 15, 2024, the office must announce the commencement of an initial
application period for license preapproval. By October 1, 2024, the office must issue license
preapprovals to eligible applicants who submit an application in the initial application period.
The office must prioritize license categories that authorize the cultivation of cannabis plants.
At a minimum, the office must make the following number of licenses available for
preapproval in the initial application period:
 new text end

new text begin (1) cannabis microbusiness licenses, 100;
 new text end

new text begin (2) cannabis mezzobusiness licenses, 25;
 new text end

new text begin (3) cannabis cultivator licenses, 26; and
 new text end

new text begin (4) cannabis testing facility licenses, 50.
 new text end

new text begin Subd. 2. new text end

new text begin Eligibility. new text end

new text begin (a) Only a social equity applicant who meets the requirements in
section 342.17 is eligible for license preapproval.
 new text end

new text begin (b) The office must not issue a license preapproval if the applicant would be prohibited
from holding the license under section 342.18, subdivision 2.
 new text end

new text begin Subd. 3. new text end

new text begin Application; contents. new text end

new text begin (a) An applicant for preapproval must:
 new text end

new text begin (1) complete an application that contains the information described in section 342.14,
subdivision 1, on a form approved by the office; and
 new text end

new text begin (2) pay the applicable application fee required under section 342.11, paragraph (b), for
the license being sought.
 new text end

new text begin (b) The office shall not require an applicant to possess or identify any property on which
the cannabis business will operate.
 new text end

new text begin Subd. 4. new text end

new text begin Application process. new text end

new text begin (a) The office must announce the commencement of an
application period for license preapproval at least 14 days before the date that the office
begins to accept applications. The announcement must include:
 new text end

new text begin (1) the types of licenses that will be available for preapproval during the application
period;
 new text end

new text begin (2) the number of each type of license available;
 new text end

new text begin (3) the date on which the application period will begin; and
 new text end

new text begin (4) the date on which the application period will end.
 new text end

new text begin (b) The office must accept applications for license preapproval for 30 calendar days
during an application period.
 new text end

new text begin (c) Before proceeding with a review of the application, the office must verify the
applicant's status as a social equity applicant.
 new text end

new text begin (d) The office may deny an application for preapproval that:
 new text end

new text begin (1) is incomplete;
 new text end

new text begin (2) contains a material false statement about the applicant or omits material information
about the applicant;
 new text end

new text begin (3) is from an applicant that does not meet the requirements in section 342.17;
 new text end

new text begin (4) fails to meet the minimum qualifications for the license in section 342.18, subdivision
3;
 new text end

new text begin (5) is from an applicant who fails to pay the applicable application fee; or
 new text end

new text begin (6) is not submitted by the deadline established by the office.
 new text end

new text begin (e) If the office denies an application for preapproval, the office must notify the applicant
of the denial and the basis for the denial.
 new text end

new text begin (f) The office may request additional information from any applicant if the office
determines that the information is necessary to review or process the application. If the
applicant does not provide the additional requested information within 14 calendar days of
the office's request for information, the office may deny the application.
 new text end

new text begin Subd. 5. new text end

new text begin Issuance of preapproval; lottery. new text end

new text begin (a) An applicant who meets the requirements
in subdivisions 2, 3, and 4 is a qualified applicant and the office may issue a license
preapproval to the applicant.
 new text end

new text begin (b) If there are fewer license preapprovals available than the number of qualified
applicants for that license type, the office must conduct a lottery to select applicants for
preapproval. The lottery must include all qualified applicants seeking preapproval for the
license type and must be impartial, random, and in a format determined by the office.
 new text end

new text begin (c) The office may remove an applicant from the lottery if the office determines that:
 new text end

new text begin (1) the applicant has violated an ownership or operational requirement in this chapter
or rules adopted pursuant to this chapter that would justify revocation or nonrenewal of a
license;
 new text end

new text begin (2) the applicant is disqualified from holding a license pursuant to section 342.15; or
 new text end

new text begin (3) the applicant is determined to be in arrears on property, business, or personal taxes.
 new text end

new text begin (d) If the office removes an applicant from a lottery, the office must notify the applicant
of the removal and the basis for the removal. If an applicant is not selected in a lottery, the
office must notify the applicant that the applicant was not selected.
 new text end

new text begin Subd. 6. new text end

new text begin License preapproval; purpose; restrictions. new text end

new text begin (a) License preapproval issued
by the office is evidence that the applicant has submitted all necessary information to the
office; the office has determined that the applicant is qualified to hold a license of the type
that is preapproved; and the office will issue the person a license after the office adopts
initial rules pursuant to section 342.02, subdivision 5, unless the office revokes preapproval
pursuant to subdivision 7.
 new text end

new text begin (b) Upon request by a person who has been preapproved for a license, the office must
provide confirmation of the preapproval to third parties to assist the person in taking the
steps necessary to prepare for business operations, including:
 new text end

new text begin (1) establishing legal control of the site of the cannabis business through lease, purchase,
or other means;
 new text end

new text begin (2) gaining zoning or planning approval for the site of the cannabis business from a local
unit of government; and
 new text end

new text begin (3) raising capital for the person's business operations.
 new text end

new text begin (c) License preapproval does not authorize a person to open a cannabis business or
engage in any activity that requires a license issued under this chapter.
 new text end

new text begin (d) A person with a license preapproval shall not:
 new text end

new text begin (1) purchase, possess, cultivate, manufacture, distribute, dispense, or sell cannabis plants,
cannabis flower, cannabis products, medical cannabis flower, or medical cannabinoid
products;
 new text end

new text begin (2) manufacture, distribute, or sell edible cannabinoid products or lower-potency hemp
edibles unless the person has explicit permission to engage in those activities from the office
and has a valid license authorizing those actions or is registered pursuant to section 151.72;
 new text end

new text begin (3) make any transfer of an ownership interest that causes a change in the individual or
entity that holds the controlling ownership interest;
 new text end

new text begin (4) make any change or transfer of ownership or control that would require a new business
registration with the secretary of state; or
 new text end

new text begin (5) make any transfer of ownership interest that causes the person with a license
preapproval to no longer qualify as a social equity applicant under section 342.17.
 new text end

new text begin Subd. 7. new text end

new text begin Revocation of preapproval. new text end

new text begin The office may revoke a license preapproval if
the individual holding the preapproval or, if preapproval is granted to a business entity, any
cooperative member or director, manager, or general partner of the business entity:
 new text end

new text begin (1) fraudulently or deceptively obtained preapproval;
 new text end

new text begin (2) fails to reveal any material fact pertaining to the qualification for preapproval;
 new text end

new text begin (3) violates any provision of this chapter;
 new text end

new text begin (4) is not registered or in good standing with the Office of the Secretary of State; or
 new text end

new text begin (5) is in arrears on property, business, or personal taxes.
 new text end

new text begin Subd. 8. new text end

new text begin Conversion of preapproval. new text end

new text begin (a) The office must grant a license to any person
who has received a license preapproval after the office:
 new text end

new text begin (1) adopts initial rules pursuant to section 342.02, subdivision 5; and
 new text end

new text begin (2) receives the applicable license fee pursuant to section 342.11.
 new text end

new text begin (b) The office must not grant a license to a person who has received a license preapproval
if:
 new text end

new text begin (1) the ownership of the business has changed since the office granted a license
preapproval and the person has not filed an updated ownership disclosure as required by
section 342.14, subdivision 1, paragraph (b); or
 new text end

new text begin (2) the cannabis business for which the office granted a license preapproval does not
meet local zoning and land use laws.
 new text end

new text begin Subd. 9. new text end

new text begin Applicants; right to a reconsideration. new text end

new text begin (a) If the office denies an application
for a license preapproval or removes an application from a lottery, the applicant may request
a records review of the submitted application materials within seven calendar days of
receiving notification that the office denied or removed the application.
 new text end

new text begin (b) Upon an applicant's request, the office must allow the applicant to examine the
applicant's records received by the office.
 new text end

new text begin (c) A person whose license preapproval is later revoked by the office may request
reconsideration by the director.
 new text end

new text begin (d) A person whose application is denied, removed from a lottery, or not selected in a
lottery may not appeal or request a hearing.
 new text end

new text begin Subd. 10. new text end

new text begin Retention of applications. new text end

new text begin (a) A qualified applicant whose application is not
selected for a license preapproval in a lottery may request that the office retain the application
for subsequent application periods.
 new text end

new text begin (b) If a qualified applicant requests that the office retain an application, the office must
retain the application for one year after the date of the request.
 new text end

new text begin (c) The office may request additional information from any applicant whose application
is retained if the office determines that the information is necessary to determine if the
applicant meets the requirements for a subsequent application period. If the applicant does
not provide the additional requested information within 14 calendar days of the office's
request for information, the office may deny the application.
 new text end

new text begin (d) The office may disqualify an application from retention under the grounds specified
in subdivision 5, paragraph (c).
 new text end

new text begin (e) If the office announces an application period, any application retained by the office
may be granted a license preapproval or be entered in a lottery if the applicant amends an
application or provides additional information at the request of the office. The office must
not charge an additional application fee before granting license preapproval to an applicant
whose application was retained by the office or entering an application retained by the office
in a lottery.
 new text end

Sec. 56.

Minnesota Statutes 2023 Supplement, section 342.13, is amended to read:


342.13 LOCAL CONTROL.

(a) A local unit of government may not prohibit the possession, transportation, or use
of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived
consumer products authorized under this chapter.

(b) Except as provided in section 342.22, a local unit of government may not prohibit
the establishment or operation of a cannabis business new text begin or hemp business new text end licensed under this
chapter.

(c) A local unit of government may adopt reasonable restrictions on the time, place, and
manner of the operation of a cannabis business provided that such restrictions do not prohibit
the establishment or operation of cannabis businesses. A local unit of government may
prohibit the operation of a cannabis business within 1,000 feet of a school, or 500 feet of a
day care, residential treatment facility, or an attraction within a public park that is regularly
used by minors, including a playground or athletic field.

(d) The office shall work with local units of government to:

(1) develop model ordinances for reasonable restrictions on the time, place, and manner
of the operation of a cannabis business;

(2) develop standardized forms and procedures for the issuance of a retail registration
pursuant to section 342.22; and

(3) develop model policies and procedures for the performance of compliance checks
required under section 342.22.

(e) If a local unit of government is conducting studies or has authorized a study to be
conducted or has held or has scheduled a hearing for the purpose of considering adoption
or amendment of reasonable restrictions on the time, place, and manner of the operation of
a cannabis business, the governing body of the local unit of government may adopt an
interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting
the planning process and the health, safety, and welfare of its citizens. Before adopting the
interim ordinance, the governing body must hold a public hearing. The interim ordinance
may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction
or a portion thereof until January 1, 2025.

(f) deleted text begin Within 30 days of receiving a copy of an application from the office, a local unit of
government shall certify on a form provided by the office whether a proposed cannabis
business complies with local zoning ordinances and, if applicable, whether the proposed
business complies with the state fire code and building code.deleted text end The office may not issue deleted text begin a
licensedeleted text end new text begin an endorsement to a cannabis business new text end if deleted text begin adeleted text end new text begin thenew text end cannabis business does not meet local
zoning and land use laws.

deleted text begin (g) Upon receipt of an application for a license issued under this chapter, the office shall
contact the local unit of government in which the business would be located and provide
the local unit of government with 30 days in which to provide input on the application. The
local unit of government may provide the office with any additional information it believes
is relevant to the office's decision on whether to issue a license, including but not limited
to identifying concerns about the proposed location of a cannabis business or sharing public
information about an applicant.
 deleted text end

deleted text begin (h)deleted text end new text begin (g)new text end The office by rule shall establish an expedited complaint process to receive,
review, and respond to complaints made by a local unit of government about a cannabis
business. deleted text begin Complaints may include alleged violations of local ordinances or other alleged
violations.deleted text end new text begin The office may only investigate complaints alleging a violation of this chapter.new text end
At a minimum, the expedited complaint process shall require the office to provide an initial
response to the complaint within seven days and perform any necessary inspections within
30 days. Nothing in this paragraph prohibits a local unit of government from enforcing a
local ordinance. If a local unit of government notifies the office that a cannabis business
other than a cannabis retailer, cannabis microbusiness new text begin or cannabis mezzobusiness new text end with a
retail operations endorsement, deleted text begin cannabis mezzobusiness,deleted text end lower-potency hemp edible retailer,
deleted text begin medical cannabis retailer,deleted text end or medical cannabis combination business new text begin operating a retail
location new text end poses an immediate threat to the health or safety of the public, the office must
respond within one business day and may take any action described in section 342.19 or
342.21.

deleted text begin (i)deleted text end new text begin (h)new text end A local government unit that issues new text begin a new text end cannabis retailer registration under section
342.22 may, by ordinance, limit the number of licensed cannabis retailers, cannabis
mezzobusinesses with a retail operations endorsement, and cannabis microbusinesses with
a retail operations endorsement to no fewer than one registration for every 12,500 residents.

deleted text begin (j)deleted text end new text begin (i)new text end If a county has one active registration for every 12,500 residents, a city or town
within the county is not obligated to register a cannabis business.

deleted text begin (k)deleted text end new text begin (j)new text end Nothing in this section shall prohibit a local government unit from allowing
licensed cannabis retailers in excess of the minimums set in paragraph deleted text begin (i)deleted text end new text begin (h)new text end .

deleted text begin (l)deleted text end new text begin (k)new text end Notwithstanding the foregoing provisions, the state shall not issue a license to
any cannabis business to operate in Indian country, as defined in United States Code, title
18, section 1151, of a Minnesota Tribal government without the consent of the Tribal
government.

Sec. 57.

Minnesota Statutes 2023 Supplement, section 342.14, is amended to read:


342.14 CANNABIS LICENSE APPLICATION AND RENEWAL.

Subdivision 1.

Application; contents.

(a) The office by rule shall establish forms and
procedures for the processing of cannabis new text begin business new text end licenses issued under this chapter. deleted text begin At a
minimum, any application to obtain or renew a cannabis license shalldeleted text end new text begin The office must direct
an applicant tonew text end include the following informationdeleted text begin , if applicabledeleted text end new text begin in an application to obtain
or renew a cannabis licensenew text end :

(1) the name, address, and date of birth of the applicant;

(2) the disclosure of ownership and control required under paragraph (b);

(3) the disclosure of whether the applicant or, if the applicant is a business, any officer,
director, manager, and general partner of the business has ever filed for bankruptcy;

(4) the address and legal property description of the businessnew text begin , if applicable, except an
applicant is not required to secure a physical premises for the business at the time of
applicationnew text end ;

(5) a general description of the location or locations that the applicant plans to operate,
including the planned square feet of deleted text begin planneddeleted text end space for cultivation, wholesaling, and retailing,
as applicable;

(6) a copy of the security plan;

(7) proof of trade name registration;

(8) a copy of the applicant's business plan showing the expected size of the business;
anticipated growth; the methods of record keeping; the knowledge and experience of the
applicant and any officer, director, manager, and general partner of the business; the
environmental plan; and other relevant financial and operational components;

(9) an attestation signed by a bona fide labor organization stating that the applicant has
entered into a labor peace agreement;

(10) certification that the applicant will comply with the requirements of this chapter
relating to the ownership and operation of a cannabis business;

(11) identification of one or more controlling persons or managerial employees as agents
who shall be responsible for dealing with the office on all matters; and

(12) a statement that the applicant agrees to respond to the office's supplemental requests
for information.

(b) An applicant must file and update as necessary a disclosure of ownership and control.
The office by rule shall establish the contents and form of the disclosure. Except as provided
in paragraph (f), the disclosure shall, at a minimum, include the following:

(1) the management structure, ownership, and control of the applicant or license holder,
including the name of each cooperative member, officer, director, manager, general partner,
or business entity; the office or position held by each person; each person's percentage
ownership interest, if any; and, if the business has a parent company, the name of each
owner, board member, and officer of the parent company and the owner's, board member's,
or officer's percentage ownership interest in the parent company and the cannabis business;

(2) a statement from the applicant and, if the applicant is a business, from every officer,
director, manager, and general partner of the business, indicating whether that person has
previously held, or currently holds, an ownership interest in a cannabis business in Minnesota,
any other state or territory of the United States, or any other country;

(3) if the applicant is a corporation, copies of the applicant's articles of incorporation
and bylaws and any amendments to the applicant's articles of incorporation or bylaws;

(4) copies of any partnership agreement, operating agreement, or shareholder agreement;

(5) copies of any promissory notes, security instruments, or other similar agreements;

(6) an explanation detailing the funding sources used to finance the business;

(7) a list of operating and investment accounts for the business, including any applicable
financial institution and account number; and

(8) a list of each outstanding loan and financial obligation obtained for use in the business,
including the loan amount, loan terms, and name and address of the creditor.

(c) An application may include:

(1) proof that the applicant is a social equity applicant;

(2) a description of the training and education that will be provided to any employee;
or

(3) a copy of business policies governing operations to ensure compliance with this
chapter.

(d) Commitments made by an applicant in its application, including but not limited to
the maintenance of a labor peace agreement, shall be an ongoing material condition of
maintaining and renewing the license.

(e) An application on behalf of a corporation or association shall be signed by at least
two officers or managing agents of that entity.

(f) The office maydeleted text begin ,deleted text end by ruledeleted text begin ,deleted text end establish exceptions to the disclosures required under
paragraph (b) for members of a cooperative who hold less than a five percent ownership
interest in the cooperative.

Subd. 2.

Application; process.

(a) An applicant must submit all required information
to the office on the forms and in the manner prescribed by the office.

(b) If the office receives an application that fails to provide the required information,
the office shall issue a deficiency notice to the applicant. The applicant shall have ten
business days from the date of the deficiency notice to submit the required information.

(c) Failure by an applicant to submit all required information will result in the application
being rejected.

deleted text begin (d) Upon receipt of a completed application and fee, the office shall forward a copy of
the application to the local unit of government in which the business operates or intends to
operate with a form for certification as to whether a proposed cannabis business complies
with local zoning ordinances and, if applicable, whether the proposed business complies
with the state fire code and building code.
 deleted text end

deleted text begin (e)deleted text end new text begin (d)new text end Within 90 days of receiving a completed application and the results of any required
criminal history check, the office shall issue the appropriate license or send the applicant a
notice of rejection setting forth specific reasons that the office did not approve the application.

new text begin Subd. 3. new text end

new text begin License revocation. new text end

new text begin The office may revoke a cannabis business license if the
licensee has not made good faith efforts to obtain an endorsement within 18 months of the
date that the license was issued.
 new text end

Sec. 58.

Minnesota Statutes 2023 Supplement, section 342.15, is amended by adding a
subdivision to read:


new text begin Subd. 5. new text end

new text begin Civil and regulatory offenses; disqualifications. new text end

new text begin The office may determine
whether any civil or regulatory violations, as determined by another state agency, local unit
of government, or any other jurisdiction, disqualify an individual from holding or receiving
a cannabis business license issued under this chapter or disqualify an individual from working
for a cannabis business and the length of the disqualification. For purposes of making a
determination under this subdivision, and notwithstanding the data's classification under
chapter 13, the office may access civil investigatory data about an applicant maintained by
any other government entity.
 new text end

Sec. 59.

new text begin [342.151] EMPLOYEES OF LICENSE HOLDERS.
 new text end

new text begin Subdivision 1. new text end

new text begin Definitions. new text end

new text begin For purposes of this section, a "license holder" includes a
cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis manufacturer,
cannabis retailer, cannabis wholesaler, cannabis transporter, cannabis testing facility, cannabis
event organizer, cannabis delivery service, lower-potency hemp edible manufacturer,
lower-potency hemp edible retailer, or medical cannabis combination business.
 new text end

new text begin Subd. 2. new text end

new text begin Disqualification. new text end

new text begin (a) A license holder must not employ an individual as a
cannabis worker if the individual has been convicted of any of the following crimes that
would constitute a felony:
 new text end

new text begin (1) human trafficking;
 new text end

new text begin (2) noncannabis controlled substance crimes in the first or second degree;
 new text end

new text begin (3) labor trafficking;
 new text end

new text begin (4) fraud;
 new text end

new text begin (5) embezzlement;
 new text end

new text begin (6) extortion;
 new text end

new text begin (7) money laundering; or
 new text end

new text begin (8) insider trading;
 new text end

new text begin if committed in this state or any other jurisdiction for which a full pardon or similar relief
has not been granted.
 new text end

new text begin (b) A license holder must not employ an individual as a cannabis worker if the individual
made any false statement in an application for employment.
 new text end

Sec. 60.

Minnesota Statutes 2023 Supplement, section 342.17, is amended to read:


342.17 SOCIAL EQUITY APPLICANTS.

(a) An applicant qualifies as a social equity applicant if the applicant:

(1) was convicted of an offense involving the possession or sale of cannabis or marijuana
prior to May 1, 2023;

(2) had a parent, guardian, child, spouse, or dependent who was convicted of an offense
involving the possession or sale of cannabis or marijuana prior to May 1, 2023;

(3) was a dependent of an individual who was convicted of an offense involving the
possession or sale of cannabis or marijuana prior to May 1, 2023;

(4) is a new text begin military veteran, including status as a new text end service-disabled veteran, current or former
member of the national guard, or any military veteran or current or former member of the
national guard who lost honorable status due to an offense involving the possession or sale
of new text begin cannabis or new text end marijuana;

(5) has been a resident for the last five years of one or more subareas, such as census
tracts or neighborhoods, that experienced a disproportionately large amount of cannabis
enforcement as determined by the study conducted by the office pursuant to section 342.04,
paragraph (b), and reported in the preliminary report, final report, or both;

(6) is an emerging farmer as defined in section deleted text begin 17.055, subdivision 1deleted text end new text begin 17.133, subdivision
1new text end ; or

(7) has been a resident for the last five years of one or more census tracts where, as
reported in the most recently completed decennial census published by the United States
Bureau of the Census, either:

(i) the poverty rate was 20 percent or more; or

(ii) the median family income did not exceed 80 percent of statewide median family
income or, if in a metropolitan area, did not exceed the greater of 80 percent of the statewide
median family income or 80 percent of the median family income for that metropolitan
area.

(b) The qualifications described in paragraph (a) apply to each individual applicant or,
in the case of a business entity, deleted text begin every cooperative member or director, manager, and general
partnerdeleted text end new text begin apply to at least 65 percent of the controlling ownershipnew text end of the business entity.

Sec. 61.

new text begin [342.175] SOCIAL EQUITY LICENSE CLASSIFICATION.
 new text end

new text begin (a) The office must classify licenses listed in section 342.10, clauses (1) to (10) and (13)
as:
 new text end

new text begin (1) available to social equity applicants who meet the requirements of section 342.17;
and
 new text end

new text begin (2) available to all applicants.
 new text end

new text begin (b) The office must classify any license issued to a social equity applicant as a social
equity license.
 new text end

Sec. 62.

Minnesota Statutes 2023 Supplement, section 342.18, subdivision 2, is amended
to read:


Subd. 2.

Vertical integration prohibited; exceptions.

(a) Except as otherwise provided
in this subdivision, the office shall not issue licenses to a single applicant that would result
in the applicant being vertically integrated in violation of the provisions of this chapter.

(b) Nothing in this section prohibits or limits the issuance of microbusiness licenses deleted text begin ordeleted text end new text begin ,new text end
mezzobusiness licenses, new text begin or medical cannabis combination business licenses, new text end or the issuance
of both lower-potency hemp edible manufacturer and lower-potency hemp edible retailer
licenses to the same person or entity.

Sec. 63.

Minnesota Statutes 2023 Supplement, section 342.18, subdivision 3, is amended
to read:


Subd. 3.

Application deleted text begin score; license prioritydeleted text end new text begin reviewnew text end .

(a) The office shall deleted text begin award points
todeleted text end new text begin reviewnew text end each completed application for a license to operate a cannabis business in the
following categories:

deleted text begin (1) status as a social equity applicant or as an applicant who is substantially similar to
a social equity applicant as described in paragraph (c);
 deleted text end

deleted text begin (2) status as a veteran or retired national guard applicant who does not meet the definition
of social equity applicant;
 deleted text end

deleted text begin (3)deleted text end new text begin (1)new text end security and record keeping;

deleted text begin (4)deleted text end new text begin (2)new text end employee training plan;

deleted text begin (5)deleted text end new text begin (3)new text end business plan and financial situation;

deleted text begin (6)deleted text end new text begin (4)new text end labor and employment practices;

deleted text begin (7)deleted text end new text begin (5)new text end knowledge and experience; and

deleted text begin (8)deleted text end new text begin (6)new text end environmental plan.

deleted text begin (b) The office may award additional points to an application if the license holder would
expand service to an underrepresented market, including but not limited to participation in
the medical cannabis program.
 deleted text end

deleted text begin (c) The office shall establish application materials permitting individual applicants to
demonstrate the impact that cannabis prohibition has had on that applicant, including but
not limited to the arrest or imprisonment of the applicant or a member of the applicant's
immediate family, and the office may award points to such applicants in the same manner
as points are awarded to social equity applicants.
 deleted text end

deleted text begin (d)deleted text end new text begin (b)new text end The office shall establish policies and guidelines, which new text begin the office new text end must deleted text begin be madedeleted text end new text begin
makenew text end available to the public, regarding the deleted text begin number of points availabledeleted text end new text begin minimum
qualificationsnew text end in each category and the deleted text begin basis for awarding those points. Status as a social
equity applicant must account for at least 20 percent of the total available points. In
determining the number of points to award to a cooperative or business applying as a social
equity applicant, the office shall consider the number or ownership percentage of cooperative
members, officers, directors, managers, and general partners who qualify as social equity
applicantsdeleted text end new text begin criteria that the office uses to determine whether an applicant meets the minimum
qualifications in each categorynew text end .

deleted text begin (e) Consistent with the goals identified in subdivision 1, the office shall issue licenses
in each license category, giving priority to applicants who receive the highest score under
paragraphs (a) and (b). If there are insufficient licenses available for entities that receive
identical scores, the office shall utilize a lottery to randomly select license recipients from
among those entities.
 deleted text end

Sec. 64.

Minnesota Statutes 2023 Supplement, section 342.18, is amended by adding a
subdivision to read:


new text begin Subd. 4. new text end

new text begin Maximum number of licenses. new text end

new text begin (a) Through as many licensing periods as the
office deems necessary, the office shall issue up to the maximum number of licenses in each
license category listed in paragraphs (e) and (f) to applicants that meet the minimum
qualifications in subdivision 3. After 24 months from the beginning of the license application
process, the office may adjust the maximum number of licenses of any type listed in this
subdivision based on market demand, consistent with the objectives in section 342.02,
subdivision 1, and the annual report required under section 342.04, paragraph (f).
 new text end

new text begin (b) If any applicant that meets the minimum qualifications in subdivision 3 is a city or
county seeking to establish, own, or operate a municipal cannabis store authorized under
section 342.32, subdivision 5, the office must issue a license to that applicant before issuing
any other licenses under this section or holding a lottery to randomly select license recipients.
Notwithstanding paragraph (f), a license issued to a city or county must not be counted
against the maximum number of licenses made available in an application period. If there
are insufficient licenses available for all applicants that meet the minimum qualifications
in subdivision 3, the office shall hold a lottery to randomly select license recipients from
among the applicants.
 new text end

new text begin (c) The office may issue as many licenses as the office deems necessary of a license
type that is not listed in this subdivision. The office is not required to issue a license for a
license type that is not listed in this subdivision.
 new text end

new text begin (d) Cannabis mezzobusiness license holders must earn no fewer than two distinctly
different endorsements for authorized actions under the license category within 18 months
of license issuance or the office may revoke the license holder's license or take appropriate
enforcement action.
 new text end

new text begin (e) The office is not required to issue licenses to meet the maximum number of licenses
that may be issued under paragraphs (f) and (g).
 new text end

new text begin (f) For licenses that are available to social equity applicants, the maximum number of
licenses that the office may issue are:
 new text end

new text begin (1) cannabis cultivator licenses, 25;
 new text end

new text begin (2) cannabis manufacturer licenses, 12;
 new text end

new text begin (3) cannabis retailer licenses, 100; and
 new text end

new text begin (4) cannabis mezzobusiness licenses, 50.
 new text end

new text begin (g) For licenses that are available to all applicants, the maximum number of licenses
that the office may issue are:
 new text end

new text begin (1) cannabis cultivator licenses, 25;
 new text end

new text begin (2) cannabis manufacturer licenses, 12;
 new text end

new text begin (3) cannabis retailer licenses, 100; and
 new text end

new text begin (4) cannabis mezzobusiness licenses, 50.
 new text end

new text begin (h) If the office holds a lottery as provided in paragraph (b), an applicant that meets the
minimum qualifications in subdivision 3 and is not selected in the lottery may request that
the office retain the application for subsequent application periods. If a qualified applicant
requests that the office retain an application, the office must retain the application for one
year after the date of the request. The office may request additional information from any
applicant whose application is retained if the office determines that the information is
necessary to determine if the applicant meets the requirements for a subsequent application
period. If the applicant does not provide the additional requested information within 14
calendar days of the office's request for information, the office may deny the application.
If the office announces an application period, any application retained by the office may be
granted a license or be entered in a lottery if the applicant amends an application or provides
additional information at the request of the office. The office must not charge an additional
application fee before granting a license to an applicant whose application was retained by
the office or entering an application retained by the office in a lottery. The office may
disqualify an application from retention if:
 new text end

new text begin (1) the applicant has violated an ownership or operational requirement in this chapter
or rules adopted pursuant to this chapter that would justify revocation or nonrenewal of a
license;
 new text end

new text begin (2) the applicant is disqualified from holding a license pursuant to section 342.15; or
 new text end

new text begin (3) the applicant is determined to be in arrears on property, business, or personal taxes.
 new text end

Sec. 65.

Minnesota Statutes 2023 Supplement, section 342.18, is amended by adding a
subdivision to read:


new text begin Subd. 5. new text end

new text begin Conversion to hemp business license. new text end

new text begin (a) After the office adopts initial rules
pursuant to section 342.02, subdivision 5, the office may permit a person selling edible
cannabinoid products who has registered pursuant to section 151.72, subdivision 5b, to
convert the registration to a comparable hemp business license if:
 new text end

new text begin (1) the registration was active before the office adopted initial rules;
 new text end

new text begin (2) the person submits documentation to the office sufficient to meet the minimum
requirements in section 342.44;
 new text end

new text begin (3) the person pays the applicable application and licensing fee as required by section
342.11; and
 new text end

new text begin (4) the person is in good standing with the state.
 new text end

new text begin (b) A person selling edible cannabinoid products who has registered pursuant to section
151.72, subdivision 5b, and remains in good standing with the state may continue operations
under an active registration for the longer of:
 new text end

new text begin (1) 30 days after the date that the office begins accepting applications for hemp business
licenses; or
 new text end

new text begin (2) if the person submits an application for a hemp business license, until the office
makes a determination regarding the registrant's application.
 new text end

Sec. 66.

Minnesota Statutes 2023 Supplement, section 342.19, is amended by adding a
subdivision to read:


new text begin Subd. 6. new text end

new text begin Inspection of unlicensed businesses and facilities. new text end

new text begin (a) The office may inspect
any commercial premises that is not licensed under this chapter where cultivation,
manufacturing, processing, or sale of cannabis plants, cannabis flower, cannabis concentrate,
artificially derived cannabinoids, hemp-derived consumer products, or edible cannabinoid
products is taking place.
 new text end

new text begin (b) A representative of the office performing an inspection under this subdivision must
present appropriate credentials to the owner, operator, or agent in charge and clearly state
the purpose of the inspection.
 new text end

new text begin (c) After providing the notice required under paragraph (b), a representative of the office
may enter the commercial premises and perform any of the following to determine if any
person is engaging in activities that are regulated by this chapter and not authorized without
the possession of a license and to determine the appropriate penalty under section 342.09,
subdivision 6:
 new text end

new text begin (1) inspect and investigate the commercial premises;
 new text end

new text begin (2) inspect and copy records; and
 new text end

new text begin (3) question privately any employer, owner, operator, agent, or employee of the
commercial operation.
 new text end

new text begin (d) Entry of a commercial premises must take place during regular working hours or at
other reasonable times.
 new text end

new text begin (e) If the office finds any cannabis plant, cannabis flower, cannabis product, artificially
derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product on
the inspected commercial premises, the office may either immediately seize the item or
affix to the item a tag, withdrawal from distribution order, or other appropriate marking
providing notice that the cannabis plant, cannabis flower, cannabis product, artificially
derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product is, or
is suspected of being, possessed or distributed in violation of this chapter, and has been
detained or embargoed, and warning all persons not to remove or dispose of the item by
sale or otherwise until permission for removal or disposal is given by the office or the court.
It is unlawful for a person to remove or dispose of a detained or embargoed cannabis plant,
cannabis flower, cannabis product, artificially derived cannabinoid, lower-potency hemp
edible, or hemp-derived consumer product by sale or otherwise without the office's or a
court's permission and each transaction may be treated as a sale for the purposes of imposing
a penalty pursuant to section 342.09, subdivision 6.
 new text end

new text begin (f) If the office has seized, detained, or embargoed any item pursuant to paragraph (e),
the office must:
 new text end

new text begin (1) petition the district court in the county in which the item was found for an order
authorizing destruction of the product; and
 new text end

new text begin (2) notify the county attorney in the county where the item was found of the office's
actions.
 new text end

new text begin (g) If the court finds that the seized, detained, or embargoed cannabis plant, cannabis
flower, cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or
hemp-derived consumer product was possessed or distributed in violation of this chapter
or rules adopted under this chapter, the office may destroy the cannabis plant, cannabis
flower, cannabis product, artificially derived cannabinoid, lower-potency hemp edible, or
hemp-derived consumer product at the expense of the person who possessed or distributed
the item in violation of this chapter and all court costs, fees, storage, and other proper
expenses must be assessed against the person or the person's agent.
 new text end

new text begin (h) The provisions of subdivision 2, paragraph (f) apply to any analysis or examination
performed under this subdivision.
 new text end

new text begin (i) The authorization under paragraph (e) does not apply to any cannabis flower, cannabis
product, lower-potency hemp edible, or hemp-derived consumer product lawfully purchased
for personal use.
 new text end

Sec. 67.

Minnesota Statutes 2023 Supplement, section 342.22, is amended to read:


342.22 RETAILERS; LOCAL REGISTRATION AND ENFORCEMENT.

Subdivision 1.

Registration required.

Before new text begin receiving a retail operations endorsement
and new text end making retail sales to customers or patients, a cannabis microbusiness deleted text begin with a retail
operations endorsementdeleted text end , cannabis mezzobusiness deleted text begin with a retail operations endorsementdeleted text end ,
cannabis retailer, deleted text begin medical cannabis retailer,deleted text end medical cannabis combination business, or
lower-potency hemp edible retailer must register with the city, town, or county in which
the retail establishment is located. A county may issue a registration in cases where a city
or town has provided consent for the county to issue the registration for the jurisdiction.

Subd. 2.

Registration fee.

(a) A local unit of government may impose an initial retail
registration fee of $500 or up to half the amount of the applicable initial license fee under
section 342.11, whichever is less. The local unit of government may also impose a renewal
retail registration fee of $1,000 or up to half the amount of the applicable renewal license
fee under section 342.11, whichever is less. The initial registration fee shall include the fee
for initial registration and the first annual renewal. Any renewal fee imposed by the local
unit of government shall be charged at the time of the second renewal and each subsequent
annual renewal thereafter.

(b) The local unit of government may not charge an application fee.

deleted text begin (c) A cannabis business with a cannabis retailer license and a medical cannabis retailer
license for the same location may only be charged a single registration fee.
 deleted text end

deleted text begin (d)deleted text end new text begin (c)new text end Registration fees are nonrefundable.

Subd. 3.

Issuance of registration.

(a) A local unit of government shall issue a retail
registration to a cannabis microbusiness with a retail operations endorsement, cannabis
mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis
deleted text begin retailerdeleted text end new text begin combination business operating a retail locationnew text end , or lower-potency hemp edible
retailer that:

(1) has a valid license new text begin or license preapproval new text end issued by the office;

(2) has paid the registration fee or renewal fee pursuant to subdivision 2;

(3) is found to be in compliance with the requirements of this chapter at any preliminary
compliance check that the local unit of government performs; and

(4) if applicable, is current on all property taxes and assessments at the location where
the retail establishment is located.

(b) Before issuing a retail registration, the local unit of government may conduct a
preliminary compliance check to ensure that the cannabis business or hemp business is in
compliance with deleted text begin thedeleted text end new text begin anynew text end applicable deleted text begin operation requirements and the limits on the types of
cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
products that may be solddeleted text end new text begin local ordinance established pursuant to section 342.13new text end .

(c) A local unit of government shall renew the retail registration of a cannabis business
or hemp business when the office renews the license of the cannabis business or hemp
business.

(d) A retail registration issued under this section may not be transferred.

Subd. 4.

Compliance checks.

(a) A local unit of government shall conduct compliance
checks of every cannabis business and hemp business with a retail registration issued by
the local unit of government. deleted text begin The checksdeleted text end new text begin During a compliance check, a local unit of
governmentnew text end shall assess new text begin a business's new text end compliance with age verification requirementsdeleted text begin , thedeleted text end new text begin
and compliance with anynew text end applicable deleted text begin operation requirements, and the applicable limits on
the types of cannabis flower, cannabis products, lower-potency hemp edibles, and
hemp-derived consumer products being solddeleted text end new text begin local ordinance established pursuant to section
342.13new text end .

(b) deleted text begin Thedeleted text end new text begin Anew text end local unit of government must conduct unannounced age verification
compliance checks new text begin of every cannabis business and hemp business new text end at least once each calendar
year. Age verification compliance checks must involve persons at least 17 years of age but
under the age of 21 who, with the prior written consent of a parent or guardian if the person
is under the age of 18, attempt to purchase adult-use cannabis flower, adult-use cannabis
products, lower-potency hemp edibles, or hemp-derived consumer products under the direct
supervision of a law enforcement officer or an employee of the local unit of government.

deleted text begin (c) Checks to ensure compliance with the applicable operation requirements and the
limits on the types of cannabis flower, cannabis products, lower-potency hemp edibles, and
hemp-derived consumer products that may be sold must be performed at least once each
calendar year and may be performed by a law enforcement officer or an employee of the
local unit of government.
 deleted text end

Subd. 5.

Registration suspension and cancellation; notice to office; penalties.

(a) If
a local unit of government determines that a cannabis business or hemp business with a
retail registration issued by the local unit of government is not operating in compliance with
the requirements of deleted text begin this chapterdeleted text end new text begin a local ordinance authorized under section 342.13new text end or that
the operation of the business poses an immediate threat to the health or safety of the public,
the local unit of government may suspend the retail registration of the cannabis business or
hemp business. The local unit of government must immediately notify the office of the
suspension and shall include a description of the grounds for the suspension.

(b) The office shall review the retail registration suspension and may order reinstatement
of the retail registration or take any action described in section 342.19 or 342.21.

(c) The retail registration suspension must be for up to 30 days unless the office suspends
the license and operating privilege of the cannabis business or hemp business for a longer
period or revokes the license.

(d) The local unit of government may reinstate the retail registration if the local unit of
government determines that any violation has been cured. The local unit of government
must reinstate the retail registration if the office orders reinstatement.

(e) No cannabis microbusiness deleted text begin with a retail operations endorsementdeleted text end , cannabis
mezzobusiness deleted text begin with a retail operations endorsementdeleted text end , cannabis retailer, deleted text begin medical cannabis
retailer,deleted text end medical cannabis combination business, or lower-potency hemp edible retailer may
make any sale to a customer or patient without a valid retail registrationnew text begin with a local unit
of government and a valid endorsement from the officenew text end . A local unit of government may
impose a civil penalty of up to $2,000 for each violation of this paragraph.

Sec. 68.

Minnesota Statutes 2023 Supplement, section 342.24, subdivision 1, is amended
to read:


Subdivision 1.

Individuals under 21 years of age.

(a) A cannabis business may not
employ an individual under 21 years of age and may not contract with an individual under
21 years of age if the individual's scope of work involves the handling of cannabis plants,
cannabis flower, artificially derived cannabinoids, or cannabinoid products.

(b) A cannabis business may not permit an individual under 21 years of age to enter the
business premises other than entry by a deleted text begin patientdeleted text end new text begin personnew text end enrolled in the registry program.

(c) A cannabis business may not sell or give cannabis flower, cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products to an individual under
21 years of age unless the individual is deleted text begin a patient; registered designated caregiver; or a parent,
legal guardian, or spouse of a patient who is authorized to use, possess, or transport medical
cannabis flower or medical cannabinoid productsdeleted text end new text begin enrolled in the registry program and the
cannabis business holds a medical cannabis retail endorsementnew text end .

Sec. 69.

Minnesota Statutes 2023 Supplement, section 342.24, subdivision 2, is amended
to read:


Subd. 2.

Use of cannabis flower and products within a licensed cannabis business.

(a)
A cannabis business may not permit an individual who is not an employee to consume
cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer
products within its licensed premises unless the business is licensed to permit on-site
consumption.

(b) Except as otherwise provided in this subdivision, a cannabis business may not permit
an employee to consume cannabis flower, cannabis products, lower-potency hemp edibles,
or hemp-derived consumer products within its licensed premises or while the employee is
otherwise engaged in activities within the course and scope of employment.

(c) A cannabis business may permit an employee to use medical cannabis flower and
medical cannabinoid products if that individual is a patientnew text begin enrolled in the registry programnew text end .

(d) For quality control, employees of a licensed cannabis business may sample cannabis
flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products.
Employees may not interact directly with customers for at least three hours after sampling
a product. Employees may not consume more than three samples in a single 24-hour period.
All samples must be recorded in the statewide monitoring system.

Sec. 70.

Minnesota Statutes 2023 Supplement, section 342.28, is amended by adding a
subdivision to read:


new text begin Subd. 1a. new text end

new text begin Cannabis research. new text end

new text begin An institution of higher education, any department or
program of an institution of higher education, and any entity working in partnership with
an institution of higher education may apply for a cannabis microbusiness license to conduct
cannabis crop research. A cannabis researcher with a cannabis microbusiness license may
perform activities identified in subdivision 1, clauses (1) to (9) and (13). Cannabis plants
and cannabis flower grown for research purposes must not be offered for sale or otherwise
enter the stream of commerce. As used in this subdivision, "institution of higher education"
has the meaning given in sections 135A.51, subdivision 5, and 136A.28, subdivision 6.
 new text end

Sec. 71.

Minnesota Statutes 2023 Supplement, section 342.28, subdivision 2, is amended
to read:


Subd. 2.

Size limitations.

(a) A cannabis microbusiness that cultivates cannabis at an
indoor facility may cultivate up to 5,000 square feet of plant canopy. The office may adjust
plant canopy limits new text begin for licensed businesses new text end upward to meet market demand consistent with
the goals identified in section 342.02, subdivision 1.new text begin In each licensing period, the office
may adjust plant canopy limits for licenses that will be issued in that period upward or
downward to meet market demand consistent with the goals identified in section 342.02,
subdivision 1, except that the office must not impose a limit of less than 5,000 square feet
of plant canopy.
new text end

(b) A cannabis microbusiness that cultivates cannabis at an outdoor location may cultivate
up to one-half acre of mature, flowering plants deleted text begin unless the office increases that limitdeleted text end . The
office may increase the limit deleted text begin to no more than one acre if the office determines that expansion
isdeleted text end new text begin for licensed businesses upward to meet market demandnew text end consistent with the goals identified
in section 342.02, subdivision 1.new text begin In each licensing period, the office may adjust the limit
for licenses that will be issued in that period upward or downward to meet market demand
consistent with the goals identified in section 342.02, subdivision 1, except that the office
must not impose a limit of less than one-half acre of mature, flowering plants.
new text end

(c) The office shall establish a limit on the manufacturing of cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products a cannabis microbusiness
that manufactures such products may perform. The limit must be equivalent to the amount
of cannabis flower that can be harvested from a facility with a plant canopy of 5,000 square
feet in a year, but may be increased if the office expands the allowable area of cultivation
under paragraph (a).

(d) A cannabis microbusiness with the appropriate endorsement may operate one retail
location.

Sec. 72.

Minnesota Statutes 2023 Supplement, section 342.28, is amended by adding a
subdivision to read:


new text begin Subd. 11. new text end

new text begin Transportation between facilities. new text end

new text begin A cannabis microbusiness may transport
immature cannabis plants and seedlings, cannabis flower, cannabis products, artificially
derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp edibles,
and hemp-derived consumer products between facilities operated by the cannabis
microbusiness if the cannabis microbusiness:
 new text end

new text begin (1) provides the office with the information described in section 342.35, subdivision 2;
and
 new text end

new text begin (2) complies with the requirements of section 342.36.
 new text end

Sec. 73.

Minnesota Statutes 2023 Supplement, section 342.29, subdivision 4, is amended
to read:


Subd. 4.

Multiple licenses; limits.

(a) A person, cooperative, or business holding a
cannabis mezzobusiness license may also hold a cannabis event organizer license deleted text begin and a
medical cannabis retailer licensedeleted text end .

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a
cannabis mezzobusiness license may own or operate any other cannabis business or hemp
business or hold more than one cannabis mezzobusiness license.

(c) For purposes of this subdivision, a restriction on the number or type of license that
a business may hold applies to every cooperative member or every director, manager, and
general partner of a cannabis business.

Sec. 74.

Minnesota Statutes 2023 Supplement, section 342.29, is amended by adding a
subdivision to read:


new text begin Subd. 10. new text end

new text begin Transportation between facilities. new text end

new text begin A cannabis mezzobusiness may transport
immature cannabis plants and seedlings, cannabis flower, cannabis products, artificially
derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp edibles,
and hemp-derived consumer products between facilities operated by the cannabis
mezzobusiness if the cannabis mezzobusiness:
 new text end

new text begin (1) provides the office with the information described in section 342.35, subdivision 2;
and
 new text end

new text begin (2) complies with the requirements of section 342.36.
 new text end

Sec. 75.

Minnesota Statutes 2023 Supplement, section 342.30, subdivision 4, is amended
to read:


Subd. 4.

Multiple licenses; limits.

(a) A person, cooperative, or business holding a
cannabis cultivator license may also hold a cannabis manufacturing license, deleted text begin medical cannabis
cultivator license,deleted text end medical cannabis producer license, license to grow industrial hemp, and
cannabis event organizer license.

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a
cannabis cultivator license may own or operate any other cannabis business or hemp business.
This prohibition does not prevent the transportation of cannabis flower from a cannabis
cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business
and located on the same premises.

(c) The office by rule may limit the number of cannabis cultivator licenses a person,
cooperative, or business may hold.

(d) For purposes of this subdivision, a restriction on the number or type of license a
business may hold applies to every cooperative member or every director, manager, and
general partner of a cannabis business.

Sec. 76.

Minnesota Statutes 2023 Supplement, section 342.31, subdivision 4, is amended
to read:


Subd. 4.

Multiple licenses; limits.

(a) A person, cooperative, or business holding a
cannabis manufacturer license may also hold a cannabis cultivator licensedeleted text begin , a medical cannabis
cultivator license, a medical cannabis processor license,deleted text end and a cannabis event organizer
license.

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a
cannabis manufacturer license may own or operate any other cannabis business or hemp
business. This prohibition does not prevent transportation of cannabis flower from a cannabis
cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business
and located on the same premises.

(c) The office by rule may limit the number of cannabis manufacturer licenses that a
person or business may hold.

(d) For purposes of this subdivision, a restriction on the number or type of license that
a business may hold applies to every cooperative member or every director, manager, and
general partner of a cannabis business.

Sec. 77.

Minnesota Statutes 2023 Supplement, section 342.32, subdivision 4, is amended
to read:


Subd. 4.

Multiple licenses; limits.

(a) A person, cooperative, or business holding a
cannabis retailer license may also hold a cannabis delivery service licensedeleted text begin , a medical cannabis
retailer license,deleted text end and a cannabis event organizer license.

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a
cannabis retailer license may own or operate any other cannabis business or hemp business.

(c) No person, cooperative, or business may hold a license to own or operate more than
one cannabis retail business in one city and three retail businesses in one county.

(d) The office by rule may limit the number of cannabis retailer licenses a person,
cooperative, or business may hold.

(e) For purposes of this subdivision, a restriction on the number or type of license a
business may hold applies to every cooperative member or every director, manager, and
general partner of a cannabis business.

Sec. 78.

Minnesota Statutes 2023 Supplement, section 342.35, subdivision 1, is amended
to read:


Subdivision 1.

Authorized actions.

A cannabis transporter license entitles the license
holder to transport immature cannabis plants and seedlings, cannabis flower, cannabis
products, artificially derived cannabinoids, hemp plant parts, hemp concentrate,
lower-potency hemp edibles, and hemp-derived consumer products from cannabis
microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,
cannabis wholesalers, lower-potency hemp edible manufacturers, deleted text begin medical cannabis retailers,
medical cannabis processors,deleted text end and industrial hemp growers to cannabis microbusinesses,
cannabis mezzobusinesses, cannabis manufacturers, cannabis testing facilities, cannabis
wholesalers, cannabis retailers, lower-potency hemp edible retailers, deleted text begin medical cannabis
processors, medical cannabis retailers,deleted text end and medical cannabis combination businesses and
perform other actions approved by the office.

Sec. 79.

Minnesota Statutes 2023 Supplement, section 342.37, subdivision 1, is amended
to read:


Subdivision 1.

Authorized actions.

A cannabis testing facility license entitles the license
holder to obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis
products, hemp plant parts, hemp concentrate, artificially derived cannabinoids,
lower-potency hemp edibles, and hemp-derived consumer products from cannabis
microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,
cannabis wholesalers, lower-potency hemp edible manufacturers, deleted text begin medical cannabis
cultivators, medical cannabis processors,deleted text end medical cannabis combination businesses, and
industrial hemp growers.

Sec. 80.

Minnesota Statutes 2023 Supplement, section 342.40, subdivision 7, is amended
to read:


Subd. 7.

Cannabis event sales.

(a) Cannabis microbusinesses with a retail endorsement,
cannabis mezzobusinesses with a retail endorsement, cannabis retailers, new text begin medical cannabis
combination businesses operating a retail location, new text end and lower-potency hemp edible retailers,
including the cannabis event organizer, may be authorized to sell cannabis plants, adult-use
cannabis flower, adult-use cannabis products, lower-potency hemp edibles, and hemp-derived
consumer products to customers at a cannabis event.

(b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must
take place in a retail area as designated in the premises diagram.

(c) Authorized retailers may only conduct sales within their specifically assigned area.

(d) Authorized retailers must verify the age of all customers pursuant to section 342.27,
subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis
flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer
products to an individual under 21 years of age.

(e) Authorized retailers may display one sample of each type of cannabis plant, adult-use
cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived
consumer product available for sale. Samples of adult-use cannabis and adult-use cannabis
products must be stored in a sample jar or display case and be accompanied by a label or
notice containing the information required to be affixed to the packaging or container
containing adult-use cannabis flower and adult-use cannabis products sold to customers. A
sample may not consist of more than eight grams of adult-use cannabis flower or adult-use
cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams
of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use
cannabis flower or adult-use cannabis product before purchase.

(f) The notice requirements under section 342.27, subdivision 6, apply to authorized
retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products,
and hemp-derived consumer products for sale at a cannabis event.

(g) Authorized retailers may not:

(1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp
edibles, or hemp-derived consumer products to a person who is visibly intoxicated;

(2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis
products, lower-potency hemp edibles, or hemp-derived consumer products than a customer
is legally permitted to possess;

(3) sell medical cannabis flower or medical cannabinoid products;

(4) give away cannabis plants, cannabis flower, cannabis products, lower-potency hemp
edibles, or hemp-derived consumer products; or

(5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products,
lower-potency hemp edibles, or hemp-derived consumer products in vending machines.

(h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis
product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis
plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles,
and hemp-derived consumer products for sale at a cannabis event must be stored in a secure,
locked container that is not accessible to the public. Such items being stored at a cannabis
event shall not be left unattended.

(i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis
event must comply with this chapter and rules adopted pursuant to this chapter regarding
the testing, packaging, and labeling of those items.

(j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold,
damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring
system.

Sec. 81.

Minnesota Statutes 2023 Supplement, section 342.41, subdivision 3, is amended
to read:


Subd. 3.

Multiple licenses; limits.

(a) A person, cooperative, or business holding a
cannabis delivery service license may also hold a cannabis retailer license, a cannabis
wholesaler license, a cannabis transporter license, new text begin and new text end a cannabis event organizer licensedeleted text begin ,
and a medical cannabis retailer licensedeleted text end subject to the ownership limitations that apply to
those licenses.

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a
cannabis delivery service license may own or operate any other cannabis business or hemp
business.

(c) The office by rule may limit the number of cannabis delivery service licenses that a
person or business may hold.

(d) For purposes of this subdivision, a restriction on the number or type of license that
a business may hold applies to every cooperative member or every director, manager, and
general partner of a cannabis business.

Sec. 82.

Minnesota Statutes 2023 Supplement, section 342.46, subdivision 8, is amended
to read:


Subd. 8.

On-site consumption.

(a) A lower-potency hemp edible retailer may permit
on-site consumption of lower-potency hemp edibles on a portion of its premises if it has an
on-site consumption endorsement.

(b) The office shall issue an on-site consumption endorsement to any lower-potency
hemp edible retailer that also holds an on-sale license issued under chapter 340A.

(c) A lower-potency hemp edible retailer must ensure that lower-potency hemp edibles
sold for on-site consumption comply with this chapter and rules adopted pursuant to this
chapter regarding testing.

(d) Lower-potency hemp edibles sold for on-site consumption, other than lower-potency
hemp edibles that are intended to be consumed as a beverage, must be served in the required
packaging, but may be removed from the products' packaging by customers and consumed
on site.

(e) Lower-potency hemp edibles that are intended to be consumed as a beverage may
be served outside of deleted text begin theirdeleted text end new text begin the edibles'new text end packaging deleted text begin provided thatdeleted text end new text begin ifnew text end the information that is
required to be contained on the label of a lower-potency hemp edible is posted or otherwise
displayed by the lower-potency hemp edible retailer. Hemp workers who serve beverages
under this paragraph are not required to obtain an edible cannabinoid product handler
endorsement under section 342.07, subdivision 3.

(f) Food and beverages not otherwise prohibited by this subdivision may be prepared
and sold on site deleted text begin provided thatdeleted text end new text begin ifnew text end the lower-potency hemp edible retailer complies with all
relevant state and local laws, ordinances, licensing requirements, and zoning requirements.

(g) A lower-potency hemp edible retailer may offer recorded or live entertainment
deleted text begin provided thatdeleted text end new text begin ifnew text end the lower-potency hemp edible retailer complies with all relevant state and
local laws, ordinances, licensing requirements, and zoning requirements.

(h) In addition to the prohibitions under subdivision 7, a lower-potency hemp edible
retailer with an on-site consumption endorsement may not:

(1) sellnew text begin , give, furnish, or in any way procure for anothernew text end lower-potency hemp edibles deleted text begin to
a customer who the lower-potency hemp edible retailer knows or reasonably should know
is intoxicated or has consumed alcohol within the previous five hoursdeleted text end new text begin for the use of an
obviously intoxicated personnew text end ;

(2) sell lower-potency hemp edibles that are designed or reasonably expected to be mixed
with an alcoholic beverage; or

(3) permit lower-potency hemp edibles that have been removed from the products'
packaging to be removed from the premises of the lower-potency hemp edible retailer.

Sec. 83.

new text begin [342.465] LOWER-POTENCY HEMP EDIBLES; PROHIBITED CONDUCT.
 new text end

new text begin No person may sell, give, furnish, or in any way procure for another lower-potency hemp
edibles for the use of an obviously intoxicated person.
 new text end

Sec. 84.

Minnesota Statutes 2023 Supplement, section 342.51, is amended to read:


342.51 MEDICAL CANNABIS deleted text begin RETAILERSdeleted text end new text begin ENDORSEMENTSnew text end .

Subdivision 1.

new text begin Endorsement; new text end authorized actions.

(a)new text begin The office may issue a medical
cannabis endorsement to a cannabis business authorizing the business to:
new text end

new text begin (1) cultivate medical cannabis;
 new text end

new text begin (2) process medical cannabinoid products; or
 new text end

new text begin (3) sell or distribute medical cannabis flower and medical cannabinoid products to any
person authorized to receive medical cannabis flower or medical cannabinoid products.
 new text end

new text begin (b) The office must issue a medical cannabis cultivation endorsement to a cannabis
license holder if the license holder:
 new text end

new text begin (1) is authorized to cultivate cannabis;
 new text end

new text begin (2) submits a medical cannabis endorsement application to the office; and
 new text end

new text begin (3) otherwise meets all applicable requirements established by the office.
 new text end

new text begin (c) A medical cannabis cultivation endorsement entitles the license holder to grow
cannabis plants within the approved amount of space from seed or immature plant to mature
plant, harvest cannabis flower from a mature plant, package and label cannabis flower as
medical cannabis flower, sell medical cannabis flower to cannabis businesses with a medical
cannabis endorsement, and perform other actions approved by the office.
 new text end

new text begin (d) The office must issue a medical cannabis processor endorsement to a cannabis license
holder if the license holder:
 new text end

new text begin (1) is authorized to manufacture cannabis products;
 new text end

new text begin (2) submits a medical cannabis endorsement application to the office; and
 new text end

new text begin (3) otherwise meets all applicable requirements established by the office.
 new text end

new text begin (e) A medical cannabis processor endorsement entitles the license holder to:
 new text end

new text begin (1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts,
and hemp concentrate from cannabis businesses with a medical cannabis cultivator
endorsement or a medical cannabis processor endorsement;
 new text end

new text begin (2) purchase hemp plant parts from industrial hemp growers;
 new text end

new text begin (3) make cannabis concentrate from medical cannabis flower;
 new text end

new text begin (4) make hemp concentrate, including hemp concentrate with a delta-9
tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
 new text end

new text begin (5) manufacture medical cannabinoid products;
 new text end

new text begin (6) package and label medical cannabinoid products for sale to cannabis businesses with
a medical cannabis processer endorsement or a medical cannabis retailer endorsement; and
 new text end

new text begin (7) perform other actions approved by the office.
 new text end

new text begin (f) The office must issue a medical cannabis retailer endorsement to a cannabis license
holder if the license holder:
 new text end

new text begin (1) submits a medical cannabis retail endorsement application to the office;
 new text end

new text begin (2) has at least one employee who earned a medical cannabis consultant certificate issued
by the office and has completed the required training or has at least one employee who is
a licensed pharmacist under chapter 151; and
 new text end

new text begin (3) otherwise meets all applicable requirements established by the office.
 new text end

new text begin (g)new text end A medical cannabis deleted text begin retailer licensedeleted text end new text begin retail endorsementnew text end entitles the license holder to
purchase medical cannabis flower and medical cannabinoid products from deleted text begin medical cannabis
cultivators and medical cannabis processorsdeleted text end new text begin cannabis businesses with medical cannabis
cultivator endorsements and medical cannabis processor endorsements,new text end and sell or distribute
medical cannabis flower deleted text begin anddeleted text end new text begin ,new text end medical cannabinoid productsnew text begin , and associated paraphernalianew text end
to any person authorized to receive medical cannabis flower or medical cannabinoid products.

deleted text begin (b)deleted text end new text begin (h)new text end A medical cannabis deleted text begin retailer license holderdeleted text end new text begin business with a medical cannabis retail
endorsementnew text end must verify that all medical cannabis flower and medical cannabinoid products
have passed safety, potency, and consistency testing at a cannabis testing facility approved
by the office for the testing of medical cannabis flower and medical cannabinoid products
before the deleted text begin medical cannabis retailerdeleted text end new text begin cannabis business with a medical cannabis retail
endorsementnew text end may distribute the medical cannabis flower or medical cannabinoid product
to any person deleted text begin authorized to receive medical cannabis flower or medical cannabinoid productsdeleted text end new text begin
enrolled in the registry programnew text end .

Subd. 2.

Distribution requirements.

(a) Prior to distribution of medical cannabis flower
or medical cannabinoid productsdeleted text begin , a medical cannabis retailer licenseedeleted text end new text begin to a person enrolled
in the registry program, an employee with a valid medical cannabis consultant certificate
issued by the office or a licensed pharmacist under chapter 151new text end must:

(1) review and confirm the patient'snew text begin enrollment in thenew text end registry deleted text begin verificationdeleted text end new text begin programnew text end ;

(2) verify that the person requesting the distribution of medical cannabis flower or
medical cannabinoid products is the patient, the patient's registered designated caregiver,
or the patient's parent, legal guardian, or spouse using the procedures deleted text begin specified in section
152.11, subdivision 2ddeleted text end new text begin established by the officenew text end ;

deleted text begin (3) ensure that a pharmacist employee of the medical cannabis retailer has consulted
with the patient if required according to subdivision 3; and
 deleted text end

new text begin (3) provide consultation to the patient to determine the proper medical cannabis flower
or medical cannabinoid product, dosage, and paraphernalia for the patient if required under
subdivision 3;
 new text end

(4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid
product that includes recommended dosage requirements and other information as required
deleted text begin by rules adopteddeleted text end by the officedeleted text begin .deleted text end new text begin ; and
new text end

new text begin (5) provide the patient with any other information required by the office.
 new text end

(b) A new text begin cannabis business with a new text end medical cannabis deleted text begin retailerdeleted text end new text begin retail endorsementnew text end may not
deliver medical cannabis flower or medical cannabinoid products new text begin to a person enrolled in
the registry program new text end unless the new text begin cannabis business with a new text end medical cannabis deleted text begin retailerdeleted text end new text begin retail
endorsementnew text end also holds a cannabis delivery service license. new text begin The new text end delivery of medical cannabis
flower and medical cannabinoid products are subject to the provisions of section 342.42.

Subd. 3.

Final approval for distribution of medical cannabis flower and medical
cannabinoid products.

(a) A cannabis worker who is employed by a new text begin cannabis business
with a new text end medical cannabis deleted text begin retailer anddeleted text end new text begin retail endorsementnew text end who is licensed as a pharmacist
pursuant to chapter 151 deleted text begin shall bedeleted text end new text begin or certified as a medical cannabis consultant by the office
isnew text end the only person who may give final approval for the distribution of medical cannabis
flower and medical cannabinoid products. Prior to the distribution of medical cannabis
flower or medical cannabinoid products, a pharmacist new text begin or certified medical cannabis consultant
new text end employed by thenew text begin cannabis business with anew text end medical cannabis deleted text begin retailerdeleted text end new text begin retail endorsementnew text end must
consult with the patient to determine the proper type of medical cannabis flower, medical
cannabinoid product, or medical cannabis paraphernalianew text begin ,new text end and new text begin the new text end proper dosage for the
patient after reviewing the range of chemical compositions of medical cannabis flower or
medical cannabinoid productdeleted text begin .deleted text end new text begin intended for distribution:
new text end

new text begin (1) if the patient is purchasing the medical cannabis flower or medical cannabinoid
product for the first time;
 new text end

new text begin (2) if the patient purchases medical cannabis flower or a medical cannabinoid product
that the patient must administer using a different method than the patient's previous method
of administration;
 new text end

new text begin (3) if the patient purchases medical cannabis flower or a medical cannabinoid product
with a cannabinoid concentration of at least double the patient's prior dosage; or
 new text end

new text begin (4) upon the request of the patient.
 new text end

new text begin (b) new text end For purposes of this subdivision, a consultation may be conducted remotely by secure
videoconference, telephone, or other remote means, as long as:

(1) the pharmacist new text begin or consultant new text end engaging in the consultation is able to confirm the
identity of the patient; and

(2) the consultation adheres to patient privacy requirements that apply to health care
services delivered through telemedicine.

deleted text begin (b) Notwithstanding paragraph (a), a pharmacist consultation is not required prior to the
distribution of medical cannabis flower or medical cannabinoid products when a medical
cannabis retailer is distributing medical cannabis flower or medical cannabinoid products
to a patient according to a patient-specific dosage plan established with that medical cannabis
retailer and is not modifying the dosage or product being distributed under that plan. Medical
cannabis flower or medical cannabinoid products distributed under this paragraph must be
distributed by a pharmacy technician employed by the medical cannabis retailer.
 deleted text end

deleted text begin Subd. 4. deleted text end

deleted text begin 90-day supply. deleted text end

deleted text begin A medical cannabis retailer shall not distribute more than a
90-day supply of medical cannabis flower or medical cannabinoid products to a patient,
registered designated caregiver, or parent, legal guardian, or spouse of a patient according
to the dosages established for the individual patient.
 deleted text end

Subd. 5.

Distribution to recipient in a motor vehicle.

A new text begin cannabis business with a
new text end medical cannabis deleted text begin retailerdeleted text end new text begin retail endorsementnew text end may distribute medical cannabis flower and
medical cannabinoid products to a deleted text begin patient, registered designated caregiver, or parent, legal
guardian, or spouse of a patientdeleted text end new text begin person enrolled in the registry programnew text end who is at a dispensary
location but remains in a motor vehicledeleted text begin , provided thatdeleted text end new text begin ifnew text end :

(1) staff receive payment and distribute medical cannabis flower and medical cannabinoid
products in a designated zone that is as close as feasible to the front door of the facility;

(2) thenew text begin cannabis business with anew text end medical cannabis deleted text begin retailerdeleted text end new text begin retail endorsementnew text end ensures
that the receipt of payment and distribution of medical cannabis flower and medical
cannabinoid products are visually recorded by a closed-circuit television surveillance camera
and provides any other necessary security safeguards;

(3) the new text begin cannabis business with a new text end medical cannabis deleted text begin retailerdeleted text end new text begin retail endorsementnew text end does not
store medical cannabis flower or medical cannabinoid products outside a restricted access
area and staff transport medical cannabis flower and medical cannabinoid products from a
restricted access area to the designated zone for distribution only after confirming that the
deleted text begin patient, designated caregiver, or parent, guardian, or spousedeleted text end new text begin person enrolled in the registry
programnew text end has arrived in the designated zone;

(4) the payment new text begin for new text end and distribution of medical cannabis flower and medical cannabinoid
products take place only after deleted text begin a pharmacist consultation takes place, if required under
subdivision 3deleted text end new text begin meeting the requirements in subdivision 2new text end ;

(5) immediately following new text begin the new text end distribution of medical cannabis flower or medical
cannabinoid products, staff deleted text begin enterdeleted text end new text begin recordnew text end the transaction in the statewide monitoring system;
and

(6) immediately following new text begin the new text end distribution of medical cannabis flower and medical
cannabinoid products, staff take the payment received into the facility.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 85.

Minnesota Statutes 2023 Supplement, section 342.515, subdivision 1, is amended
to read:


Subdivision 1.

Authorized actions.

new text begin (a) A person, cooperative, or business holding a
medical cannabis combination business license is prohibited from owning or operating any
other cannabis business or hemp business. Notwithstanding any law to the contrary, issuance
of a medical cannabis combination business license to a medical cannabis manufacturer
registered pursuant to section 152.25 cancels the medical cannabis manufacturer registration.
 new text end

new text begin (b) A person or business may hold only one medical cannabis combination business
license.
 new text end

new text begin (c) new text end A medical cannabis combination business license entitles the license holder to perform
any or all of the following within the limits established by this section:

(1) grow cannabis plants from seed or immature plant to mature plant and harvest
adult-use cannabis flower and medical cannabis flower from a mature plant;

(2) make cannabis concentrate;

(3) make hemp concentrate, including hemp concentrate with a delta-9
tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;

(4) manufacture artificially derived cannabinoids;

(5) manufacture medical cannabinoid products;

(6) manufacture adult-use cannabis products, lower-potency hemp edibles, and
hemp-derived consumer products for public consumption;

(7) purchase immature cannabis plants and seedlings and cannabis flower from a cannabis
microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a cannabis wholesaler,
deleted text begin a medical cannabis cultivator,deleted text end or another medical cannabis combination business;

(8) purchase hemp plant parts and propagules from an industrial hemp grower licensed
under chapter 18K;

(9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids
from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a
cannabis wholesaler, deleted text begin a medical cannabis processor,deleted text end or another medical cannabis combination
business;

(10) purchase hemp concentrate from an industrial hemp processor licensed under chapter
18K;

(11) package and label medical cannabis new text begin flower new text end and medical cannabinoid products for
sale to new text begin cannabis businesses with a new text end medical cannabis deleted text begin processorsdeleted text end new text begin processor endorsementnew text end ,
new text begin cannabis businesses with a new text end medical cannabis deleted text begin retailersdeleted text end new text begin retail endorsementnew text end , other medical
cannabis combination businesses, and deleted text begin patients enrolleddeleted text end new text begin personsnew text end in the registry programdeleted text begin ,
registered designated caregivers, and parents, legal guardians, and spouses of an enrolled
patientdeleted text end ;

(12) package and label adult-use cannabis flower, adult-use cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;

(13) sell medical cannabis flower and medical cannabinoid products to patients enrolled
in the registry program, registered designated caregivers, and parents, legal guardians, and
spouses of an enrolled patient;

(14) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
other products authorized by law to other cannabis businesses and to customers; and

(15) perform other actions approved by the office.

Sec. 86.

Minnesota Statutes 2023 Supplement, section 342.515, is amended by adding a
subdivision to read:


new text begin Subd. 7. new text end

new text begin Transportation between facilities. new text end

new text begin A medical cannabis combination business
may transport immature cannabis plants and seedlings, cannabis flower, cannabis products,
artificially derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp
edibles, and hemp-derived consumer products between facilities operated by the medical
cannabis combination business if the medical cannabis combination business:
 new text end

new text begin (1) provides the office with the information described in section 342.35, subdivision 2;
and
 new text end

new text begin (2) complies with the requirements of section 342.36.
 new text end

Sec. 87.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 1, is amended
to read:


Subdivision 1.

Administration.

The deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end must administer
the medical cannabis new text begin patient new text end registry program.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 88.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 2, is amended
to read:


Subd. 2.

Application procedure for patients.

(a) A patient seeking to enroll in the
registry program must submit to the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end an application
established by the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end and a copy of the certification
specified in paragraph (b) or, if the patient is a veteran who receives care from the United
States Department of Veterans Affairs, the information required pursuant to subdivision 3.
The patient must provide at least the following information in the application:

(1) the patient's name, mailing address, and date of birth;

(2) the name, mailing address, and telephone number of the patient's health care
practitioner;

(3) the name, mailing address, and date of birth of the patient's registered designated
caregiver, if any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian,
or spouse will be acting as the patient's caregiver;

(4) a disclosure signed by the patient that includes:

(i) a statement that, notwithstanding any law to the contrary, the office deleted text begin of Cannabis
Management, the Division of Medical Cannabis,deleted text end or an employee of the office deleted text begin of Cannabis
Management or Division of Medical Cannabisdeleted text end may not be held civilly or criminally liable
for any injury, loss of property, personal injury, or death caused by an act or omission while
acting within the employee's scope of office or employment under this section; and

(ii) the patient's acknowledgment that enrollment in the registry program is conditional
on the patient's agreement to meet all other requirements of this section; and

(5) all other information required by the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end .

(b) As part of the application under this subdivision, a patient must submit a copy of a
certification from the patient's health care practitioner that is dated within 90 days prior to
the submission of the application and that certifies that the patient has been diagnosed with
a qualifying medical condition.

(c) A patient's health care practitioner may submit a statement to the deleted text begin Division of Medical
Cannabisdeleted text end new text begin officenew text end declaring that the patient is no longer diagnosed with a qualifying medical
condition. Within 30 days after receipt of a statement from a patient's health care practitioner,
the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end must provide written notice to a patient stating that
the patient's enrollment in the registry program will be revoked in 30 days unless the patient
submits a certification from a health care practitioner that the patient is currently diagnosed
with a qualifying medical condition or, if the patient is a veteran, the patient submits
confirmation that the patient is currently diagnosed with a qualifying medical condition in
a form and manner consistent with the information required for an application made pursuant
to subdivision 3. If the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end revokes a patient's enrollment
in the registry program pursuant to this paragraph, the division must provide notice to the
patient and to the patient's health care practitioner.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 89.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 3, is amended
to read:


Subd. 3.

Application procedure for veterans.

(a) The deleted text begin Division of Medical Cannabisdeleted text end new text begin
officenew text end shall establish an alternative certification procedure for veterans who receive care
from the United States Department of Veterans Affairs to deleted text begin confirm that the veteran has been
diagnosed with a qualifying medical conditiondeleted text end new text begin enroll in the patient registry programnew text end .

(b) A patient who is deleted text begin alsodeleted text end a veteran new text begin receiving care from the United States Department of
Veterans Affairs new text end and is seeking to enroll in the registry program must submit to the deleted text begin Division
of Medical Cannabisdeleted text end new text begin office a copy of the patient's veteran health identification card issued
by the United States Department of Veterans Affairs andnew text end an application established by the
deleted text begin Division of Medical Cannabis that includes the information identified in subdivision 2,
paragraph (a), and the additional information required by the Division of Medical Cannabis
to certify that the patient has been diagnosed with a qualifying medical conditiondeleted text end new text begin office to
confirm that the veteran has been diagnosed with a condition that may benefit from the
therapeutic use of medical cannabisnew text end .

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 90.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 4, is amended
to read:


Subd. 4.

Enrollment; denial of enrollment; revocation.

(a) Within 30 days after the
receipt of an application and certification or other documentation of a diagnosis with a
qualifying medical condition, the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end must approve or
deny a patient's enrollment in the registry program. If the deleted text begin Division of Medical Cannabisdeleted text end new text begin
officenew text end approves a patient's enrollment in the registry program, the office must provide notice
to the patient and to the patient's health care practitioner.

(b) new text begin The office may deny new text end a patient's enrollment in the registry program deleted text begin must only be
denieddeleted text end new text begin onlynew text end if the patient:

(1) does not submit a certification from a health care practitioner or, if the patient is a
veteran, the documentation required under subdivision 3 that the patient has been diagnosed
with a qualifying medical condition;

(2) has not signed the disclosure required in subdivision 2;

(3) does not provide the information required by the deleted text begin Division of Medical Cannabisdeleted text end new text begin
officenew text end ;

(4) provided false information on the application; or

(5) at the time of application, is also enrolled in a federally approved clinical trial for
the treatment of a qualifying medical condition with medical cannabis.

(c) If the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end denies a patient's enrollment in the registry
program, the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end must provide written notice to a patient
of all reasons for denying enrollment. Denial of enrollment in the registry program is
considered a final decision of the office and is subject to judicial review under chapter 14.

(d) new text begin The office may revoke new text end a patient's enrollment in the registry program deleted text begin may be revokeddeleted text end
only:

(1) pursuant to subdivision 2, paragraph (c);

(2) upon the death of the patient;

(3) if the patient's certifying health care practitioner has filed a declaration under
subdivision 2, paragraph (c), that the patient's qualifying diagnosis no longer exists and the
patient does not submit another certification within 30 days;

(4) if the patient does not comply with subdivision 6; or

(5) if the patient intentionally sells or diverts medical cannabis flower or medical
cannabinoid products in violation of this chapter.

new text begin (e) new text end If new text begin the office has revoked new text end a patient's enrollment in the registry program deleted text begin has been
revokeddeleted text end due to a violation of subdivision 6, the patient may apply for enrollment 12 months
after the date on which the patient's enrollment was revoked. The office must process such
an application in accordance with this subdivision.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 91.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 5, is amended
to read:


Subd. 5.

Registry verification.

When a patient is enrolled in the registry program, the
deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end must assign the patient a patient registry number and
must issue the patient and the patient's registered designated caregiver, parent, legal guardian,
or spouse, if applicable, a registry verification. The deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end
must also make the registry verification available to deleted text begin medicaldeleted text end cannabis deleted text begin retailersdeleted text end new text begin businesses
with a medical cannabis retail endorsementnew text end . The registry verification must include:

(1) the patient's name and date of birth;

(2) the patient registry number assigned to the patient; and

(3) the name and date of birth of the patient's registered designated caregiver, if any, or
the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or
spouse will act as a caregiver.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 92.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 9, is amended
to read:


Subd. 9.

Registered designated caregiver.

(a) The deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end
must register a designated caregiver for a patient if the patient requires assistance in
administering medical cannabis flower or medical cannabinoid products deleted text begin or indeleted text end new text begin ;new text end obtaining
medical cannabis flower, medical cannabinoid products, or medical cannabis paraphernalia
from a new text begin cannabis business with a new text end medical cannabis deleted text begin retailerdeleted text end new text begin retail endorsement; or cultivating
cannabis plants as permitted by section 342.09, subdivision 2new text end .

(b) In order to serve as a designated caregiver, a person must:

(1) be at least 18 years of age;

(2) agree to only possess the patient's medical cannabis flower and medical cannabinoid
products for purposes of assisting the patient; and

(3) agree that if the application is approved, the person will not serve as a registered
designated caregiver for more than six registered patients at one time. Patients who reside
in the same residence count as one patient.

deleted text begin (c) The office shall conduct a criminal background check on the designated caregiver
prior to registration to ensure that the person does not have a conviction for a disqualifying
felony offense. Any cost of the background check shall be paid by the person seeking
deleted text end deleted text begin registration as a designated caregiver. A designated caregiver must have the criminal
background check renewed every two years.
 deleted text end

deleted text begin (d)deleted text end new text begin (c)new text end Nothing in this section shall be construed to prevent a registered designated
caregiver from being enrolled in the registry program as a patient and possessing and
administering medical cannabis flower or medical cannabinoid products as a patient.

new text begin (d) Notwithstanding any law to the contrary, a registered designated caregiver approved
to assist a patient enrolled in the registry program with obtaining medical cannabis flower
may cultivate cannabis plants on behalf of one patient. A registered designated caregiver
may grow up to eight cannabis plants for the patient household that the registered designated
caregiver is approved to assist with obtaining medical cannabis flower. If a patient enrolled
in the registry program directs the patient's registered designated caregiver to cultivate
cannabis plants on behalf of the patient, the patient must assign the patient's right to cultivate
cannabis plants to the registered designated caregiver and the patient is prohibited from
cultivating cannabis plants for personal use. Nothing in this paragraph limits the right of a
registered designated caregiver cultivating cannabis plants on behalf of a patient enrolled
in the registry program to also cultivate cannabis plants for personal use pursuant to section
342.09, subdivision 2.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 93.

Minnesota Statutes 2023 Supplement, section 342.52, subdivision 11, is amended
to read:


Subd. 11.

Notice of change of name or address.

Patients and registered designated
caregivers must notify the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end of any address or name
change within 30 days of the change having occurred. A patient or registered designated
caregiver is subject to a $100 fine for failure to notify the office of the change.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 94.

Minnesota Statutes 2023 Supplement, section 342.53, is amended to read:


342.53 DUTIES OF OFFICE OF CANNABIS MANAGEMENT; new text begin APPROVAL OF
CANNABINOID PRODUCTS FOR new text end REGISTRY PROGRAM.

The office may add an allowable form of medical cannabinoid productdeleted text begin , and may add or
modify a qualifying medical condition upon its own initiative,deleted text end upon a petition from a member
of the public or from the Cannabis Advisory Council or as directed by law. The office must
evaluate all petitions and must make the addition deleted text begin or modificationdeleted text end if the office determines
that the addition deleted text begin or modificationdeleted text end is warranted by the best available evidence and research.
If the office wishes to add an allowable form deleted text begin or add or modify a qualifying medical conditiondeleted text end ,
the office must notify the chairs and ranking minority members of the legislative committees
and divisions with jurisdiction over health finance and policy by January 15 of the year in
which the change becomes effective. In this notification, the office must specify the proposed
addition deleted text begin or modificationdeleted text end , the reasons for the addition deleted text begin or modificationdeleted text end , any written comments
received by the office from the public about the addition deleted text begin or modificationdeleted text end , and any guidance
received from the Cannabis Advisory Council. An addition or modification by the office
under this subdivision becomes effective on August 1 of that year unless the legislature by
law provides otherwise.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 95.

Minnesota Statutes 2023 Supplement, section 342.54, is amended to read:


342.54 DUTIES OF deleted text begin DIVISION OF MEDICAL CANNABISdeleted text end new text begin OFFICE OF
CANNABIS MANAGEMENTnew text end ; REGISTRY PROGRAM.

Subdivision 1.

Duties related to health care practitioners.

The deleted text begin Division of Medical
Cannabisdeleted text end new text begin officenew text end must:

(1) provide notice of the registry program to health care practitioners in the state;

(2) allow health care practitioners to participate in the registry program if they request
to participate and meet the program's requirements;

(3) provide explanatory information and assistance to health care practitioners to
understand the nature of the therapeutic use of medical cannabis flower and medical
cannabinoid products within program requirements;

(4) make available to participating health care practitioners a certification form in which
a health care practitioner certifies that a patient has a qualifying medical condition; and

(5) supervise the participation of health care practitioners in the registry reporting system
in which health care practitioners report patient treatment and health records information
to the office in a manner that ensures stringent security and record keeping requirements
and that prevents the unauthorized release of private data on individuals as defined in section
13.02.

Subd. 2.

Duties related to the registry program.

The deleted text begin Division of Medical Cannabisdeleted text end new text begin
officenew text end must:

(1) administer the registry program according to section 342.52;

(2) provide information to patients enrolled in the registry program on the existence of
federally approved clinical trials for the treatment of the patient's qualifying medical condition
with medical cannabis flower or medical cannabinoid products as an alternative to enrollment
in the registry program;

(3) maintain safety criteria with which patients must comply as a condition of participation
in the registry program to prevent patients from undertaking any task under the influence
of medical cannabis flower or medical cannabinoid products that would constitute negligence
or professional malpractice;

(4) review and publicly report on existing medical and scientific literature regarding the
range of recommended dosages for each qualifying medical condition, the range of chemical
compositions of medical cannabis flower and medical cannabinoid products that will likely
be medically beneficial for each qualifying medical condition, and any risks of noncannabis
drug interactions. This information must be updated by December 1 deleted text begin of each yeardeleted text end new text begin every three
yearsnew text end . The office may consult with an independent laboratory under contract with the office
or other experts in reporting and updating this information; and

(5) annually consult with cannabis businesses about medical cannabis that the businesses
cultivate, manufacture, and offer for sale and post on the deleted text begin Division of Medical Cannabisdeleted text end new text begin
officenew text end website a list of the medical cannabis flower and medical cannabinoid products offered
for sale by each new text begin cannabis business with a new text end medical cannabis retailernew text begin endorsementnew text end .

Subd. 3.

Research.

(a) The deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end must conduct or contract
with a third party to conduct research and studies using data from health records submitted
to the registry program under section 342.55, subdivision 2, and data submitted to the registry
program under section 342.52, subdivisions 2 and 3. If the deleted text begin divisiondeleted text end new text begin officenew text end contracts with a
third party for research and studies, the third party must provide the deleted text begin divisiondeleted text end new text begin officenew text end with
access to all research and study results. The deleted text begin divisiondeleted text end new text begin officenew text end must submit reports on
intermediate or final research results to the legislature and major scientific journals. All
data used by the deleted text begin divisiondeleted text end new text begin officenew text end or a third party under this subdivision must be used or
reported in an aggregated nonidentifiable form as part of a scientific peer-reviewed
publication of research or in the creation of summary data, as defined in section 13.02,
subdivision 19.

(b) The deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end may submit medical research based on the
data collected under sections 342.55, subdivision 2, and data collected through the statewide
monitoring system to any federal agency with regulatory or enforcement authority over
medical cannabis flower and medical cannabinoid products to demonstrate the effectiveness
of medical cannabis flower or medical cannabinoid products for treating or alleviating the
symptoms of a qualifying medical condition.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 96.

Minnesota Statutes 2023 Supplement, section 342.55, subdivision 1, is amended
to read:


Subdivision 1.

Health care practitioner duties before patient enrollment.

Before a
patient's enrollment in the registry program, a health care practitioner must:

(1) determine, in the health care practitioner's medical judgment, whether a patient has
a qualifying medical condition and, if so determined, provide the patient with a certification
of that diagnosis;

(2) advise patients, registered designated caregivers, and parents, legal guardians, and
spouses acting as caregivers of any nonprofit patient support groups or organizations;

(3) provide to patients explanatory information from the deleted text begin Division of Medical Cannabisdeleted text end new text begin
officenew text end , including information about the experimental nature of the therapeutic use of medical
cannabis flower and medical cannabinoid products; the possible risks, benefits, and side
effects of the proposed treatment; and the application and other materials from the office;

(4) provide to patients a Tennessen warning as required under section 13.04, subdivision
2; and

(5) agree to continue treatment of the patient's qualifying medical condition and to report
findings to the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end .

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 97.

Minnesota Statutes 2023 Supplement, section 342.55, subdivision 2, is amended
to read:


Subd. 2.

Duties upon patient's enrollment in registry program.

Upon receiving
notification from the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end of the patient's enrollment in the
registry program, a health care practitioner must:

(1) participate in the patient registry reporting system under the guidance and supervision
of the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end ;

(2) report to the deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end patient health records throughout
the patient's ongoing treatment in a manner determined by the office and in accordance with
subdivision 4;

(3) determine deleted text begin on a yearly basisdeleted text end new text begin , every three years,new text end if the patient continues to have a
qualifying medical condition and, if so, issue the patient a new certification of that diagnosis.
The patient assessment conducted under this clause may be conducted via telehealth, as
defined in section 62A.673, subdivision 2; and

(4) otherwise comply with requirements established by the office deleted text begin of Cannabis
Management and the Division of Medical Cannabisdeleted text end .

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 98.

Minnesota Statutes 2023 Supplement, section 342.56, subdivision 1, is amended
to read:


Subdivision 1.

Limitations on consumption; locations of consumption.

(a) Nothing
in sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60 permits any person to engage in, and does not prevent
the imposition of any civil, criminal, or other penalties for:

(1) undertaking a task under the influence of medical cannabis flower or medical
cannabinoid products that would constitute negligence or professional malpractice;

(2) possessing or consuming medical cannabis flower or medical cannabinoid products:

(i) on a school bus or van;

(ii) in a correctional facility;

(iii) in a state-operated treatment program, including the Minnesota sex offender program;
or

(iv) on the grounds of a child care facility or family or group family day care program;

(3) vaporizing or smoking medical cannabis:

(i) on any form of public transportation;

(ii) where the vapor would be inhaled by a nonpatient minor or where the smoke would
be inhaled by a minor; or

(iii) in any public place, including any indoor or outdoor area used by or open to the
general public or a place of employment, as defined in section 144.413, subdivision 1b; and

(4) operating, navigating, or being in actual physical control of a motor vehicle, aircraft,
train, or motorboat or working on transportation property, equipment, or facilities while
under the influence of medical cannabis flower or a medical cannabinoid product.

(b) Except for the use of medical cannabis flower or medical cannabinoid products, the
vaporizing or smoking of cannabis flower, cannabis products, artificially derived
cannabinoids, or hemp-derived consumer products is prohibited in a multifamily housing
building, including balconies and patios appurtenant thereto. A violation of this paragraph
is punishable through a civil administrative fine in an amount of $250.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 99.

Minnesota Statutes 2023 Supplement, section 342.56, subdivision 2, is amended
to read:


Subd. 2.

Health care facilities.

(a) Health care facilities licensed under chapter 144A;
hospice providers licensed under chapter 144A; boarding care homes or supervised living
facilities licensed under section 144.50; assisted living facilities under chapter 144G; facilities
owned, controlled, managed, or under common control with hospitals licensed under chapter
144; and other health care facilities licensed by the commissioner of health or the
commissioner of human services may adopt reasonable restrictions on the use of medical
cannabis flower or medical cannabinoid products by a patient enrolled in the registry program
who resides at or is actively receiving treatment or care at the facility. The restrictions may
include a provision that the facility must not store or maintain a patient's supply of medical
cannabis flower or medical cannabinoid products on behalf of the patient; that a patient
store the patient's supply of medical cannabis flower or medicinal cannabinoid products in
a locked container accessible only to the patient, the patient's designated caregiver, or the
patient's parent, legal guardian, or spouse; that the facility is not responsible for providing
medical cannabis for patients; and that medical cannabis flower or medical cannabinoid
products are used only in a location specified by the facility or provider. Nothing in this
subdivision requires facilities and providers listed in this subdivision to adopt such
restrictions.

(b) No facility or provider listed in this subdivision may unreasonably limit a patient's
access to or use of medical cannabis flower or medical cannabinoid products to the extent
that such use is authorized under sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.59. No facility or provider
listed in this subdivision may prohibit a patient access to or use of medical cannabis flower
or medical cannabinoid products due solely to the fact that cannabis is a deleted text begin Schedule I drugdeleted text end new text begin
controlled substancenew text end pursuant to the federal Uniform Controlled Substances Act. If a federal
regulatory agency, the United States Department of Justice, or the federal Centers for
Medicare and Medicaid Services takes one of the following actions, a facility or provider
may suspend compliance with this paragraph until the regulatory agency, the United States
Department of Justice, or the federal Centers for Medicare and Medicaid Services notifies
the facility or provider that it may resume permitting the use of medical cannabis flower or
medical cannabinoid products within the facility or in the provider's service setting:

(1) a federal regulatory agency or the United States Department of Justice initiates
enforcement action against a facility or provider related to the facility's compliance with
the medical cannabis program; or

(2) a federal regulatory agency, the United States Department of Justice, or the federal
Centers for Medicare and Medicaid Services issues a rule or otherwise provides notification
to the facility or provider that expressly prohibits the use of medical cannabis in health care
facilities or otherwise prohibits compliance with the medical cannabis program.

(c) An employee or agent of a facility or provider listed in this subdivision or a person
licensed under chapter 144E is not violating this chapter or chapter 152 for the possession
of medical cannabis flower or medical cannabinoid products while carrying out employment
duties, including providing or supervising care to a patient enrolled in the registry program,
or distribution of medical cannabis flower or medical cannabinoid products to a patient
enrolled in the registry program who resides at or is actively receiving treatment or care at
the facility or from the provider with which the employee or agent is affiliated.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 100.

Minnesota Statutes 2023 Supplement, section 342.57, subdivision 1, is amended
to read:


Subdivision 1.

Presumption.

There is a presumption that a patient new text begin or other person
new text end enrolled in the registry program is engaged in the authorized use new text begin or possession new text end of medical
cannabis flower and medical cannabinoid products. This presumption may be rebutted by
evidence that the deleted text begin patient's use of medical cannabis flower or medical cannabinoid productsdeleted text end new text begin
use or possession of medical cannabis flower or medical cannabinoid products by a patient
or other person enrolled in the registry programnew text end was not for the purpose of new text begin assisting with,
new text end treatingnew text begin ,new text end or alleviating the patient's qualifying medical condition or symptoms associated
with the patient's qualifying medical condition.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 101.

Minnesota Statutes 2023 Supplement, section 342.57, subdivision 2, is amended
to read:


Subd. 2.

Criminal and civil protections.

(a) Subject to section 342.56, the following
are not violations of this chapter or chapter 152:

(1) use or possession of medical cannabis flower, medical cannabinoid products, or
medical cannabis paraphernalia by a patient enrolled in the registry program or by a visiting
patient to whom medical cannabis flower or medical cannabinoid products are distributed
under section 342.51, subdivision 5;

(2) possession of medical cannabis flower, medical cannabinoid products, or medical
cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or
spouse of a patient enrolled in the registry program; or

(3) possession of medical cannabis flower, medical cannabinoid products, or medical
cannabis paraphernalia by any person while carrying out duties required under sections
deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60.

(b) The Office of Cannabis Management, members of the Cannabis Advisory Council,
Office of Cannabis Management employees, agents or contractors of the Office of Cannabis
Management, and health care practitioners participating in the registry program are not
subject to any civil penalties or disciplinary action by the Board of Medical Practice, the
Board of Nursing, or any business, occupational, or professional licensing board or entity
solely for participating in the registry program either in a professional capacity or as a
patient. A pharmacist licensed under chapter 151 is not subject to any civil penalties or
disciplinary action by the Board of Pharmacy when acting in accordance with sections
deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60 either in a professional capacity or as a patient. Nothing in this
section prohibits a professional licensing board from taking action in response to a violation
of law.

(c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the
governor, or an employee of a state agency must not be held civilly or criminally liable for
any injury, loss of property, personal injury, or death caused by any act or omission while
acting within the scope of office or employment under sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60.

(d) Federal, state, and local law enforcement authorities are prohibited from accessing
the registry except when acting pursuant to a valid search warrant. Notwithstanding section
13.09, a violation of this paragraph is a gross misdemeanor.

(e) Notwithstanding any law to the contrary, the office and employees of the office must
not release data or information about an individual contained in any report or document or
in the registry and must not release data or information obtained about a patient enrolled in
the registry program, except as provided in sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60.
Notwithstanding section 13.09, a violation of this paragraph is a gross misdemeanor.

(f) No information contained in a report or document, contained in the registry, or
obtained from a patient under sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60 may be admitted as evidence
in a criminal proceeding, unless:

(1) the information is independently obtained; or

(2) admission of the information is sought in a criminal proceeding involving a criminal
violation of sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60.

(g) Possession of a registry verification or an application for enrollment in the registry
program:

(1) does not constitute probable cause or reasonable suspicion;

(2) must not be used to support a search of the person or property of the person with a
registry verification or application to enroll in the registry program; and

(3) must not subject the person or the property of the person to inspection by any
government agency.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 102.

Minnesota Statutes 2023 Supplement, section 342.57, subdivision 4, is amended
to read:


Subd. 4.

Medical care.

For purposes of medical care, including organ transplants, a
patient's use of medical cannabis flower or medical cannabinoid products according to
sections deleted text begin 342.47deleted text end new text begin 342.51new text end to 342.60 is considered the equivalent of the authorized use of a
medication used at the discretion of a health care practitioner and does not disqualify a
patient from needed medical care.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 103.

Minnesota Statutes 2023 Supplement, section 342.60, is amended to read:


342.60 APPLIED RESEARCH.

The deleted text begin Division of Medical Cannabisdeleted text end new text begin officenew text end may conduct, or award grants to health care
providers or research organizations to conduct, applied research on the safety and efficacy
of using medical cannabis flower or medical cannabinoid products to treat a specific health
condition. A health care provider or research organization receiving a grant under this section
must provide the office with access to all data collected in applied research funded under
this section. The office may use data from applied research conducted or funded under this
section as evidence to approve additional qualifying medical conditions or additional
allowable forms of medical cannabis.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2025.
 new text end

Sec. 104.

Minnesota Statutes 2023 Supplement, section 342.61, subdivision 1, is amended
to read:


Subdivision 1.

Testing required.

new text begin (a) new text end Cannabis businesses and hemp businesses shall
not sell or offer for sale cannabis flower, cannabis products, artificially derived cannabinoids,
lower-potency hemp edibles, or hemp-derived consumer products to another cannabis
business or hemp business, or to a customer or patient, or otherwise transfer cannabis flower,
cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or
hemp-derived consumer products to another cannabis business or hemp business, unless:

(1) a representative sample of the batch of cannabis flower, cannabis products, artificially
derived cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products
has been tested according to this section and rules adopted under this chapter;

(2) the testing was completed by a cannabis testing facility licensed under this chapternew text begin
or meeting the requirements of paragraph (b)new text end ; and

(3) the tested sample of cannabis flower, cannabis products, artificially derived
cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products was found
to meet testing standards established by the office.

new text begin (b) Testing of lower-potency hemp edibles and hemp-derived consumer products that
do not contain intoxicating cannabinoids may be performed by any laboratory that has been
accredited pursuant to standard ISO/IEC 17025 of the International Organization for
Standardization with specific accreditation for cannabis testing.
 new text end

Sec. 105.

Minnesota Statutes 2023 Supplement, section 342.61, subdivision 4, is amended
to read:


Subd. 4.

Testing of samples; disclosures.

(a) On a schedule determined by the office,
every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, deleted text begin medical cannabis cultivator, medical cannabis processor,deleted text end or
medical cannabis combination business shall make each batch of cannabis flower, cannabis
products, artificially derived cannabinoids, lower-potency hemp edibles, or hemp-derived
consumer products grown, manufactured, or imported by the cannabis business or hemp
business available to a cannabis testing facility.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, deleted text begin medical cannabis cultivator, medical cannabis processor,deleted text end or
medical cannabis combination business must disclose all known information regarding
pesticides, fertilizers, solvents, or other foreign materials, including but not limited to
catalysts used in creating artificially derived cannabinoids, applied or added to the batch of
cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency hemp
edibles, or hemp-derived consumer products subject to testing. Disclosure must be made
to the cannabis testing facility and must include information about all applications by any
person, whether intentional or accidental.

(c) The cannabis testing facility shall select one or more representative samples from
each batch, test the samples for the presence of contaminants, and test the samples for
potency and homogeneity and to allow the cannabis flower, cannabis product, artificially
derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product to be
accurately labeled with its cannabinoid profile. Testing for contaminants must include testing
for residual solvents, foreign material, microbiological contaminants, heavy metals, pesticide
residue, mycotoxins, and any items identified pursuant to paragraph (b), and may include
testing for other contaminants. A cannabis testing facility must destroy or return to the
cannabis business or hemp business any part of the sample that remains after testing.

Sec. 106.

Minnesota Statutes 2023 Supplement, section 342.61, subdivision 5, is amended
to read:


Subd. 5.

Test results.

(a) If a sample meets the applicable testing standards, a cannabis
testing facility shall issue a certification to a cannabis microbusiness, cannabis
mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis wholesaler with an
endorsement to import products, lower-potency hemp edible manufacturer, deleted text begin medical cannabis
cultivator, medical cannabis processor,deleted text end or medical cannabis combination business and the
cannabis business or hemp business may then sell or transfer the batch of cannabis flower,
cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or
hemp-derived consumer products from which the sample was taken to another cannabis
business or hemp business, or offer the cannabis flower, cannabis products, lower-potency
hemp edibles, or hemp-derived consumer products for sale to customers or patients. If a
sample does not meet the applicable testing standards or if the testing facility is unable to
test for a substance identified pursuant to subdivision 4, paragraph (b), the batch from which
the sample was taken shall be subject to procedures established by the office for such batches,
including destruction, remediation, or retesting.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, deleted text begin medical cannabis cultivator, medical cannabis processor,deleted text end or
medical cannabis combination business must maintain the test results for cannabis flower,
cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or
hemp-derived consumer products grown, manufactured, or imported by that cannabis
business or hemp business for at least five years after the date of testing.

(c) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
hemp edible manufacturer, deleted text begin medical cannabis cultivator, medical cannabis processor,deleted text end or
medical cannabis combination business shall make test results maintained by that cannabis
business or hemp business available for review by any member of the public, upon request.
Test results made available to the public must be in plain language.

Sec. 107.

Minnesota Statutes 2023 Supplement, section 342.62, is amended by adding a
subdivision to read:


new text begin Subd. 4. new text end

new text begin Prohibition of sale of certain empty packaging. new text end

new text begin No person shall sell, offer
for sale, or facilitate the sale of empty packaging that, if used, would be a violation of any
provision of this section. Enforcement of this subdivision is subject to section 8.31.
 new text end

Sec. 108.

Minnesota Statutes 2023 Supplement, section 342.63, subdivision 2, is amended
to read:


Subd. 2.

Content of label; cannabis.

All cannabis flower and hemp-derived consumer
products that consist of hemp plant parts sold to customers or patients must have affixed
on the packaging or container of the cannabis flower or hemp-derived consumer product a
label that contains at least the following information:

(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
cannabis cultivator, medical cannabis deleted text begin cultivatordeleted text end new text begin combination businessnew text end , or industrial hemp
grower where the cannabis flower or hemp plant part was cultivated;

(2) the net weight or volume of cannabis flower or hemp plant parts in the package or
container;

(3) the batch number;

(4) the cannabinoid profile;

(5) a universal symbol established by the office indicating that the package or container
contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
hemp-derived consumer product;

(6) verification that the cannabis flower or hemp plant part was tested according to
section 342.61 and that the cannabis flower or hemp plant part complies with the applicable
standards;

(7) deleted text begin the maximum dose, quantity, or consumption that may be considered medically safe
within a 24-hour perioddeleted text end new text begin information on the usage of the cannabis flower or hemp-derived
consumer productnew text end ;

(8) the following statement: "Keep this product out of reach of children."; and

(9) any other statements or information required by the office.

Sec. 109.

Minnesota Statutes 2023 Supplement, section 342.63, subdivision 3, is amended
to read:


Subd. 3.

Content of label; cannabinoid products.

(a) All cannabis products,
lower-potency hemp edibles, hemp-derived consumer products other than products subject
to the requirements under subdivision 2, medical cannabinoid products, and hemp-derived
topical products sold to customers or patients must have affixed to the packaging or container
of the cannabis product a label that contains at least the following information:

(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
cannabis cultivator, medical cannabis deleted text begin cultivatordeleted text end new text begin combination businessnew text end , or industrial hemp
grower that cultivated the cannabis flower or hemp plant parts used in the cannabis product,
lower-potency hemp edible, hemp-derived consumer product, or medical cannabinoid
product;

(2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis deleted text begin processordeleted text end new text begin
combination businessnew text end , or industrial hemp grower that manufactured the cannabis concentrate,
hemp concentrate, or artificially derived cannabinoid and, if different, the name and license
number of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer,
lower-potency hemp edible manufacturer, or medical cannabis deleted text begin processordeleted text end new text begin combination
businessnew text end that manufactured the product;

(3) the net weight or volume of the cannabis product, lower-potency hemp edible, or
hemp-derived consumer product in the package or container;

(4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer
product;

(5) the batch number;

(6) the serving size;

(7) the cannabinoid profile per serving and in total;

(8) a list of ingredients;

(9) a universal symbol established by the office indicating that the package or container
contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
hemp-derived consumer product;

(10) a warning symbol developed by the office in consultation with the commissioner
of health and the Minnesota Poison Control System that:

(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;

(ii) is in a highly visible color;

(iii) includes a visual element that is commonly understood to mean a person should
stop;

(iv) indicates that the product is not for children; and

(v) includes the phone number of the Minnesota Poison Control System;

(11) verification that the cannabis product, lower-potency hemp edible, hemp-derived
consumer product, or medical cannabinoid product was tested according to section 342.61
and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product,
or medical cannabinoid product complies with the applicable standards;

(12) deleted text begin the maximum dose, quantity, or consumption that may be considered medically
safe within a 24-hour perioddeleted text end new text begin information on the usage of the productnew text end ;

(13) the following statement: "Keep this product out of reach of children."; and

(14) any other statements or information required by the office.

(b) The office may by rule establish alternative labeling requirements for lower-potency
hemp edibles that are imported into the state deleted text begin provided thatdeleted text end new text begin ifnew text end those requirements provide
consumers with information that is substantially similar to the information described in
paragraph (a).

Sec. 110.

Minnesota Statutes 2023 Supplement, section 342.63, subdivision 6, is amended
to read:


Subd. 6.

Additional information.

(a) A cannabis microbusiness, cannabis mezzobusiness,
cannabis retailer, deleted text begin medical cannabis retailer,deleted text end or medical cannabis combination business must
provide customers and patients with the following information:

(1) factual information about impairment effects and the expected timing of impairment
effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products;

(2) a statement that customers and patients must not operate a motor vehicle or heavy
machinery while under the influence of cannabis flower, cannabis products, lower-potency
hemp edibles, and hemp-derived consumer products;

(3) resources customers and patients may consult to answer questions about cannabis
flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
products, and any side effects and adverse effects;

(4) contact information for the poison control center and a safety hotline or website for
customers to report and obtain advice about side effects and adverse effects of cannabis
flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
products;

(5) substance use disorder treatment options; and

(6) any other information specified by the office.

(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical
cannabis deleted text begin retailerdeleted text end new text begin combination businessnew text end may include the information described in paragraph
(a) on the label affixed to the packaging or container of cannabis flower, cannabis products,
lower-potency hemp edibles, and hemp-derived consumer products by:

(1) posting the information in the premises of the cannabis microbusiness, cannabis
mezzobusiness, cannabis retailer, deleted text begin medical cannabis retailer,deleted text end or medical cannabis combination
business; or

(2) providing the information on a separate document or pamphlet provided to customers
or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency
hemp edible, or a hemp-derived consumer product.

Sec. 111.

Minnesota Statutes 2023 Supplement, section 342.64, subdivision 1, is amended
to read:


Subdivision 1.

Limitations applicable to all advertisements.

Cannabis businesses,
hemp businesses, and other persons shall not publish or cause to be published an
advertisement for a cannabis business, a hemp business, cannabis flower, a cannabis product,
a lower-potency hemp edible, or a hemp-derived consumer product in a manner that:

(1) contains false or misleading statements;

(2) contains unverified claims about the health or therapeutic benefits or effects of
consuming cannabis flower, a cannabis product, a lower-potency hemp edible, or a
hemp-derived consumer product;

(3) promotes the overconsumption of cannabis flower, a cannabis product, a
lower-potency hemp edible, or a hemp-derived consumer product;

(4) depicts a person under 21 years of age consuming cannabis flower, a cannabis product,
a lower-potency hemp edible, or a hemp-derived consumer product; or

(5) includes an image designed or likely to appeal to individuals under 21 years of age,
including cartoons, toys, animals, new text begin candy, dessert, new text end or children, or any other likeness to images,
characters, or phrases that is designed to be appealing to individuals under 21 years of age
or encourage consumption by individuals under 21 years of age; deleted text begin and
deleted text end

(6) new text begin contains an image of alcohol or a person or persons consuming alcohol; and
new text end

new text begin (7) new text end does not contain a warning as specified by the office regarding impairment and health
risks.

Sec. 112.

Minnesota Statutes 2023 Supplement, section 342.73, subdivision 4, is amended
to read:


Subd. 4.

Loan financing grants.

(a) The CanGrow revolving loan account is established
in the special revenue fund. Money in the account, including interest, is appropriated to the
deleted text begin commissionerdeleted text end new text begin officenew text end to make loan financing grants under the CanGrow program.

(b) The office must award grants to nonprofit corporations through a competitive grant
process.

(c) To receive grant money, a nonprofit corporation must submit a written application
to the office using a form developed by the office.

(d) In awarding grants under this subdivision, the office shall give weight to whether
the nonprofit corporation:

(1) has a board of directors that includes individuals experienced in agricultural business
development;

(2) has the technical skills to analyze projects;

(3) is familiar with other available public and private funding sources and economic
development programs;

(4) can initiate and implement economic development projects;

(5) can establish and administer a revolving loan account; and

(6) has established relationships with communities where long-term residents are eligible
to be social equity applicants.

The office shall make grants that will help farmers enter the legal cannabis industry
throughout the state.

(e) A nonprofit corporation that receives grants under the program must:

(1) establish an office-certified revolving loan account for the purpose of making eligible
loans; and

(2) enter into an agreement with the office that the office shall fund loans that the
nonprofit corporation makes to farmers entering the legal cannabis industry. The office shall
review existing agreements with nonprofit corporations every five years and may renew or
terminate an agreement based on that review. In making this review, the office shall consider,
among other criteria, the criteria in paragraph (d).

Sec. 113.

Minnesota Statutes 2023 Supplement, section 342.80, is amended to read:


342.80 LAWFUL ACTIVITIES.

(a) Notwithstanding any law to the contrary, the cultivation, manufacturing, possessing,
and selling of cannabis flower, cannabis products, artificially derived cannabinoids,
lower-potency hemp edibles, and hemp-derived consumer products by a licensed cannabis
business or hemp business in conformity with the rights granted by a cannabis business
license or hemp business license is lawful and may not be the grounds for the seizure or
forfeiture of property, arrest or prosecution, or search or inspections except as provided by
this chapter.

(b) A person acting as an agent of a cannabis microbusiness, cannabis mezzobusiness,
cannabis retailer, new text begin medical cannabis combination business, new text end or lower-potency hemp edible
retailer who sells or otherwise transfers cannabis flower, cannabis products, lower-potency
hemp edibles, or hemp-derived consumer products to a person under 21 years of age is not
subject to arrest, prosecution, or forfeiture of property if the person complied with section
342.27, subdivision 4, and any rules promulgated pursuant to this chapter.

Sec. 114.

Laws 2023, chapter 63, article 1, section 2, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective July 1, 2023deleted text begin , except for subdivision 3,
which is effective March 1, 2025deleted text end .

Sec. 115.

Laws 2023, chapter 63, article 1, section 51, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective deleted text begin Marchdeleted text end new text begin Julynew text end 1, 2025.

Sec. 116.

Laws 2023, chapter 63, article 1, section 52, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective deleted text begin March 1, 2025deleted text end new text begin the day following final
enactmentnew text end .

Sec. 117.

Laws 2023, chapter 63, article 1, section 53, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective deleted text begin Marchdeleted text end new text begin Julynew text end 1, 2025.

Sec. 118.

Laws 2023, chapter 63, article 1, section 54, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective deleted text begin Marchdeleted text end new text begin Julynew text end 1, 2025.

Sec. 119.

Laws 2023, chapter 63, article 1, section 55, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective deleted text begin Marchdeleted text end new text begin Julynew text end 1, 2025.

Sec. 120.

Laws 2023, chapter 63, article 1, section 56, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective deleted text begin Marchdeleted text end new text begin Julynew text end 1, 2025.

Sec. 121.

Laws 2023, chapter 63, article 1, section 57, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective deleted text begin Marchdeleted text end new text begin Julynew text end 1, 2025.

Sec. 122.

Laws 2023, chapter 63, article 1, section 58, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective deleted text begin Marchdeleted text end new text begin Julynew text end 1, 2025.

Sec. 123.

Laws 2023, chapter 63, article 1, section 59, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective deleted text begin Marchdeleted text end new text begin Julynew text end 1, 2025.

Sec. 124.

Laws 2023, chapter 63, article 1, section 61, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective deleted text begin Marchdeleted text end new text begin Julynew text end 1, 2025.

Sec. 125.

Laws 2023, chapter 63, article 6, section 10, the effective date, is amended to
read:


EFFECTIVE DATE.

This section is effective deleted text begin Marchdeleted text end new text begin Julynew text end 1, deleted text begin 2025deleted text end new text begin 2024new text end .

Sec. 126.

Laws 2023, chapter 63, article 6, section 73, the effective date, is amended to
read:


EFFECTIVE DATE.

Paragraph (a) is effective deleted text begin Marchdeleted text end new text begin Decembernew text end 1, 2025. Paragraph
(b) is effective August 1, 2023. Paragraph (c) is effective July 1, 2023.

Sec. 127. new text begin EMPLOYEE TRANSFER.
new text end

new text begin (a) The powers and duties of the Department of Health with respect to the sale of certain
cannabinoid products under Minnesota Statutes, section 151.72, are transferred to the Office
of Cannabis Management under Minnesota Statutes, section 15.039.
 new text end

new text begin (b) The following protections shall apply to employees who are transferred from the
Department of Health to the Office of Cannabis Management:
 new text end

new text begin (1) the employment status and job classification of a transferred employee shall not be
altered as a result of the transfer;
 new text end

new text begin (2) transferred employees who were represented by an exclusive representative prior to
the transfer shall continue to be represented by the same exclusive representative after the
transfer;
 new text end

new text begin (3) the applicable collective bargaining agreements with exclusive representatives shall
continue in full force and effect for such transferred employees after the transfer;
 new text end

new text begin (4) the state must meet and negotiate with the exclusive representatives of the transferred
employees about any proposed changes affecting or relating to the transferred employees'
terms and conditions of employment to the extent such changes are not addressed in the
applicable collective bargaining agreement; and
 new text end

new text begin (5) for an employee in a temporary unclassified position transferred to the Office of
Cannabis Management, the total length of time that the employee has served in the
appointment shall include all time served in the appointment at the transferring agency and
the time served in the appointment at the Office of Cannabis Management. An employee
in a temporary unclassified position who was hired by a transferring agency through an
open competitive selection process in accordance with a policy enacted by Minnesota
Management and Budget shall be considered to have been hired through such process after
the transfer.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 128. new text begin TRANSFER OF ACTIVE AND INACTIVE COMPLAINTS.
new text end

new text begin The Department of Health shall transfer all data, including not public data as defined in
Minnesota Statutes, section 13.02, subdivision 8a, on active complaints and inactive
complaints involving alleged violations of Minnesota Statutes 2023 Supplement, section
151.72, as well as registration data collected under Minnesota Statutes 2023 Supplement,
section 151.72, subdivision 5b, to the Office of Cannabis Management. The Department of
Health and the Office of Cannabis Management shall ensure that the transfer takes place in
a manner and on a schedule that prioritizes public health.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2024.
 new text end

Sec. 129. new text begin TRANSFER OF MEDICAL PROGRAM.
new text end

new text begin (a) Notwithstanding the data's classification under Minnesota Statutes, chapter 13, the
Office of Cannabis Management may access data maintained by the commissioner of health
related to the responsibilities transferred under Minnesota Statutes, section 342.02,
subdivision 3. Data sharing authorized by this subdivision includes not public data as defined
in Minnesota Statutes, section 13.02, subdivision 8a, on active complaints and inactive
complaints involving any alleged violation of Minnesota Statutes, sections 152.22 to 152.37,
by a medical cannabis manufacturer. Data sharing under this paragraph further includes
data in patient files maintained by the commissioner and the health care practitioner and
data submitted to or by a medical cannabis manufacturer classified as private data on
individuals, as defined in Minnesota Statutes, section 13.02, subdivision 12, or nonpublic
data, as defined in Minnesota Statutes, section 13.02, subdivision 9. Any data shared under
this section retain the data's classification from the agency holding the data. The office must
establish written procedures to ensure that only individuals authorized by law may enter,
update, or access data classified as nonpublic or private data on individuals. An authorized
individual's ability to enter, update, or access not public data must correspond to the official
duties or training level of the individual and to the statutory authorization granting access
for that purpose. All queries and responses, and all actions in which not public data are
entered, updated, accessed, shared, or disseminated, must be recorded in a data audit trail.
Data contained in the audit trail have the same classification as the underlying data tracked
by the audit trail.
 new text end

new text begin (b) All rules adopted by the commissioner of health pursuant to Minnesota Statutes,
sections 152.22 to 152.37, including but not limited to Minnesota Rules, chapter 4770,
remain effective and shall be enforced until amended or repealed consistent with Minnesota
Statutes, section 15.039, subdivision 3.
 new text end

new text begin (c) The director of the Office of Cannabis Management may use the good cause exempt
rulemaking process under Minnesota Statutes, section 14.388, subdivision 1, clauses (3)
and (4), to copy and adopt any portions of Minnesota Rules, parts 4770.0100 to 4770.4030,
that are necessary to effectuate the transfer of authority granted under Minnesota Statutes,
section 342.02, subdivision 3. The commissioner may make technical changes and any
changes necessary to conform with the transfer of authority. Any change to the rules that
is not authorized under this paragraph must be adopted according to Minnesota Statutes,
sections 14.001 to 14.366.
 new text end

new text begin (d) Unless otherwise specified in this section or Minnesota Statutes, section 342.02,
subdivision 3, transfer of the powers, duties, rights, obligations, and other authority imposed
by law on the Department of Health with respect to the medical cannabis program under
Minnesota Statutes 2022, sections 152.22 to 152.37, to the Office of Cannabis Management
is subject to Minnesota Statutes, section 15.039.
 new text end

Sec. 130. new text begin REPEALER.
new text end

new text begin (a) new text end new text begin Minnesota Statutes 2022, sections 152.22, subdivision 3; and 152.36, new text end new text begin are repealed.
 new text end

new text begin (b) new text end new text begin Minnesota Statutes 2023 Supplement, sections 342.01, subdivision 28; 342.18,
subdivision 1; 342.27, subdivision 13; and 342.29, subdivision 9, new text end new text begin are repealed.
 new text end

new text begin (c) new text end new text begin Minnesota Statutes 2023 Supplement, sections 342.47; 342.48; 342.49; and 342.50, new text end new text begin
are repealed.
 new text end

new text begin (d) new text end new text begin Laws 2023, chapter 63, article 7, sections 4; and 6, new text end new text begin are repealed.
 new text end

new text begin EFFECTIVE DATE. new text end

new text begin Paragraphs (a), (b), and (d) are effective the day following final
enactment. Paragraph (c) is effective July 1, 2025.
 new text end

Sec. 131. new text begin EFFECTIVE DATE.
new text end

new text begin Except as otherwise provided, this act is effective the day following final enactment.
 new text end

APPENDIX

Repealed Minnesota Statutes: H4757-3

152.22 DEFINITIONS.

Subd. 3.

Disqualifying felony offense.

"Disqualifying felony offense" means a violation of a state or federal controlled substance law that is a felony under Minnesota law, or would be a felony if committed in Minnesota, regardless of the sentence imposed, unless the commissioner determines that the person's conviction was for the medical use of cannabis or assisting with the medical use of cannabis.

152.36 IMPACT ASSESSMENT OF MEDICAL CANNABIS THERAPEUTIC RESEARCH.

Subdivision 1.

Task force on medical cannabis therapeutic research.

(a) A 23-member task force on medical cannabis therapeutic research is created to conduct an impact assessment of medical cannabis therapeutic research. The task force shall consist of the following members:

(1) two members of the house of representatives, one selected by the speaker of the house, the other selected by the minority leader;

(2) two members of the senate, one selected by the majority leader, the other selected by the minority leader;

(3) four members representing consumers or patients enrolled in the registry program, including at least two parents of patients under age 18;

(4) four members representing health care providers, including one licensed pharmacist;

(5) four members representing law enforcement, one from the Minnesota Chiefs of Police Association, one from the Minnesota Sheriff's Association, one from the Minnesota Police and Peace Officers Association, and one from the Minnesota County Attorneys Association;

(6) four members representing substance use disorder treatment providers; and

(7) the commissioners of health, human services, and public safety.

(b) Task force members listed under paragraph (a), clauses (3), (4), (5), and (6), shall be appointed by the governor under the appointment process in section 15.0597. Members shall serve on the task force at the pleasure of the appointing authority. All members must be appointed by July 15, 2014, and the commissioner of health shall convene the first meeting of the task force by August 1, 2014.

(c) There shall be two cochairs of the task force chosen from the members listed under paragraph (a). One cochair shall be selected by the speaker of the house and the other cochair shall be selected by the majority leader of the senate. The authority to convene meetings shall alternate between the cochairs.

(d) Members of the task force other than those in paragraph (a), clauses (1), (2), and (7), shall receive expenses as provided in section 15.059, subdivision 6.

Subd. 1a.

Administration.

The commissioner of health shall provide administrative and technical support to the task force.

Subd. 2.

Impact assessment.

The task force shall hold hearings to evaluate the impact of the use of medical cannabis and hemp and Minnesota's activities involving medical cannabis and hemp, including, but not limited to:

(1) program design and implementation;

(2) the impact on the health care provider community;

(3) patient experiences;

(4) the impact on the incidence of substance abuse;

(5) access to and quality of medical cannabis, hemp, and medical cannabis products;

(6) the impact on law enforcement and prosecutions;

(7) public awareness and perception; and

(8) any unintended consequences.

Subd. 3.

Cost assessment.

By January 15 of each year, beginning January 15, 2015, and ending January 15, 2019, the commissioners of state departments impacted by the medical cannabis therapeutic research study shall report to the cochairs of the task force on the costs incurred by each department on implementing sections 152.22 to 152.37. The reports must compare actual costs to the estimated costs of implementing these sections and must be submitted to the task force on medical cannabis therapeutic research.

Subd. 4.

Reports to the legislature.

(a) The cochairs of the task force shall submit the following reports to the chairs and ranking minority members of the legislative committees and divisions with jurisdiction over health and human services, public safety, judiciary, and civil law:

(1) by February 1, 2015, a report on the design and implementation of the registry program; and every two years thereafter, a complete impact assessment report; and

(2) upon receipt of a cost assessment from a commissioner of a state agency, the completed cost assessment.

(b) The task force may make recommendations to the legislature on whether to add or remove conditions from the list of qualifying medical conditions.

Subd. 5.

No expiration.

The task force on medical cannabis therapeutic research does not expire.

342.01 DEFINITIONS.

Subd. 28.

Division of Medical Cannabis.

"Division of Medical Cannabis" means a division housed in the Office of Cannabis Management that operates the medical cannabis program.

342.18 LICENSE SELECTION CRITERIA.

Subdivision 1.

Market stability.

The office shall issue the necessary number of licenses in order to ensure the sufficient supply of cannabis flower and cannabis products to meet demand, provide market stability, ensure a competitive market, and limit the sale of unregulated cannabis flower and cannabis products.

342.27 RETAIL SALE OF CANNABIS FLOWER AND PRODUCTS; GENERAL REQUIREMENTS.

Subd. 13.

Adult-use and medical cannabis; colocation.

(a) A cannabis business with a license or endorsement authorizing the retail sale of adult-use cannabis flower or adult-use cannabis products that is also a licensed medical cannabis retailer may sell medical cannabis flower and medical cannabinoid products on a portion of the business's premises.

(b) The premises must provide an appropriate space for a pharmacist employee of the medical cannabis retailer to consult with a patient to determine the proper type of medical cannabis flower and medical cannabinoid products and proper dosage for the patient.

342.29 CANNABIS MEZZOBUSINESS LICENSING AND OPERATIONS.

Subd. 9.

Medical cannabis endorsement.

A cannabis mezzobusiness that cultivates cannabis plants for use as medical cannabis flower or for use in medical cannabinoid products, processes medical cannabinoid products, or both, must comply with sections 342.49, paragraph (d); 342.50, paragraph (c), and any additional requirements established by the office.

342.47 MEDICAL CANNABIS BUSINESS LICENSES.

Subdivision 1.

License types.

(a) The office shall issue the following types of medical cannabis business licenses:

(1) medical cannabis cultivator;

(2) medical cannabis processor;

(3) medical cannabis retailer; and

(4) medical cannabis combination business license.

(b) The Division of Medical Cannabis may oversee the licensing and regulation of medical cannabis businesses.

Subd. 2.

Multiple licenses; limits.

(a) Except as provided in subdivision 3, a person, cooperative, or business holding:

(1) a medical cannabis cultivator license may also hold a medical cannabis processor license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses;

(2) a medical cannabis processor license may also hold a medical cannabis cultivator license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses; or

(3) a medical cannabis retailer license may also hold a cannabis mezzobusiness license, a cannabis retailer license, a cannabis delivery service license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses.

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a medical cannabis license may own or operate any other cannabis business or hemp business.

(c) The office by rule may limit the number of medical cannabis business licenses that a person or business may hold.

(d) For purposes of this subdivision, a restriction on the number of licenses or type of license that a business may hold applies to every cooperative member or every director, manager, and general partner of a medical cannabis business.

Subd. 3.

Medical cannabis combination business license.

(a) A person, cooperative, or business holding a medical cannabis combination license is prohibited from owning or operating any other cannabis business or hemp business.

(b) A person or business may only hold one medical cannabis combination license.

342.48 MEDICAL CANNABIS BUSINESS APPLICATIONS.

In addition to the information required to be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, a person, cooperative, or business seeking a medical cannabis business license must submit the following information in a form approved by the office:

(1) for medical cannabis cultivator license applicants:

(i) an operating plan demonstrating the proposed size and layout of the cultivation facility; plans for wastewater and waste disposal for the cultivation facility; plans for providing electricity, water, and other utilities necessary for the normal operation of the cultivation facility; and plans for compliance with applicable building code and federal and state environmental and workplace safety requirements;

(ii) a cultivation plan demonstrating the proposed size and layout of the cultivation facility that will be used exclusively for cultivation for medical cannabis, including the total amount of plant canopy; and

(iii) evidence that the business will comply with the applicable operation requirements for the license being sought;

(2) for medical cannabis processor license applicants:

(i) an operating plan demonstrating the proposed layout of the facility, including a diagram of ventilation and filtration systems; plans for wastewater and waste disposal for the manufacturing facility; plans for providing electricity, water, and other utilities necessary for the normal operation of the manufacturing facility; and plans for compliance with applicable building code and federal and state environmental and workplace safety requirements;

(ii) all methods of extraction and concentration that the applicant intends to use and the volatile chemicals, if any, that are involved in extraction or concentration;

(iii) if the applicant is seeking an endorsement to manufacture products infused with cannabinoids for consumption by patients enrolled in the registry program, proof of an edible cannabinoid product handler endorsement from the office; and

(iv) evidence that the applicant will comply with the applicable operation requirements for the license being sought;

(3) for medical cannabis retailer license applicants:

(i) a list of every retail license held by the applicant and, if the applicant is a business, every retail license held, either as an individual or as part of another business, by each officer, director, manager, and general partner of the cannabis business;

(ii) an operating plan demonstrating the proposed layout of the facility, including a diagram of ventilation and filtration systems, policies to avoid sales to individuals who are not authorized to receive the distribution of medical cannabis flower or medical cannabinoid products, identification of a restricted area for storage, and plans to prevent the visibility of cannabis flower and cannabinoid products; and

(iii) evidence that the applicant will comply with the applicable operation requirements for the license being sought; or

(4) for medical cannabis combination license applicants:

(i) the information required under clauses (1) to (3); and

(ii) any additional information required under sections 342.30, subdivision 3; 342.31, subdivision 3; and 342.32, subdivision 3.

342.49 MEDICAL CANNABIS CULTIVATORS.

(a) A medical cannabis cultivator license entitles the license holder to grow cannabis plants within the approved amount of space up to 60,000 square feet of plant canopy from seed or immature plant to mature plant, harvest cannabis flower from a mature plant, package and label cannabis flower as medical cannabis flower, sell medical cannabis flower to medical cannabis processors and medical cannabis retailers, transport medical cannabis flower to a medical cannabis processor located on the same premises, and perform other actions approved by the office.

(b) A medical cannabis cultivator license holder must comply with all requirements of section 342.25.

(c) A medical cannabis cultivator license holder must verify that every batch of medical cannabis flower has passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabis flower before the medical cannabis cultivator may package, label, or sell the medical cannabis flower to any other entity.

(d) A medical cannabis cultivator may exceed the limit of 60,000 square feet of plant canopy if it was legally cultivating medical cannabis with a greater plant canopy as of April 1, 2023.

342.50 MEDICAL CANNABIS PROCESSORS.

(a) A medical cannabis processor license, consistent with the specific license endorsement or endorsements, entitles the license holder to:

(1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts, and hemp concentrate from medical cannabis cultivators and other medical cannabis processors;

(2) purchase hemp plant parts from industrial hemp growers;

(3) make cannabis concentrate from medical cannabis flower;

(4) make hemp concentrate, including hemp concentrate with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;

(5) manufacture medical cannabinoid products;

(6) package and label medical cannabinoid products for sale to other medical cannabis processors and to medical cannabis retailers; and

(7) perform other actions approved by the office.

(b) A medical cannabis processor license holder must comply with all requirements of section 342.26, including requirements to obtain specific license endorsements.

(c) A medical cannabis processor license holder must verify that every batch of medical cannabinoid product has passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabinoid products before the medical cannabis processor may package, label, or sell the medical cannabinoid product to any other entity.

Repealed Minnesota Session Laws: H4757-3

Laws 2023, chapter 63, article 7, section 4

Sec. 4. new text begin EDIBLE CANNABINOID PRODUCTS; ENFORCEMENT.new text end

new text begin (a) The Department of Health shall enforce the provisions of Minnesota Statutes, section 151.72, and all rules, orders, stipulation agreements, settlements, compliance agreements, and registrations related to that section adopted or issued by the Office of Medical Cannabis or the Department of Health pursuant to the Health Enforcement Consolidation Act of 1993 contained in Minnesota Statutes, sections 144.989 to 144.993, and the authority to embargo products described in paragraph (b). The commissioner of health may assign enforcement responsibilities to the Office of Medical Cannabis. new text end

new text begin (b) Whenever a duly authorized agent of the Department of Health finds or has probable cause to believe that any product is being sold in violation of the provisions of Minnesota Statutes, section 151.72, the agent shall affix thereto an appropriate marking, giving notice that the article is, or is suspected of being in violation of Minnesota Statutes, section 151.72, has been embargoed, and warning that it is unlawful for any person to remove or dispose of the embargoed article by sale or otherwise without permission from the agent or the court. When an agent of the Department of Health has embargoed an article, the Department of Health shall, within 30 days, petition the district court in whose jurisdiction the article is embargoed for an order of condemnation. When an embargoed article is not so found by the agent, the agent shall remove the marking. If the court finds that an embargoed article is being sold in violation of the provisions of Minnesota Statutes, section 151.72, the article shall be destroyed at the expense of the claimant thereof, who shall also pay all court costs and fees, storage, and other proper expenses. If the violation can be corrected by proper labeling or processing of the article, or by filing the proper documents with the court, the court, after the costs, fees, and expenses have been paid and a sufficient bond has been executed, may order that the article be delivered to the claimant for labeling, processing, or filing under supervision of an agent of the board. The expense of the supervision shall be paid by the claimant. The bond shall be returned to the claimant on the representation to the court by the board that the article is no longer in violation of this chapter and that the expenses of supervision have been paid. new text end

new text begin (c) The enforcement authority under paragraphs (a) and (b) shall transfer to the Office of Cannabis Management at any such time that the powers and duties of the Department of Health with respect to the medical cannabis program under Minnesota Statutes, sections 152.22 to 152.37, are transferred to the Office of Cannabis Management. The director of the Office of Cannabis Management may assign enforcement responsibilities to the Division of Medical Cannabis. new text end

new text begin (d) This section shall expire on March 1, 2025. new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective the day following final enactment. new text end

Laws 2023, chapter 63, article 7, section 6

Sec. 6. new text begin REPEALER.new text end

new text begin Minnesota Statutes 2022, section 151.72, new text end new text begin is repealed. new text end

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective March 1, 2025. new text end